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Hormonal Determinants of Successful ~<>ing in lV!en: Introduction 
The average length of human life is currently 75 to 78 years and may increase to 85 
years during the coming two decades {1). but it is not clear whether these additional 
years will be satisfying to live. Most data indicate modest gain in the number of healthy 
years lived but a far greater increase in years of compromised physicaL mental and 
social function (2). The number of days of restricted activity and the number of 
admissions to hospitals and nursing homes sharply increases after age 70 (3). One U.S. 
health interview survey indicates that. at present, more than 25 million aging people 
suffer from physical impairment. whereas the number of people requiring assistance in 
activities of daily living increases from 14% at age 65 to 75 to 45% in those over 85 years 
old (4). 
Aging and Physical Frailty 
Throughout adult life. all physiological functions gradually decline (5). There is a 
diminished capacity for cellular protein synthesis. a decline in immune function, an 
increase in fat mass. a loss of muscle mass and strength. and a decrease in bone mineral 
density (5). Most elderly individuals will die from atherosclerosis, cancer or dementia: 
but in an increasing number of the healthy oldest old. loss of muscle strength is the 
limiting factor that determines their chances of living an independent life until death. 
Age~related disability is characterized by generalized weakness. impaired mobility 
and balance and poor endurance. In the oldest old. this state is called physical frailty, 
which is defined as "a state of reduced physiological reserves associated vvith an 
increased susceptibility to disability" (6). Clinical correlates of physical frailty include 
falls. fractures. impairment in activities of daily living, and loss of independence; falls 
contribute to 40% of admissions to nursing homes (7). 
Loss of muscle strength is an important factor in the process of frailty. Muscle 
weakness can be caused by aging of the muscle fibers and their innervation, 
osteoarthritis, and chronic debilitating diseases (8). However. a sedentary lifestyle and 
decreased physical activity and disuse are also important determinants of the decline in 
muscle strength. In a study of 100 frail nursing home residents (average age 87 years). 
lower-extremity muscle mass and strength were closely related (9). Supervised 
resistance exercise training (for 45 min three times per week for 10 weeks) doubled 
muscle strength and significantly increased gait velocity and stair~climbing power. This 
demonstrates that frailty in the elderly is not an irreversible effect of aging and disease 
but can be reduced and perhaps even prevented {9). Also, among non-disabled elderly 
people living in the community, objective measures of lower~eA"tremity function are 
highly predictive of subsequent disability (10). Prevention of frailty can be achieved only 
by exercise. However. exercise is difficult to implement in the daily routine of the aging 
population. and the number of dropouts from exercise programs is very high (11). 
Part of the aging process affecting body composition (loss of muscle size and strength. 
loss of bone. and increase in fat mass) might also be related to changes in the endocrine 
system (6.12). 
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Endocrinology of Aging 
One of the clinically most important changes in endocrine activity during aging 
involves the pancreas. Approximately 40% of individuals 65 to 74 years old and 50% of 
individuals older than 80 years have impaired glucose tolerance or diabetes mellitus, 
and nearly half of elderly diabetics are undiagnosed (13.14). These persons are at risk of 
developing secondary. mainly macrovascular. complications at an accelerated rate (15). 
Apart from decreased (relative) insulin secretion by the ~ cells, peripheral insulin 
resistance related to poor diet. physical inactivity, increased abdominal fat mass. and 
decreased lean body mass contribute to the deterioration of glucose metabolism (15.16). 
The changes in insulin sensitivity that occur in the aging population are frequently of 
clinical importance and are recognized and treated as diseases. Three other hormonal 
systems show decreasing circulating hormone concentrations during normal aging, and 
these changes have been considered mainly physiological (Figure 1). In recent years. 
hormone replacement strategies have been developed. but many of their aspects remain 
controversial. and increasing hormone blood levels to those found in 30- to 50-year-old 
individuals has not yet been uniformly proven to be safe and of benefit. 
The most dramatic and rapidly occurring change in women around the age of 50 is 
menopause (17). Cycling estradiol (E2) production during the reproductive years is 
replaced by very low. constant E2. For many years. the prevailing view was that 
menopause resulted from an exhaustion of ovarian follicles. An alternative perspective is 
that age-related changes in the central nervous system and the hypothalamo-pituitary 
unit initiate the menopausal transition. The evidence that both the ovary and the brain 
are key pacemakers in menopause is compelling (18). Changes in the activity of the 
hypothalamo-pituitary-gonadal a..-.::is in males are slower and more subtle. During aging. 
a gradual decline in serum total and free testosterone (T) levels occurs (19). This 
··andropause'' is characterized by a decrease in testicular Leydig cell numbers and in 
their secretory capacity, as well as by an age-related decrease in episodic and stimulated 
gonadotropin secretion (20). 
The second hormonal system demonstrating age-related changes is the circulating 
levels of dehydroepiandrosterone (DHEA) and its sulphate (DHEAS). which gradually 
decline with age. resulting in ''adrenopause'' (21.22). Adrenal secretion of DHEA 
gradually decreases over time, whereas adrenocorticotropin (ACTH) secretion. which is 
physiologically linked to plasma cortisol levels. remains largely unchanged. The decline 
in DHEA(S) levels in both sexes contrasts therefore with the maintenance of plasma 
cortisol levels and seems to be caused by a selective decrease in the number of functional 
zona reticularis cells in the adrenal cortex rather than regulated by a central 
(hypothalamic) pacemaker of aging (21). 
The third endocrine system that gradually declines in activity during aging is the 
growth hormone (GH)/insu!in-like growth factor I (IGF-I) axis (23). Mean pulse 
amplitude. duration, and free fraction of GH secreted. but not pulse frequency. gradually 
decrease during aging. In paralleL there is a progressive fall in circulating IGF-I levels 
in both sexes (23). There is no evidence for a "peripheral" factor in this process of 
''somatopause", and its triggering pacemaker seems mainly localized in the 
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hypothalamus, because pituitary somatotrophic cells, even of the oldest old, can be 
restored to their youthful secretory capacity during treatment with GH-releasing 
peptides. 
We do not know whether the changes in gonadal function (menopause and 
andropause) are interrelated with the processes of adrenopause and somatopause. which 
occur in both sexes. In addition. functional correlates (such as muscle size and function. 
fat and bone mass. progression of atherosclerosis, and changes in cognitive function) 
have not been related to these changes in endocrine activity. However, a number of 
effects of normal aging closely resemble features of (isolated) hormonal deficiency (such 
as hypogonadism and GH deficiency), which in mid-adult patients are successfully 
reversed by replacement therapy with the appropriate hormone (24). Although aging 
does not simply result from a variety of hormone deficiency states, medical intervention 
in the processes of meno-. andro-, adreno-. or somatopause might successfully prevent or 
delay some aspects of the aging process. 
"Andropause" 
Luteinizing hormone (LH) is secreted in pulses by the pituitary after stimulation by 
LH releasing hormone (LHRH) secreted by the hypothalamus. Pulsatile secretion of 
follicle stimulating hormone (FSH) is temporally coupled to that of LH but lower in 
amplitude. LH stimulates testosterone secretion by the Leydig cells of the testis. The 
control of LH in men operates primarily by negative feedback of both testosterone and 
estradiol. 
Both cross-sectional (19) and longitudinal (25) studies have shown that in healthy 
males mean serum total testosterone (T) levels decrease by about 30% between age 25 
and 75, whereas mean serum free T (FT) levels decrease by as much as 50% over the 
same period. The variability in circulating (free) T levels among elderly is considerable. 
however. The steeper decline of FT levels compared to that of total T levels is explained 
by an age-associated increase in sex-hormone binding globulin (SHBG) binding capacity 
(26). Genetics appear to play an important role in determination ofT levels. The age-
related decrease in T secretion in elderly men is the consequence of both primary 
testicular changes (decreased number of Leydig cells), and an altered neuroendocrine 
regulation of Leydig cell function with inappropriate LH secretory response to prevailing 
hypoandrogenism. In the presence of an inadequate neuroendocrine response to 
decreased T levels, the independent progressive increase of plasma SHBG binding 
capacity may then cause an even sharper fall of FT levels (26). 
Numerous studies of large populations of healthy men have shown a marked rise in 
the incidence of impotence to over 50% in men aged 60 to 70 (27). Although this increase 
in impotence seems to occur in the same age group that shows a clear decline in free T 
levels. no causal relationships have been demonstrated. Testosterone replacement 
therapy is in most instances not effective for the treatment of impotence in elderly 
males: other factors such as atherosclerosis. alcohol consumption, smoking, and the 
quality of personal relationships seem to be more important denominators (28). 
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and fragility, impaired functioning, and chronic diseases (such as osteoporosis, diabetes, 
cancer, and heart disease) have not been studied yet. 
"Adrenopause'" 
Dehydroepiandrosterone (DHEA) in its free. sulfated or lipoidal form is the most 
abundant steroid secreted by the zona reticularis of the adult human adrenal. 
Circulating DHEAS levels in healthy adults are more than 10 times higher than those of 
cortisol (22). It is well known that aging is associated with a marked decrease of the 
adrenal C1, steroid DHEA and its sulfate (39AO). At age 30. DHEAS levels are 
approximately five times higher than at age 85. DHEA is a universal precursor for 
androgenic and estrogenic steroid formation in peripheral tissues. which contain a 
number of DHEA.metabolizing enzymes (21). A variety of factors influence cortisol and 
DHEA levels: obesity. meals. insulin. stress, alcohol and smoking alter adrenal steroid 
levels. 
The knowledge about the functions of adrenal C19 steroids is mainly derived from 
animal studies. Animal studies in rodents. which have very low circulating DHEAS 
levels. suggest that DHEA administration prevents obesity, diabetes mellitus, cancer 
and heart disease. while enhancing immune function (21). These results suggest that 
DHEA prolongs life·span and might be an ''elixir of youth". Supportive data in humans 
are few, highly controversial and unresolved. Higher DHEAS levels are accompanied by 
a modestly reduced risk of death from cardiovascular disease in males (41). Functional 
parameters of daily living in males over 90 years old were lowest in those with the 
lowest DHEAS levels (22). 
Two randomized placebo·controlled studies support the concept that oral 
administration of DHEA has beneficial effects (42,43). Three months of daily treatment 
with 50 mg of DHEA of 20 adults. most of whom were non·elderly individuals (40 to 70 
years old). increased DHEA(S) levels to young adult levels, increased plasma androgen 
and IGF·I concentrations. and induced a remarkable increase in perceived physical and 
psychological well·being in both sexes without an effect on libido. However, several other 
studies on DHEA replacement in humans, yielded inconsistent and controversial results 
(44·47). DHEA might influence the central nervous system activity (48). However. 
whether DHEA is related to cognitive function remains controversial. 
It is unknown whether the increase in sex steroid levels induced by DHEA is safe 
with regard to the development of prostate or other types of cancer. DHEA is currently 
widely used in the United States as a "treatment for aging". With the scientific verdict 
still out. without confirmation of DHEA's reported beneficial actions in humans, and 
without a better understanding of its potential risks. it is premature to recommend the 
routine use of DHEA for delaying or preventing the physiologic consequences of aging 
(49). 
"Somatopause'" 
Growth hormone (GH) is a single chain polypeptide, which is produced by the 
pituitary gland. It is an important anabolic hormone with stimulatory effects on protein 
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synthesis and on lipolysis. GH secretion is regulated by the interaction of two 
hypothalamic peptides, GH~releasing hormone (GHRH) and somatostatin. GH has both 
direct and indirect actions on peripheral tissues. Indirect effects of GH are mediated 
mainly by insulin~like growth factor (IGF) L generated in the liver. IGF-L in turn, has a 
negative feedback action on the hypothalamus and pituitary to inhibit GH release. IGF-1 
as well as IGF-II play a pivotal role in the regulation of proliferation. differentiation and 
specific functions of many cell types. The major regulators of IGF-I are growth hormone 
(GH) and nutrition. although its production in specific tissues is regulated by a 
multitude of tropic hormones and other peptide growth factors. IGFs are bound to 
specific binding proteins (IGFBP). The si' IGFBPs which are known at present either 
bind IGF-I and IGF~II with similar affinities or show a preference for IGF~II. Each of the 
IGFBPs has a unique role as a modulator of IGF action. The predominant IGFBP in the 
blood is IGFBP-3 which is part of a large molecular weight ternary complex. IGFBP-3 is 
mainly regulated by GH. Circulating IGFBP~3 levels reach a ma.ximum at puberty and 
decrease between 18 and 79 years in both sexes (23). It increases the half~ life ofiGF~I by 
a 100 fold and acts as an inhibitor as well as a stimulator of IGF-I action. In addition. 
the acid-stable IGFBP~3 subunit may have mitogenic activity independent of IGF-I itself 
(50). The secondary most abundant IGFBP in the circulation is IGFBP-2. Its affinity for 
IGF-II is an order of magnitude higher than its affinity for IGF-I. IGFBP-2 is regulated 
by several mechanisms. It decreases after birth until puberty. after which it gradually 
increases again. especially after the age of 60 (51). At age 80. concentrations are nearly 
twice as high as in young adults. Serum IGFBP-2 concentrations are higher during 
starvation. fasting and protein restriction. as well as in growth hormone deficiency. 
IGFBP~2 has been shown to inhibit IGF-I receptor binding and action (52), although its 
cellular action in IGF-mediated functions also has reported to be stimulatory. IGFBP-1 
is GH-independent. increases with fasting and is most prominently characterized by its 
inverse relationship to plasma insulin concentrations. IGFBP-1 is most strongly 
expressed in liver and kidney. IGFBP-1 is thought to modulate the free fraction of 
circulating IGF. in part by its stimulating transcapillary transport of IGFs to the 
extravascular space. a process promoted by insulin (53). 
In man both aging and GH deficiency are associated with reduced protein synthesis, 
decreases in lean body mass and bone mass. and increases in body fat (23). The 
reduction of circulating GH levels during aging (54.55) is due mainly to a reduction in 
pulse amplitude (56). Plasma IGF-I concentrations are reduced in healthy older adults. 
although there is wide individual variation. Tl:e IGF-I reduction probably results from a 
reduced stimulus of the liver to produce IGF-I rather than an age~ related insensitivity or 
inability of the liver to respond to circulating GH. 
Little is known concerning the biological consequences of somatopause (57). In several 
studies of healthy individuals of a broad age range. an association was observed between 
the maximum aerobic capacity and circulating IGF~I levels (58). The expectation that 
somatopause contributes to the decline of functional capacity in the elderly is mainly 
derived from studies in which GH replacement therapy of GH-deficient adults was 
shown to increase muscle mass. muscle strength. bone mass. and quality of life. A 
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beneficial effect on the lipid profile and an important decrease in fat mass were also 
observed in such patients (59). The GH/IGF-1 axis may also play a role in the age-related 
decline of certain cognitive functions (60). As in hypogonadal individuals. GH deficiency 
in adults is considered a model of normal aging. because a number of catabolic processes 
that are central in the biology of aging can be reversed by GH administration. 
GH administration for 3 to 6 months to healthy elderly individuals increased IGF-I 
levels to those observed in control individuals half their age. while muscle mass. skin 
thickness. and bone mineral content significantly increased and fat mass decreased 
(61,62). A disappointing aspect of the studies is that no positive effect of GH therapy was 
observed on muscle strength (63). while controversial results are reported on the effect 
on maximal oxygen consumption (63.64). If GH was administered in combination with 
resistance exercise training. however. a significant positive effect on muscle mass and 
muscle strength was recorded that did not differ from that seen with placebo treatment. 
which suggests that GH does not add to the beneficial effects of exercise (65.66). 
Earlier studies have demonstrated that pharmacological doses of GH prevent the 
"auto-cannibalistic" effects of acute diseases on muscle mass (67). This prompted us to 
carry out a randomized placebo-controlled trial of 6 weeks of GH administration in 
elderly indiv--iduals wit an acute hip fracture. Our results indicate that in individuals 
over 75 years old, GH administration causes a statistically significant earlier return to 
independent living after the fracture (68). Comparable studies are currently being done 
in several countries. and confirmation is needed before GH might gain a place in the 
treatment of acute catabolic states in the frail elderly. 
Other components in the regulation of the GH/IGF-I axis are effective in activating 
GH and IGF-I secretion. Long-acting derivates of the hypothalamic peptide growth 
hormone releasing hormone (GHRH). given twice daily subcutaneously for 14 days to 
healthy 70 years old men. increased GH and IGF-I levels to those encountered in 35-
years-olds (54). These studies support the concept that somatopause is primarily 
hypothalamically driven and that pituitary somatotrophic cells retain their capaCity to 
synthesize and secrete high levels of GH. GH releasing peptides (GHRPs) are 
oligopeptides with even more powerful GH-releasing effects (69). Originally developed by 
design. it has recently been suggested that they mediate their GH-secretory effects 
through endogenous specific receptors (70). Non-peptides analogs such as MK-677 and L-
692.429 have powerful GH-releasing effects, restoring IGF-I secretion in the elderly to 
levels encountered in young adults (71.72). Long-term oral administration ofMK-677 to 
healthy elderly individuals increased lean body mass but not muscle strength. If proven 
to be GH-specific. these orally active GHRP derivates might be important alternatives to 
subcutaneously administered GH in the reversal of somatopause. in the prevention of 
frailty. and in the reversal of acute catabolism. The long-term safety of the activation of 
GH/IGF-1 levels remain uncertain with regard to tumor growth. as most human solid 
cancers express IGF-I receptors (73). 
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Thyroid function 
Age~related thyroid dysfunction is also common in the elderly (74). Lowered plasma 
thyroxine (T4) and increased thyrotropin~stimulating hormone (TSH) concentrations 
occur in 5 to 10% of elderly women (74). These abnormalities seem to be mainly caused 
by autoimmunity and may therefore be an expression of age~associated disease rather 
than a consequence of the aging process (75. 76). Normal aging is accompanied by a slight 
decrease in pituitary TSH release (74), but especially by a decreased peripheral 
degradation of T4, which results in a gradual age~dependent decline in serum 
triiodothyronine (T3) concentration, without an important change in T4 levels (77). This 
slight decrease in plasma T3 concentration occurs largely within the broad normal range 
of the healthy elderly population and has not been convincingly related to functional 
changes during the aging process (7 4). 
The production of thyroxine (T4) and triiodothyronine (T3) by the thyroid is 
stimulated by thyroid~stimulating hormone (TSH), which is secreted by the pituitary. 
TSH release, in turn. increases in response to thyrotropin~releasing hormone (TRH). 
produced by the hypothalamus. T4 and T3 inhibit both TSH and TRH secretion by a 
negative feedback mechanism. T 4 is considered as a pro~ hormone of T3. which is the 
metabolically active hormone. Thyroidal T3 release accounts for 20% of daily T3 
production. whereas 80% is formed via extra-thyToidal deiodonation of T4. Peripheral 
conversion of T4 to T3 occurs predominantly in the liver and is mediated through 
deiodination of the outer ring of T4. catalyzed by an enzyme termed type I deiodonase. 
Inner ring deiodination converts T4 to reverse triodothyronine (rT3), an inactive 
metabolite. Inner ring or outer ring deioclination of T3 and rT3 respectively result in the 
formation of diiodothyronine (T2). In the circulation. thyroid hormones are bound to 
plasma proteins. in particular thyroxine-binding globulin (TBG) and. to a lesser extent. 
albumin and pre~albumin. The biological actions of thyroid hormones are thought to be 
mediated by the free fractions of T4 and T3 (78). Thyroxine sulfate (T4S) is another 
inactive metabolite of T4. T4S is produced mainly in peripheral tissues equipped with 
appropriate sulfotransferases. e.g. liver. brain, platelets, and granulocytes (79~81). T4S 
levels are not changed significantly in hyperthyroidism or hypothyroidism. 
It is well recognized that symptoms of aging can be easily confused with 
hypothyroidism, and in the past decreased thyroid function was believed to be one of the 
hall~marks of the aging process (82). During aging a complex number of changes occur in 
thyroid hormone concentrations. Reduced outer ring deiodination mediated by type I 
deiodinase results in a decline in T4 degradation. with a reduced generation of T3 and a 
decreased clearance of rT3. In addition TSH secretion appears to be slightly decreased in 
healthy elderly humans when subjects with subclinical hypothyroidism are carefully 
excluded. The reason for such age-dependent reduction of TSH is uncertain (7 4). 
However, in spite of these complex changes in biochemical parameters. recent studies 
suggest that normal aging is associated with an essentially normal thyroid function. 
although evaluation of thyroid function in the elderly is confounded by the increased 
prevalence of autoimmune subclinical hypothyroidism and non~th:yroidal illness (83). 
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Inflammation 
Frailty is contributed to by, at least. chronic and acute diseases, the physiological 
decline that occurs during the aging process. and a dysregulation of systems that also 
appears to accompany aging (84). Also the immune system seems to play a role in frailty. 
The role of inflammation in the pathogenesis of atherothrombosis (85) and other acute 
and chronic conditions has been well described (86.87). However. recently it has been 
observed that markers of inflammation. such as C-reactive protein (CRP) and 
interleukin-6 (IL-6) levels may have broader applicability as indicators of disability and 
mortality (88.89). Aging is associated with an elevation in pro-inflammatory cytokines. 
such as IL-6 (90). which play a central role in the hepatic production of CRP and other 
acute-phase proteins involved in the inflammatory response (91). It is hypothesized that 
in older adults a chronic inflammatory state may contribute to the pathophysiology of 
medical conditions that result in functional decline and disability. 
The Concept of Successful Aging 
There is considerable variation in the effects of aging in healthy individuals. with 
some persons exhibiting extensive alteration in physiological functions with age and 
others little or none. It has been suggested that it might be useful to distinguish between 
usual and successful patterns of aging (92). Genetic factors, lifestyle. and societal 
investments in a safe and healthful environment are important aspects of successful 
aging (93). Traditionally, the aging process. including the development of frailty toward 
the end of life. has been considered to be physiological and unavoidable. In recent years. 
however. it has become evident that it might not be necessary to accept the grim 
stereotype of aging as an unalterable process of decline and loss (9.92). The concept 
frailty focuses mainly on the physical or physiological aspects of aging, while the concept 
of successful aging comprises a broader range of aspects. Both concepts are not easy to 
define in a single measure. As life expectancy will increase further in coming decades 
(94). the overarching goal for the year 2000 and thereafter should be "an increase in 
years of healthy life with a full range of functional capacity at each stage of life"". Such a 
compression of morbidity can often be achieved through lifestyle measures. but a number 
of aspects of the aging process of the endocrine system invite the development of 
··routine" medical intervention programs offering long-term replacement therapy with 
one or more hormones. in order to delay the aging process and to allow us to live for a 
longer period in a relatively intact state. 
Scope of the thesis 
In this thesis the definition of successful aging as illustrated in the model by Rowe. 
with 'maintaining high cognitive and physical functional capacity". 'avoiding disease and 
disability'. and 'maintaining active engagement with life" as main determinants (Figure 
2), will be taken as a starting point in order to obtain more insight in the value and the 
interactions of the different aspects which are important to age successfully. For an 
individual assessment of successful aging adequate. reproducible, and if possible. 
predictive measures are needed. Therefore one of the aims of our study is to find 
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parameters which reliably reflect the three different parts of the model. To measure 
overall successful aging we will use two parameters; quality of life and survival. 
Since part of the aging process seems to be related to the endocrine system and 
because markers of inflammation may have an applicability as indicators of disability 
and mortality, another aim of tbis study is to investigate the role of the hormonal system 
and inflammation in different parts of successful aging. 
In principle successful aging should be investigated in both sexes. However. 
logistically it is complex to investigate it in both sexes, since it doubles the number of 
subjects which should be examined. In addition. there will be slightly different questions 
in men compared to women with regard to successful aging. Therefore we only focused 
on men in this study. 
Figure 2. The concept of 
Successful Aging as illustrated 
by Rowe with 'maintaining 
high cognitive and physical 
functional capacity'. 
'avoiding disease and disability', 
and 'maintaining active 
engagement with life' as main 
determinants. 
ENGAGEMENT 
WI'TH LIFE 
AVOlDING 
DISEASE AND 
DISABILITY 
SUCCESSFUL 
AGING 
HlCH COGNmVE 
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FUNCTION 
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IGFBP-2 as an indicator of functional ability 
ABSTRACT 
Background In a cross-sectional study in 403 healthy, independently living elderly men 
(mean age 78 years), we determined which are the main physiological determinants of 
functional ability in the elderly, and which components of the somatotropic system 
contribute to the maintenance of functional ability. 
Methods Functional ability was assessed by the number of problems in activities of daily 
living and by a measure of physical performance. Other physical characteristics included leg 
extensor strength, bone mineral density of total body and proximal femur and body 
composition, including lean mass and fat mass. Serum insulin-like growth factor (IGF)-I and 
its binding proteins (IGFBP) -L ·2 and -3 concentrations were all measured by RIA.. 
Results Muscle strength was positively related to activities of daily living. which indicates 
a lower degree of disability. It was also positively related to physical performance and bone 
mineral density (all P<O.OOl). Fat mass influenced activities of daily living and physical 
performance negatively and bone mineral density positively (all P<O.OOl). Serum 
concentrations ofiGF-I andiGFBP-3 were not related to any of the physical characteristics. 
Serum IGFBP-2 concentrations were negatively related to activities in daily living 
(P<O.OOl). physical performance (P=0.006). muscle strength (P=0.002). bone mineral density 
of proximal femur (P=0.007). lean mass and fat mass (both P<O.OOl). Serum insulin 
concentrations were positively and IGFBP-1 concentrations negatively related to lean mass 
(P<O.OOl) and fat mass (P<O.OOl). 
Conclusions In independently living elderly men. functional ability appears to be 
determined by muscle strength (positive) and fat mass (negative). Low serum IGFBP-2 
concentrations are a powerful indicator for an overall good physical functional status, 
probably inversely reflecting the integrated sum of nutrition and the biological effects of 
growth hormone, IGF-I and insulin. 
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INTRODUCTION 
Traditionally. the aging process has been considered to be physiological and unavoidable. 
Loss of muscle mass and strength are important predictors of a decrease in physical 
performance (1). Physical frailty. which is defined as "a state of reduced physiologic reserves 
associated with increased susceptibility to disability" (2). frequently occurs towards the end 
of life. and often results in the loss of independence. In recent years it has become evident 
that it might not be necessary to accept the grim stereotype of aging as an unalterable 
process of decline and loss (1,2). Since many of the predictors of physical functional status 
appear to be potentially modifiable. research must be done to refine diagnostic criteria and 
develop practical methods of measurement of key physiological capacities in order to identify 
proper targets for interventions in disabled elderly or for preventive interventions in 
'normal' elderly individuals. with the ultimate goal to enhance the proportion of the older 
population that ages successfully. Prevention ofloss of physical functions can be achieved by 
exercise (1). while hormone replacement with growth hormone (3-6) in the elderly has been 
demonstrated to improve physical performance in selected groups of elderly individuals. 
Recently, also data have been reported which suggest that the IGF I IGF -binding protein 
system might be related to the presence or development of prostate malignancies (7). 
With regard to the study of the age-related decline of physical function and its 
relationships with the endocrine system, we investigated two central questions in the 
present study: Which are the main physiological determinants of functional ability in the 
elderly and: Which components of the somatotropic system contribute to the maintenance of 
functional ability. Also a possible relationship between prostate disorders and the serum 
concentrations of these hormones was studied. We have investigated these questions in a 
cross-sectional study in 403 healthy. independently living elderly men. 
METHODS 
Subjects. 
A cross-sectional, single-center study was conducted in 403 independently living men. 
aged 70 years and higher. Names and addresses of all male inhabitants 70 years and older 
were drawn from the municipal register of Zoetermeer. a medium sized town in the mid-
western part of the Netherlands. 1567 men were invited. A total of886 men did not respond 
to the mailed invitation in which it was mentioned that only subjects who lived 
independently and had no severe mobility problems could participate. After exclusion of 
subjects who did not live independently and subjects who were not physically or mentally 
able to visit the study center independently. eventually 403 men participated (25. 7%). The 
main reason not to participate among the respondents was because they were currently 
under the care of a medical specialist or general practitioner (28%). while 16% was excluded 
on the basis of physical (10%) or mental (6%) problems. Participants signed an informed con-
sent. The study has been approved by the Medical Ethics Committee of the Erasmus 
University Hospital Rotterdam. No additional health related eligibility criteria were used. A 
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number of participants were taking medications for chronic illnesses, including 
hypertension (n=96) and mild congestive heart failure (n=28). However, in retrospect, none 
of these medications did influence the relations described in this study. Some of the 
illnesses, for example mild knee pain (n=79), influenced the physical characteristics 
measured, but they did not change the relations between the physical characteristics. nor 
between the circulating hormone levels and the physical characteristics reported in this 
study. 
Hormone measurements 
Blood samples were collected in the morning after an overnight fast. Serum was 
separated by centrifugation and deeply frozen. The period of storage at ·40°C varied from 0 
till 5 months. Total insulin~ like growth factor-! was measured by an insulin-like growth 
factor binding protein (IGFBP) blocked radioimmunoassay (RIA) as described previously (8). 
IGFBP-l. IGFBP-2 and IGFBP-3 were determined by RIA as described previously (9-ll). 
Insulin was measured by a commercially available RIA (Pharmacia, Freyburg. Germany). 
Physical characteristics 
Physical Performance 
Lower extremity function. or physical performance. was assessed as described by 
Guralnik et al. (12). including measurements of standing balance. walking speed and ability 
to rise from a chair. The three tests of standing balance were considered in hierarchical 
difficulty by assigning a single score of 0 to 4 for standing balance. For the 8-foot walk and 
repeated chair stands. those who could not complete the task were assigned a score of 0. 
Those completing the task were assigned scores of 1 to 4. corresponding to the quartiles of 
time needed to complete the task with the fastest times scored as 4. A summary 
performance scale was created by summing the category scores for the walking. chair stand, 
and balance test. which ranged from 0 (worst performance) to 12 (best performance). Mean 
scores of the three tests as well as of the summary performance scale measured in this study 
were comparable to those reported in subjects of the same age group investigated by 
Guralnik (12). 
Activities of daily living 
Self-reported disability or satisfaction in performing activities of daily living was assessed 
by a self·administered questionnaire modified from the Stanford Health i\ssessment 
Questionnaire as described by Pincus et al (13). A score of 8 points was obtained if the 
participants reported no problems in activities of daily living, needed no help and when 
there was no difference compared with the situation 6 months ago. A minimum score of 0 
was given if participants improved compared to 6 months previously, while a ma.ximum 
score of 36 points was assigned to participants who reported severe problems in activities of 
daily living. needed help and had more problems in activities of daily living compared to 6 
months ago. The lower the points measured in this ADL score, the lower the degree of 
disability. 
The Mini-Mental State Examination was used to determine cognitive function (14). 
Muscle Strength 
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Isometric leg extensor strength was measured as described by Hsieh and Philips using 
the Hoggan MicroFET hand held dynamometer (15). The measurement requires that the 
participant. in a seated position. pushes with maximal strength to the dynamometer. which 
is held at the tibia preferably 33 em below the knee joint. The investigator holds the 
dynamometer in the hand with an extended arm and pushes back until the breaking point is 
reached. The measurements were done in two positions and at both legs. During the first 
series of measurements the leg was held in 120° extension and during the second series of 
measurements the leg was in extended position (180°). During the first series of 
measurements the participant holds a device over the leg tested. which keeps the leg in 
exactly 120°. The measurements were done three times and the maximum performance at 
each position was recorded. To obtain one measure of leg muscle strength. "maximum leg 
extensor strength" was defmed as the ma.-Gmum strength for the right or left leg in a 
position of 120°. Statistical analyses were based on the physical unit measurement moments 
(N*m). obtained by multiplying the maximum strength (in Newton) and the distance of the 
dynamometer to the knee joint (in meters). 
Bone mineral density and Body.Composition 
Total body bone mineral density was measured using dual energy x~ray absorptiometry 
(DXA. Lunar. Madison. WI). as were hip bone mineral densities at the femoral neck. 
trochanter and Ward's triangle. In addition total lean body mass and fat mass were 
measured (16.17). Quality control including calibration was performed routinely every 
morning for DXA. using the standard provided by the manufacturer. 
Height and weight were measured in standing position without shoes. Body mass index 
was calculated as the weight in kilograms divided by the square of the height in meters. 
Measurements of prostate 
Medical history on signs of enlarged prostate were obtained. Rectal examination was 
performed. Prostate Specific Antigen (PSA) was determined by a commercially available kit. 
Data analyses 
Results are expressed. unless otherwise stated. as mean and standard deviation with the 
interquartile (IQ) range. Variables which were not normally distributed were 
logarithmically transformed. Relations between variables were assessed using linear 
regression for continuous variables. stated as linear regression coefficient(~) and standard 
errors. Multiple regression analysis was used to adjust for age and body mass index. as well 
as to assess the contribution of different independent variables to the dependent variable. 
Partial correlations between variables were assessed by calculating Pearson's product r. 
Unless otherwise mentioned all analyses are done after adjustment for age. Analyses were 
performed using Stata statistical package (StataCorp. 1997. Stata Statistical Software: 
Release 5.0). 
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RESULTS 
Characteristics of the study population are given in Table l. Mean age of the study 
population was 77.8 yr (Standard Deviation 3.58). 
Relations between age and the different physical characteristics 
Physical performance. muscle strength, bone mineral density, lean body mass and fat 
mass all decreased with age (Table 2). With increasing age. more limitations in activities of 
daily living were reported. 
Table l. Descriptive Data of the study population 
Age (yr) 
Body Mass Index 
Physical Performance (points) 
Activities of daily living (points) 
Total Body Bone Mineral Density (g/cm2) 
Femoral Neck Bone J\fineral Density (g/cm2) 
Femoral Ward Bone Mineral Density (g/cmZ) 
Femoral Trochanter Bone Mineral Density (g/cmZ) 
Total Fat Mass (kg) 
Total Lean Mass (kg) 
Ma:-..-imum Leg E:-..'tensor Strength (Nm) 
Table 2. Relations between physical characteristics and age 
Physical Performance Score (points/yr) 
Activities in Daily Living (log) 
Total Body Bone Mineral Density (g/cmZ/yr) 
Total Fat Mass (kgiyr) 
Total Lean Mass (kglyr) 
Maximum Leg Extensor Strength (Nm/yr) 
Means SD 
77.8 3.6 
25 . .5 3.0 
8.5 2.4 
10.7 4.3 
1.17 0.10 
0.88 0.14 
0.72 0.16 
0.85 0.1.5 
21.2 6.4 
51.7 5.6 
103.2 20.9 
~ 
-0.22 
0.01 
-0.01 
-0.18 
-0.38 
-1.54 
IQ-range 
75 so 
23.3 27.3 
7 10 
8 12 
1.11 1.23 
0.78 0.97 
0.60 0.82 
0.76 0.94 
17.4 24 . .5 
47.8 5.5.5 
89.4 117. 
Age 
±S.E. p 
0.03 <0.001 
0.005 0.02 
0.001 <0.001 
0.09 0.05 
0.08 <0.001 
0.28 <0.001 
13 regression coefficient denotes changes in unit per year. For example: Physical Performance score 
decreases 0.22 point per year. 
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Relationships among the different physical characteristics 
Relations among the different physical characteristics. estimated by linear regression 
analysis. are illustrated in Figure 1. Subjects that scored better in the physical performance 
test had significantly less problems in activities of daily living (i.e. a lower disability) and 
significantly higher bone mineral density (at all sites measured). Muscle strength was 
positively. independently related to the physical performance score and bone mineral 
density at all sites measured. while muscle strength and the number of problems in 
activities of daily living were inversely related. This implies that subjects with high muscle 
strength reported significantly less problems with activities of daily living (lower disability), 
scored significantly better in the physical performance test and had significantly higher 
bone mineral density compared to subjects with low muscle strength. Further, lean body 
mass was strongly associated with muscle strength. 
Fat mass was inversely related to the physical performance score, but independently positive 
with problems in activities of daily living and total body as well as proximal femur bone mineral 
density. This implies that subjects with a high fat mass scored significantly lower on the physical 
performance test had more problems with activities of daily living, but had significantly higher 
bone mineral density compared to subjects with low fat mass. 
Relations between the hormones and age 
Summarized values of the hormones are presented in Table 3. Serum concentrations of 
Insulin-like Growth Factor -I (IGF-I) and its binding protein-3 (IGFBP-3) decreased with 
age (~=-0.8-5± 0.41 (~g/1)/year. P=0.04, and ~=-0.07 ± 0.01 (mg/1)/year, P<0.001, respectively). 
Serum concentrations of IGFBP-1 and IGFBP-2 increased with age (~=0.03 ± 0.006 
(~g/1)/year. P<0.001 and ~=0.26 ± 0.04 (mg/1)/year. P<O.OOL respectively). Serum insulin 
levels were not associated with age. 
Table 3: Summarized values of serum hormone concentrations 
mean S.D. IQ-range 
!GF -I ("gil) 100.9 29.2 81.2- 118.9 
!GFBP-1 ("gil) 31.7 15 . .5 21.2- 38.6 
!GFBP-2 (mgll) 0.62 0.32 0.40- 0.76 
!GFBP-3(mgll) 2.59 0.70 2.09- 3.04 
Insulin (lUI!) 8.91 4.25 6.07- 10.5 
38 
IGFBP-2 as an indicator of functional ability 
Figure 1. Relations between the physical characteristics. f3 denotes linear regression coefficient. F.e. 
Physical performance increases 0.05 ± 0.01 point per Nm muscle strength.·~< denotes P-value <0.001. 
Since physical performance. activities in daily living. bone mineral density and muscle strength were 
all associated with body mass index. analysis including these parameters were done after adjustment 
for body mass index (and age). Activities in daily living were not normally distributed; therefore 
activities of daily living were included in the analyses after logarithmic transformation. The linear 
regression coefficient of the relation between muscle strength and activities of daily living is negative: 
the lowest scores in activities in daily living (i.e. few problems) were reported in men with the highest 
muscle strength. Thus. a higher muscle strength is associated with a better performance in activities 
of daily living and therefore with less disability. Part of the relation between physical performance 
and bone mineral density was explained through muscle strength. 
'P<0.001 
= -0.005:: 0.0008 polnt/Nm* 
-
-Disability 
.B = -0.07:: 0.005 pointlpolnr 
+ 
.B =0.01 ± 0.003 point/k~* 
Lean Body 
Mass 
+ 
+ J3 '= 1.44 ± 0.17 Nm/kq~ 
Muscle + 
Strength 
+ J3 =0.05 ± 0.005 polnt/Nm* 
+ Physical 
Performance 
j3 =0.006 ± 0.0001 
kg• (g/cm2)/ 
j3 =0.001 ± 0.0002 
Nm· (g/cm2)/ 
Bone Mineral 
Density 
J3 =0.008 ± 0.002 (g/cm2)/point* 
- j3 = -0.10 ± 0.02 pointlkg* 
+ 
Fat Mass 
j3 =0.006 = 0.0008 (g/cm2)/kg* 
39 
Chapter 2 
Relationships amongst serum somatotropic hormone concentrations 
Serum IGF-I and IGFBP~3 concentrations were strongly and positively related (r=0.53. 
P<0.001). Serum IGF-I concentrations were inversely related to those of IGFBP-1 (r=-0.17, 
P<0.001) and IGFBP-2 (r=-0.19. P<0.001). However, as the IGFBP-1 and IGFBP-2 concen-
trations were interrelated (r=0.49. P<0.001). a multiple regression analysis including 
IGFBP-1. as well as !GFBP-2. was performed. In this analysis serum IGF-1 levels remained 
only related to those of IGFBP-2. The relations between the serum IGFBP-3 and those of 
IGFBP~1 and IGFBP-2. respectively. were dependent on IGF-I. Insulin concentrations were 
independently related to those of IGFBP-1 and IGFBP-2 (r=-0.30 and r=-0.28. P<0.001, 
respectively). 
Serum IGF~I and the binding proteins in relation with physical characteristics 
Serum IGF-I and IGFBP~3 concentrations were not directly related to any of the physical 
characteristics studied. In contrast. serum IGFBP-2 levels were significantly. inversely 
related to virtually all these variables measured, including femur bone mineral density, 
except for total body bone mineral density (Figure 2). As IGFBP-2 levels were strongly 
related to body mass index (~= -4.00 ± 0.45 (kgim2)/(mg/l), P<0.001). all analyses were 
repeated after adjustment for body mass index (except for lean and fat mass). Physical 
performance scores decreased 1.13 ± 0.41 points per mgll increase in IGFBP-2 (P=0.005). 
Significantly more problems in activities of daily living were reported with increasing serum 
IGFBP-2 concentrations (logarithmically transformed: ~=0.19± 0.06 points/(mg/l). P<0.001). 
Further. muscle strength decreased 11.33 ± 3.51 Nm per mgll increase in IGFBP-2 
(P=0.001). Bone mineral density of the ward region decreased 0.08 ± 0.03 g!cm"2 per mgll 
increase in IGFBP~2 (P=0.005). In addition. both lean body mass and fat mass were lower in 
individuals with higher IGFBP-2 concentrations (respectively 13=-4.09 ± 0.88 kg/(mgll). and 
~=-5.58 ± 0.90 kg/(mg/l). both P<0.001). The inverse relation between IGFBP-2 and physical 
performance was explained through the inverse relation between IGFBP-2 and muscle 
strength. All the other relations were independent from each other. 
Serum IGFBP~1levels were inversely related to physical performance scores. fat mass 
and lean body mass. and positively to problems in activities of daily living. However. serum 
IGFBP~1 and -2 levels were positively related and the relations between IGFBP~1 and 
physical performance and activities in daily living. respectively. were no longer significant 
after adjustment for IGFBP-2. The relations between IGFBP~1 and fat mass and lean body 
mass. respectively. were independent of!GFBP-2 (~=-0.14± 0.02 kgi(Mgil) and ~=-0.09 ± 0.02 
kgi(Mgil), P<0.001 respectively). 
Serum insulin concentrations were positively. and independent of serum IGFBP~ 1 and 
IGFBP~2 concentrations. related to lean body mass as well as fat mass (13=0.23 ± 0.06 
kg/(IU/l) and ~=0.40 ± 0.06 kg/(IU/l). P<0.001 respectively). 
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Figure 2. Relations of serum concentrations of Insulin-like Growth Factor Binding Protein-2. 
Insulin-like Growth Factor Binding Protein-1. and insulin with the characteristics of physical 
function. The effects of all hormones mentioned in this figure were independent from each other 
+ 
Disability 
IGFBP-1 
Muscle 
Strength 
Physical 
Performance 
Fat Mass 
+ 
IGFBP-1 
-
Relations between measurements of the IGF-system and prostate 
Bone 
Density 
IGFBP-2 
Subjects with a medical history of an enlarged prostate (n=120) or with an enlarged 
prostate at palpation (n=95) did not have circulating IGF-L IGFBP-1. -2 and -3 
concentrations which differed from the other subjects. In addition. subjects with a suspicion 
of prostate malignancy at palpation (n=19) or a PSA level above 10 ng/ml (n=34) did not 
have different IGF-L IGFBP-1, -2 and -3 concentrations compared to the other subjects. 
Serum PSA concentrations were also not related with IGF-L IGFBP-1. -2 or -3 in a linear 
regression analysis. The proportion of subjects with clinical symptoms of and enlarged 
prostate, an enlarged prostate at palpation or PSA levels above 10 ng/ml was not different in 
quartiles of IGF-I. IGFBP-L -2 and -3. The 35 subjects with a malignancy in the medical 
history. did not have serum IGFBP-2 concentrations which differed from those of the other 
subjects. 
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DISCUSSION 
To appreciate the findings of this study. some aspects need to be discussed. In evaluating 
the physical functional status of the elderly. the choice of the best approach to measure this 
status remains uncertain. The main clinical correlate used in this study is functional ability. 
self-reported as well as objectively assessed as a physical performance score using the 
approach proposed by Guralnik eta!. (12). Guralnik demonstrated that a short battery of 
performance measures of lower extremity function predicts mortality and loss of 
independence amongst older persons. In addition. bone mineral density. muscle strength 
and body composition were measured as physical characteristics. Overall physical function. 
as well as cognitive function in this group of elderly men were relatively good. Only 30 
individuals scored less than 24 points in the mini-mental state examination. which indicates 
mild cognitive impairment. In less selected populations with a broader range of functional 
ability. if anything, associations are likely to be stronger. 
In the present study two major questions in the study of the age-related decline of 
physical function were addressed. With regard to the first question asked, our findings in 
this large population of independently living elderly men suggest that high muscle strength 
and low fat mass are independent determinants of functional ability. This finding agrees 
with other studies. which demonstrated that muscle strength is independently. positively 
related to physical performance (1,18) and to bone mineral density (19.20). and inversely to 
the number of problems in activities of daily living. Fat mass. on the other hand is inversely 
related to physical performance and restricted activities in daily living. but positively to 
bone mineral density. This latter relation probably reflects the effect of hormones. such as 
estradiol or insulin. or simply of mechanical loading. These observations. as well as the 
other significant relations found in this study. led us to a diagram representing the 
relationships between activities in daily living, physical performance, bone mineral density, 
muscle strength and body composition. as summarized in Figure 1. 
Part of the age-related physiological changes might be influenced by the activity of the 
endocrine system (21.22). In this population. physical function declines with age. In paralleL 
serum IGF-I and IGFBP-3 concentrations significantly decreased with age. while those of 
IGFBP-1 and IGFBP-2 increased. With regard to the second question. e.g. which 
components of the somatotropic system contribute to the maintenance of functional ability, 
we found no correlation between serum IGF -I or IGFBP-3 concentrations on the one hand 
and measures of functional ability, muscle strength. bone mass and body composition on the 
other. These fmdings agree with previous reports (23-28). We did. however. demonstrate 
highly significant inverse relations between serum IGFBP-2 concentrations and virtually all 
the physical characteristics measured. IGFBP-2 is present in the human serum in very high 
concentrations. In adult life IGFBP-2 probably acts to inhibit the biological effects ofiGF-I 
(29). IGFBP-2 is regulated by several mechanisms. It decreases after birth until puberty. 
after which it gradually increases again, especially after the age of 60 (10.30). At age 80. 
concentrations are nearly twice as high as in young adults (0.60 mg/l versus 0.35 mgll). 
Therefore. the decline in functional ability and the increase in serum IGFBP-2 
concentrations proceed in parallel. The precise mechanisms regulating IGFBP-2 
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concentrations remain unclear, although it is recognized that serum IGFBP-2 
concentrations are higher during starvation. fasting and protein restriction, as well as in 
growth hormone deficiency (31-33). while they respond with a decrease during growth 
hormone treatment (34,35). In this study. serum IGFBP-2 levels were strongly inversely 
related to serum albumin concentrations (data not shown). which is generally regarded as a 
measure of nutritional status (36). In addition, IGF-I appears to be a regulator ofiGFBP-2. 
since IGF-I administration increases its serum levels (37), possibly, however. via a 
suppression of growth hormone secretion (38). Finally, insulin has been proposed as a 
regulator of!GFBP-2. although evidence is not yet clear-cut (39). In this study. serumiGF-I. 
IGFBP-3 as well as fasting insulin concentrations were all inversely related to IGFBP-2 as 
well. Insulin. which is considered to be an anabolic hormone. was independently ofiGFBP-2 
related to fat mass and lean mass only. Low serum IGFBP-2 concentrations seem to be 
related to an anabolic state and turn out to be a powerful indicator of an overall good 
physical functional status of elderly men. We suggest that serum IGFBP-2 concentrations 
inversely reflect the integrated sum of the nutritional state~ as well as the biological effects 
of growth hormone, IGF-I as well as insulin. 
As IGFBP-2 concentrations have been reported to be elevated in patients with several 
malignant tumors (40Al), in particular prostate carcinoma (37), one might hypothesize that 
the association between IGFBP-2 and functional ability is dependent on the presence of 
prostate malignancies. However, even within the group of individuals with elevated PSA 
levels, there was no relation between IGFBP-2 and PSA, or other prostate abnormalities. 
Additionally, in agreement with Ho et al.. we did not find abnormal IGFBP-2 concentrations 
in subjects with an enlarged prostate (42). Consequently, from our study, we do not have 
indications that IGFBP-2 is produced by the prostate. This implies that the relations 
between IGFBP-2 and the physical characteristics are not dependent on the presence of 
prostate hypertrophy or malignancy. 
In conclusion. muscle strength and functional ability are considered to be the key 
characteristics of physical functional status in independently living elderly men. Functional 
ability appears to be determined by muscle strength (positive) and fat mass (negative). The 
more marked the functional ability, the higher bone mineral density. Low serum IGFBP-2 
concentrations are a powerful indicator for an overall good physical functional status. 
probably inversely reflecting the integrated sum of nutritional status as well as of the 
biological effects of growth hormone, IGF-I. and insulin. 
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ABSTRACT 
Background In the present cross-sectional study of 403 independently living elderly 
men. we tested the hypothesis that the decreases in bone mass. body composition and 
muscle strength with age are related to the fall in circulating endogenous testosterone 
and estrogen concentrations. We compared various measures of the level of bioactive 
androgen and estrogen to which tissues are exposed. 
Methods After exclusion of subjects with severe mobility problems and signs of 
dementia. 403 healthy men (aged 73-94 years) were randomly selected from a population 
based sample. Total testosterone (TT). free testosterone (FT). estrone (El). estradiol (E2) 
and SHBG were determined by RIA. Levels of non-SHBG-bound testosterone (non-
SHBG-T). FT (calc-FT). the TT/SHBG ratio, non-SHBG-bound E2 and free E2 were 
calculated. Physical characteristics of aging included muscle strength measured using 
dynamometry, total body bone mineral density (BMD), hip BMD and body composition. 
including lean mass and fat mass. measured by DEXA.. 
Results In this population of healthy elderly men. calc-FT. non-SHBG-T, El. and E2 
(total, free and non-SHBG-bound) decreased significantly with age. Testosterone (T. total 
and non-SHBG-T) was positively related with muscle strength and total body BMD (for 
non-SHBG-T respectively ~=1.93 ± 0.52. P<O.OOl and ~=O.Oll ± 0.002. P<O.OOl). An 
inverse association existed between T and fat mass (13=-0.53 ± 0.15. P<O.OOI). Non-
SHBG-T and calc-FT were more strongly related to muscle strength. B:MD and fat mass 
than TT and were also significantly related to hip BMD. El and E2 were both positively. 
independently associated with BMD (for E2 ~=0.21 ± 0.08. P<O.Ol). Non-SHBG bound E2 
was slightly stronger related to B:M:D than total E2. The positive relation between T and 
BMD. was independent of E2. El and E2 were not related with muscle strength or body 
composition. 
Conclusion In summary, bioavailable testosterone. estrone. total estradioL and 
bioavailable estradiol all decrease with age in healthy old men. In this cross-sectional 
study in healthy elderly men, non-SHBG-bound testosterone seems to be the best 
parameter for serum levels of bioactive testosterone. which appears to play a direct role 
in the various physiological changes which occur during aging. A positive relation with 
muscle strength and bone mineral density and a negative relation with fat mass was 
found. In addition. both serum estrone and estradiol seem to play a role in the age-
related bone loss in elderly men. although the cross-sectional nature of the study 
precludes a definitive conclusion. Non-SHBG bound estradiol seems to be the best 
parameter of serum bioactive estradiol in describing its positive relation with bone 
mineral density. 
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INTRODUCTION 
Throughout adult lUe, all physiological functions gradually decline. In men. part of 
these age-related physiological changes (loss of muscle size and strength. loss of bone, 
and increase in fat mass) may be related to the decrease in serum levels in bioavailable 
testosterone with aging (L2). Some studies report a positive relation between estimates 
of serum testosterone levels and bone density in older men (1,3,4). although this has not 
been a universal finding (5.6). Androgen administration to older men with low plasma 
testosterone levels results in increases in lean body mass. bone density and/or muscle 
strength (7-10). 
Recently it has been suggested that estrogens may play an important role in the 
development and maintenance of the male skeleton (11). Several studies have reported 
positive relations between serum estradiol concentrations and bone mineral density or 
bone turnover markers in men (12). 
Serum testosterone as well as estradiol are mainly bound to sex-hormone binding 
globulin (SHBG) and albumin. It has been suggested that the fraction of testosterone 
bound to albumin has access to target tissues (13). It remains to be established whether 
totaL non-SHBG-bound (albumin bound and free) or free testosterone levels are the best 
representation of the bioactive hormone concentrations. The same holds true for serum 
estradiol concentrations. 
Therefore, in the present cross-sectional study of 403 independently living elderly 
men. we tested the hypothesis that the decreases in bone mass. body composition and 
muscle strength with age are related to the fall in circulating endogenous testosterone 
and estrogen concentrations. We compared various measures of the level of bioactive 
androgen to which tissues are exposed: total and free testosterone levels in serum. the 
total testosterone I SHBG ratio, calculated free and non-SHBG-bound testosterone levels 
and total testosterone adjusted for SHBG. In addition, relationships with total. non-
SHBG-bound and free estradiol were compared. 
METHODS 
Subjects 
The study is a cross-sectionaL single-center study in 403 independently living men, 
aged 70 years and higher. Names and addresses of all male inhabitants 70 years and 
older were drawn from the municipal register of Zoetermeer, a medium sized town in the 
mid-western part of the Netherlands. 1567 Men were invited and after exclusion of 
subjects who did not live independently and subjects who were not physically or 
mentally able to visit the study center independently. eventually 403 men participated 
(25. 7%). A total of 886 men did not respond to the mailed invitation in which it was 
already mentioned that subjects who did not live independently or with severe mobility 
problems would not be allowed to participate. The main reason not to participate among 
the respondents was because they were already being seen by a specialist or general 
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practitioner at the moment (28%), while 16% was excluded on the basis of physical (10%) 
or mental (6%) problems. Participants signed an informed consent. The study has been 
approved by the Medical Ethics Committee of the Erasmus University Hospital 
Rotterdam. No additional health related eligibility criteria were used. A number of 
participants were taking medications for chronic illnesses. like hypertension (n=96) and 
mild congestive heart failure (n=28). However, none of these medications did in 
retrospect influence the relations described in this study. Some of the illnesses, for 
example mild knee pain (n=79), influenced the physical characteristics measured. but in 
retrospect they did not change the relations between the physical characteristics, nor 
between the circulating hormone levels and the physical characteristics reported in this 
study. 
Hormone measurements 
Blood samples were collected in the morning after an overnight fast. The period of 
storage at ~40DC varied from 0 till5 months. Serum concentrations of total testosterone 
(TT. nmoJJl). free testosterone (FT. nmoJJl), and sex hormone binding globulin (SHBG. 
nmoJJl) were all measured by radioimmunoassay using commercial kits (Diagnostic 
Systems Laboratories. Webster. Texas, USA). The intraassay coefficients of variation 
(CV) for these assays were 8.1%, 6.2% and 3.0% respectively. The interassay CVs were 
10.5%, 9.7% and 4.4%. The free testosterone RIA uses an [I-125]-labeled testosterone 
analog which has a low affinity for SHBG and albumin. This analog competes with the 
unbound testosterone in the test sample for binding to specific anti-testosterone 
polyclonal antibodies which have been immobilized on the assay tube. This competitive 
binding format allows direct estimation of unlabelled free testosterone levels in 
unextracted samples. Furthermore, as measures of biologically active testosterone, the 
TT I SHBG ratios were calculated. as well as free testosterone (calc-FT, nmoJJl) and non-
SHBG-bound testosterone (non-SHBG-T. nmol/1, is calc-FT plus albumin bound 
testosterone) (Table 1) (14). In these calculations. the possible binding of other steroids 
to SHBG was disregarded. Finally. total testosterone adjusted for SHBG in a multiple 
regression analysis was used as a measure of non-SHBG-bound testosterone. 
Serum concentrations of estrone (EL nmoJJl) and estradiol (E2, nmol!l) were also 
measured by radioimmunoassay using commercial kits (Diagnostic Systems 
Laboratories). The intraassay coefficients of variation (CV) were respectively 5.6% and 
5.3%. The interassay CV were resp. 10.2% and 8.1%. As measures of biologically active 
E2, free E2 and non-SHBG-bound E2 were calculated according to the method described 
by SOderg3.rd (14), taking the concentration of T into account. Albumin (gil) was 
measured by photometry using a commercial kit (ALB. Boehringer. Mannheim. 
Germany). 
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Table 1. Measurements and calculations for the various concentrations of testosterone and 
estradiol 
Steroid variables 
Total Testosterone 
(TT. nmol/1) 
Free Testosterone 
(FT. nmol/1) 
Calculated Free 
Testosterone 
(calc-FT. nmolll) 
Non SHBG bound 
Testosterone 
(non-SHBG-T. nmol/1) 
TT I SHBG ratio 
TT adj. SHBG. nmol/1 
Estradiol (nmolll) 
Calculated Free Estradiol 
(fE2. nmol/1) 
Non SHBG bound Estradiol 
(non-SHBG-E2. nmol/1) 
Measurements and calculations 
Measured by RIA (Diagnostic Systems Laboratories-4100. 
Webster. Texas. USA) 
Measured by RIA (Diagnostic Systems Laboratories-4900. 
Webster. Texas. USA) 
According to S6degfu-d et al. (14): 
calc-FT ~ -b + -Jeoz + 4a[':TT]) I 2a 
a~ KA+ KT + (Eh 10) ([SHBG] + [Albumin] - [l:TT]) 
b~ 1+ KT(SHBG] + KA(AJbumin] -(IV'+ KT)( :ETT] 
According to Si:ideg&rd et al. (14): 
non-SHBG-T= (K" x [Albumin] x [calc-FT] 11 + K"x [calc-FT]) + 
[cal e-FT] 
Measured Total Testosterone I Measured Sex Hormone Binding 
Globulin ratio 
Measured Total Testosterone 
Adjusted for measured SHBG in a multiple regression analysis 
Measured by RIA (Diagnostic Systems Laboratories-4400. 
Webster. Texas. USA) 
According to Si:ideg&rd et al. (14): fE2 = -b + .,J(bz + 4ac) 12a 
a~ (K'x [Albumin] +l)(KE) 
b~ ([':E2]x KE)-(KAEx [Albumin]+l)(l+ KT(SHBG]x calc-FT)-
(KTE X [SHBG]) 
c~ [':E2]x (l+KT(SHBG]x calc-FT) 
According to Si:ideg&rd et al. (14): non-SHBG-E2 = [~E2]- (h_'"TEx 
[SHBG]x fE2/ (1+ II."'Ex fE2 + KT[SHBG]x calc-FT) 
KA:: association constant for binding of testosterone to Albumin 
KT= association constant for binding of testosterone to SHBG 
KAE= association constant for binding of estradiol to ~t\lbumin 
KE= association constant for binding of estradiol to SHBG 
Physical characteristics of aging 
Muscle Strength 
Isometric grip strength (IGS) was measured using an adjustable hand held 
dynamometer (,JAJ\tlAR dynamometer) at the non-dominant hand (1.5). Each test was 
repeated three times ·and the average was used in the analyses. Leg or knee extensor 
strength (LES) was measured as described previously (16.17) using the Hoggan 
MicroFET hand held dynamometer. To obtain one main outcome measurement for leg 
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extensor strength, ''maximum leg extensor strength" (ma.xLES) was defmed as the 
maximum strength for the right or left leg, whichever is largest. in a position of 120° 
extension. Statistical analyses were based on the physical unit momentum (Nm). 
obtained by multiplying the ma.\.imum strength (in Newton) and the distance of the 
dynamometer to the knee joint (in meters). 
Bone mineral density and body composition 
Total body bone mineral density (TBBMD) was measured using dual energy x·ray 
absorptiometry (DEXA Lunar. Madison. WI). as were hip bone mineral densities at the 
femoral neck. trochanter and Ward's triangle (18). In addition, total and trunk lean body 
mass and fat mass were measured (19,20). Quality assurance for DEXA, including 
calibration was performed every morning. using the standard provided by the 
manufacturer. 
Height and weight were measured in standing position without shoes. Body mass 
index (BMI) was calculated as the weight in kilograms divided by the square of the 
height in meters. The waist circumference was measured at the level of the umbilicus 
and the hip circumference was measured at the level of the greater trochanter. The 
average of two readings was used in the analyses. Waist J hip ratio (WHR). which 
represents a measure of upper body adiposity. was calculated from these two measure-
ments. 
Data analyses 
Results were expressed. unless otherwise stated. as mean and standard deviation 
with the interquartile (IQ) range. Comparisons between groups were made by using 
Student's t-test. Differences were given together with the 95% confidence-interval (CI). 
Relations between variables were assessed using linear regression for continuous 
variables and logistic regression for binary variables. and described as the linear 
regression coefficient (j3) and its standard error (S.E.). Multiple regression analysis was 
used to adjust for age and BML as well as to assess the contribution of different 
independent variables to the dependent variable. To assess the contribution of different 
variables on the dependent parameter. we used standardized regression. described as 
the standardized regression coefficient (B). Standardized regression coefficients are 
regression coefficients normalized by the ratio of the standard deviation of the dependent 
variable. Correlations between variables were assessed by using Pearson's correlation 
coefficient r. All analyses were done using STATA Statistical Software: Release 5.0: 
Stata Corporation. 
RESULTS 
Descriptive data of the physical characteristics. as well as age and body mass index 
(BMI) are shown in Table 2. Muscle strength. bone mineral density (BMD). lean body 
mass (LBM). and fat mass all decreased with age in our study group (Table 3). Because 
virtually all parameters were related with age. all further analyses were done after 
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adjustment for age. Descriptive data of the hormone measurements are shown in Table 
4. 
Relations of the hormone concentrations with age 
The relations of the hormone measurements 'With age are shown in Table 5. In our 
population all testosterone (T) measurements. except total testosterone (TT), 
signillcantly decreased with age. The relation between non~SHBG.bound T and age is 
illustrated in Figure 1. Serum SHBG and percentages of SHBG·bound T and estradiol 
(E2) increased with age. Estrone (E1) and total E2 concentrations were inversely related 
with age. Calculated free E2 (fE2) and calculated non-SHBG-bound E2 (non-SHBG-E2) 
decreased relatively more with age compared with total estradiol (E2) (standardized 
regression coefficients (B) were respectively -0.15. -0.15 and ·0.12). 
Table 2. Descriptive Data of the study population 
Mean ±SD Interquartile range 
Age (yr) 77.8 3.58 75 so 
Body Mass Index 25.5 3.0 23.3 27.3 
Isometric Grip Strength (kg) 34.3 6.9 30.0 38.7 
Ma..ximum Leg E::..."tensor Strength (Nm) 103.2 20.9 89.43 117.12 
Total Fat Mass (kg) 21.2 6.4 17.4 24.5 
Trunk Fat Mass (kg) 10.6 2.6 9.0 12.4 
Total Lean Mass (kg) 51.7 5.6 47.8 55.5 
Total Body Bone Mineral Density (g/cmZ) 1.17 0.10 1.11 1.23 
Femoral Neck Bone Mineral Density (g/cm2) 0.88 0.14 0.78 0.97 
Femoral Ward Bone Mineral Density (g/cmZ) 0.72 0.16 0.60 0.82 
Femoral Trochanter Bone Mineral Density (g/cmZ) 0.85 0.15 0.76 0.94 
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Table 3. Relationship between physical characteristics and age 
Age (year) 
~ 
Isometric Grip Strength (kg) -0.53 
Ma.ximum Leg Extensor Strength (Nm) -1.30 
Total Fat Mass (kg) -0.18 
Trunk Fat Mass (kg) -0.10 
Total Lean Mass (kg) -0.38 
Total Body Bone Mineral Density (g/cm2) -0.003 
Femoral Neck Bone Mineral Density (g/cm2) -0.002 
Femoral Ward Bone Mineral Density (g/cm2) -0.003 
Femoral Trochanter Bone Mineral Density (g/cm2) -0.004 
Table 4. Summarized values of hormone levels of the 403 men 
Mean±S.D. 
Total Testosterone (TT. nmol/1) 8.83 2.98 
Free Testosterone (Fr. nmol/1) 0.03 O.Ql 
Sex Hormone Binding Globulin (nmol/1) 31.5 14.4 
Calculated FT (nmol/1) 0.19 0.06 
Non-SHBG-bound Testosterone (nmol/l) -5.68 1.89 
Percentage SHBG bound T (%) 35.0 9.51 
Percentage albumin bound T (%) 62.8 9.23 
Percentage free T (%) 2.21 0.31 
TT/SHBG ratio 0.32 0.15 
Estrone (nmol/1) 0.102 0.039 
Estradiol (E2. nmoJJl) 0.098 0.058 
Calculated Free E2 (pmol/l) 2.5 1.4 
Non-SHBG-bound E2 (nmolll) 0.077 0.045 
Percentage SHBG bound E2 (%) 21.9 7.40 
Percentage albumin bound E2 (%) 75.5 7.21 
Percentage free E2 (%) 2.56 0.24 
±SE 
0.09 
0.28 
0.08 
0.04 
0.08 
0.001 
0.002 
0.002 
0.002 
P-value 
<0.001 
<0.001 
0.02 
0.007 
<0.001 
0.006 
0.25 
0.17 
0.04 
Interquartile range 
7.19 10.66 
0.024 0.038 
23.18 37.46 
0.16 0.23 
4.62 6.76 
29.2 41.1 
56.9 68.6 
2.03 2.39 
0.23 0.39 
0.075 0.126 
0.059 0.126 
1.5 3.2 
0.045 0.100 
17.2 26.1 
71.4 80.2 
2.42 2.72 
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Table 5. Relationship between age and hormone levels 
Age (yr) 
~ ± S.E. p 
Total Testosterone (TT. nmol!l) -0.04 0.04 0.37 
Free Testosterone (FT, nmol!l) -0.001 0.0001 <0.001 
Sex Hormone Binding Globulin (nmol!l) 0.92 0.20 <0.001 
Calculated FT (nmol!l) -0.002 0.001 0.02 
Non-SHBG-bound Testosterone (nmol!l) -0.07 0.03 0.01 
Percentage SHBG bound T (%) 0.66 0.13 <0.001 
Percentage albumin bound T (%) -0.64 0.12 <0.001 
Percentage free T (%) -0.029 0.004 <0.001 
TT/SHBG ratio -0.009 0.002 <0.001 
Estrone (nmol!l) -0.005 0.0005 <0.001 
Estradiol (E2. nmol!l) -0.002 0.0008 0.01 
Calculated Free E2 (pmol!l) -0.060 0.020 0.003 
Non-SHBG-bound E2 (nmolll) -0.002 0.001 0.002 
Percentage SHBG bound E2 (%) 0.51 0.10 <0.001 
Percentage albumin bound E2 (%) -0.50 0.10 <0.001 
Percentage free E2 (%) -0.013 0.003 <0.001 
p = coefficient of linear regression represents changes in unit per year. E.g.: Non-SHBG-T 
decreases 0.07 nmol!l per year. 
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Figure 1. Relationship between non-SHBG-bound testosterone and age. Coefficient denotes the 
linear regression coefficient. F.e. non-SHBG-bound testosterone decreases 0.07 nmolll per year. 
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Relations between physical characteristics 
Lean mass, fat mass and ma'"d.ES were all positively, independently related with 
TBBMD (respectively; ~=0.0060 ± 0.0008 kgl(glcm2). P<O.OOl. ~=0.0063 ± 0.0008 
kgl(glcm2). P<0.001 and ~=O.OOll ± 0.0002 Nml(glcm2). P<0.001). Lean mass and 
maxLES were both positively associated (~=0.12 ± 0.01 Nmlkg, P<0.001). 
Relations between hormone concentrations 
Mean values of measured FT were significantly lower than calc-FT (difference 0.16 ± 
0.003 nmol/1, CI= 0.156-0.166, P<0.001). Results of the different T measurements 
correlated well with each other (Table 6). Correlations between serum levels ofT. Eland 
E2 are shown in Table 7. El and E2 were positively related with each other. and with 
the various measures of testosterone. 
Table 6. Age adjusted relations between ilifferent measures of testosterone concentrations 
TT (nmolll) TTISHBG ratio Calculated FT (nmolll) 
~±S.E. r ~±S.E. r ~±S.E. r 
Meas. FT 181.1 ± 7.19 0.781 0.03 ± 0.004 0.:391 0.15 ± 0.007 0.751 
(nmol/1) 
Calc. FT -12.80 ± 1.00 0.91' 0.29 ± 0.02 0.681 
(nmoL!l) 
Non-SHBG-T 1.42 ±0.04 0.891 8.98 ± 0.45 0.711 
(nmoL!l) 
TTISHBG ratio 8.04 ±0.92 0.4.-01 
1= P-value <0.001. TT =Total Testosterone. FT =Free Testosterone. Non-SHBG-T = calculated 
non SHBG bound testosterone 
Table 7. Age adjusted relations between serum testosterone and estrogens levels 
TT Non- calc FT E1 E2 Free E2 
SHBG-T 
r r r r r r 
Estrone (E1) 0.281 0.281 0.291 
Estradiol (E2) 0.171 0.181 0.142 0.241 
Free E2 0.142 0.201 0.162 0.241 0.981 
Non-SHBG-E2 0.132 0.201 0.181 0.24.1 0.991 0.995' 
r denotes correlation coefficient 1= P-value <0.001. 2= P-value <0.01 
TT =Total Testosterone. calc FT = calculated free testosterone. Non-SHBG-T/E2 = calculated non 
SHBG bound testosterone I estradiol 
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Relation between testosterone concentrations and physical characteristics 
Because BMI was significantly related to levels of T, maxLES, IGS and BMD, all 
analyses including these parameters were done after adjustment for BMI. 
All T measurements were positively related to TBB:rviD after adjustment for age 
(Table 8). Calc-FT. non-SHBG-T, the TT/SHBG ratio and TT adjusted for SHBG were 
also significantly positively related to all regions of proximal femur BMD. As an 
example. the relationships between the different T measures and BJ\.ID of the Ward's 
triangle are shown in Table 8. 
None of the T measurements. with the exception of the TT I SHBG ratio. was related 
with lean mass (not shown). Fat mass was negatively associated with all T 
measurements. except with the TT I SHBG ratio (Table 8). 
All measurements for T were positively related with ma..xLES (Table 8) and with IGS 
and after adjustment for age (with the exception that FT was not related with IGS). T 
was independently related to both muscle strength and B:rviD. 
The SHBG-bound fraction of T was not related to any of the physical characteristics, 
with the exception offat mass (~=-1.03 ± 0.18, P<0.001). The strength of the relations of 
the albumin bound fraction of T to the physical characteristics was equal to those for 
non-SHBG-T. 
Serum SHBG concentrations were inversely related to lean mass (~=-0.07 ± 0.02 
kg/(nmolll), P<0.001). fat mass (~=-0.08 ± 0.02 kg/(nmolll), P<0.001) and BMD (e.g. 
TBBMD: ~=-0.001 ± 0.0003 (g/cm2)/(nmolll). P=0.01). 
Relations between estrogens and physical characteristics 
Serum E1 and E2 concentrations were not related to muscle strength. In this elderly 
male population. serum E1levels were positively associated with TBBMD (~=0.36 ± 0.12 
(g/cm2)/(nmol!l). P=0.004. age adjusted). Serum E2 concentrations (totaL free and non-
SHBG bound) were positively related to TBBMD as well as to hip BMD (Table 9). Serum 
E1 contributed slightly more to the variation in TBB:rviD. as shown by the standardized 
regression coefficients (respectively 0.10 for E2 and 0.13 for E1). To investigate whether 
the above described effect ofT on BMD might be mediated through its aromatization to 
estrogens, a multiple regression analysis was performed, including BMD as the 
dependent variable and E2 and T as the independent variables. E2 and TT remained 
independently related to TBBMD, and contributed equally to the variation of TBBMD, 
as shown by the standardized regression coefficients (both 0.11). Again, serum E1 
contributed to a slightly greater variation in TBBMD compared to TT (standardized 
regression coefficients respectively 0.12 and 0.10). Further. with regard to hip BMD. E2 
and non-SHBG-T remained independently, significantly related to BMD. Similar results 
were obtained when non-SHBG-E2 was the independent variable. 
Measures of E1 and E2 were not related to body composition: neither to lean mass. 
nor to total or trunk fat mass. Nor were they related to fat mass after adjustment forT. 
A weak positive association was found between E1 and waist-hip ratio (j3=0.13 ± 0.07 
/(nmolll). P=0.0-5). 
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1-Iaximun Leg Total Body Bone Ward Bone AHneral Fat Mass (kg) 
Extensor Strength Mineral Density Density (g/cm2) 
(Nm) (g/cm2) 
~ S.E. B p S.E. B p S.E. B p S.E. B 
Total Testosterone (TI, 0.99 0.33 0.14 2 0.00 0.00 0.132 0.005 0.003 0.081 -0.49 0.09 -0.131 
nmol/1) 
Free 1'estosterone (FT, 151. 76.6 0.101 0.69 0.35 0.093 0.88 0.63 0.074 -86.0 21.8 -0.101 
nmolll) 
Calculated FT (nmolll) 55.5 15.4 0.171 0.28 0.07 0.181 0.35 0.13 0.142 -16.6 4.5 -0.131 
Non-SHBG-'1' (nmolll) 1.93 0.52 0.171 0.01 0.00 0.201 0.012 0.004 0.142 -0.53 0.15 -0.131 
TT I SHBG ratio 25.5 6.56 0.181 0.14 0.03 0.221 0.14 0.05 0.132 -1.77 1.93 -0.124 
TT adjusted for SHBG 1.11 0.3•1 0.161 0.00 0.00 0.161 0.007 0.003 0.12:1 -0.42 0.10 -0.141 
(nmoln) 
p denotes coefficient of linear regression, B denotes standardized linear regTession coefficient 
Non-SHBG-T denotes non SHBG bound testosterone 
All analyses were done after adjustment. for age and BMI. 
1 P5:0.001, 2 P5:0.01, -~ P5:0.05, 4 P>0.05 
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Table 9. Relation between serum estradiol concentrations and bone mineral density 
(BMD) 
Estradiol Free E2 (pmolJl) Non-SHBG-E2 
(E2. nmolll) (nmolll) 
r ± s.E. B r ± s.E. B r± s.E. B 
Total body BMD (g/cm2) 0.21 ± 0.08 0.13' 0.009 ± 0.003 0.14' 0.31 ± 0.10 0.14' 
Femur Neck BMD (g/cm2) 0.26::::: 0.12 0.113 0.011 ± 0.005 0.113 0.36 ± 0.16 0.113 
Femur Ward BMD (g/cm2) 0.29 ± 0.14 O.ll3 0.013 ± 0.006 0.113 0.42 ± 0.18 0.123 
Femur Trochanter BMD 0.32 ± 0.12 0.12:! 0.013 ± 0.005 0.13:! 0.41 ± 0.15 0.13:! 
(g/cm') 
)3 denotes coefficient of linear regression. B denotes standardized linear regression coefficient 
All analyses were done after adjustment for age and BMI. 1 P::;O.OOl. 2 P::;O.Ol. 3 P::;0.05 
DISCUSSION 
In this population, circulating non~SHBG-bound and free testosterone (T). estrone 
(El). and estradiol (E2) (total. free and non-SHBG-bound) levels all declined with age. 
Serum total testosterone (TT) did not change \Vith age. while the SHBG bound fraction of 
both T and E2 increased with age. Serum concentrations of the non-SHBG-bound T were 
most strongly related to several physical characteristics of aging: positively with muscle 
strength and bone mineral density (BMD). and inversely with fat mass. Serum El and 
E2 concentrations were positively associated with BMD. but not with muscle strength. 
Free and non-SHBG~bound E2 were more strongly related to BMD than total E2. 
Serum T concentrations as found in this study seem to be relatively low. Furthermore. 
calc-FT concentrations were significantly higher than measured FT. It has to be 
questioned if the FT assay provides a good method to measure the biologically active 
fraction of circulating T. Our findings that FT (both measured and calculated). non~ 
SHBG-T and the TT/SHBG ratio decrease with increasing age. are in agreement with 
prev-ious studies (2.21,22). Total testosterone (TT) levels did not decrease with age. but 
TT levels in this population were below the normal range for middle aged adults. 
suggesting that T levels had already declined in comparison with younger men. To our 
knowledge. no reference values for percentage of SHBG bound. albumin bound and free 
fractions of testosterone exist in the elderly. The decrease of bioavailable T is probably 
due to the increase of SHBG-bound T with age. in combination to the decrease of the 
albumin bound fraction to a similar extent. 
Until recently not much attention has been paid to the role of estrogens in elderly 
men. The studies which have been reported so far. show no change of total E2levels with 
age in men (23-25). or a decrease of E2 levels only at old age (26). In the present study 
serum total E2 was inversely associated with age. Bioavailable and free E2 
concentrations decreased with age to an even greater extent than total E2. Two earlier 
studies also reported a decrease ofbioavailable E2 (12.25). We studied. however. an older 
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and larger population compared to these studies. As with T. the SHBG bound fraction of 
serum E2 increased with age, while the albumin fraction decreased. In addition. serum 
E1 concentrations decreased with age. 
A number of clinical problems prevalent in older men may be related to androgen 
deficiency. including reduced muscle strength (27.28). changes in body composition and 
loss of bone mineral density (1,3,4). It should be of interest to know whether the decrease 
in bone mass with age is causally related with the decrease in lean mass, and/or in 
serum testosterone or estradiol concentrations. Also, it would be important to investigate 
whether the fall in lean mass with age is caused by the decrease in muscle strength. 
and/or serum testosterone or estradiol concentrations. Finally, also the reverse could be 
the case. in which the decrease in muscle strength with age. is caused by the fall in lean 
mass. and/or serum testosterone levels or other factors. Unfortunately, the cross~ 
sectional nature of our study does not allow a differentiation between cause and effect. 
All the factors are statistically related, making it impossible to differentiate which factor 
explains another. Therefore no conclusions can be drawn concerning the physiological 
pathway(s). For example. also physical activity per se might be a factor contributing to 
the relationships found. A longitudinal study is necessary to answer these questions. 
From the results of our study, we can. however. confirm previous findings, that serum 
testosterone was. independent of age, positively related to both IGS and ma.-..::LES. In 
addition. we found a positive. age independent. relation between estimates of serum 
testosterone levels and bone density. Further. in agreement with previous findings, 
testosterone was inversely associated with fat mass. but not with lean body mass (1). 
Serum non~SHBG·bound T concentrations are not only related to TBB:MD. but also to all 
regions of the proximal femur BMD. 
In this study we established whether free T. the non~SHBG~bound fraction ofT or TT 
measured in plasma represent the bioactive hormone best. Pardridge suggested that 
albumin~bound T is available for uptake by most tissues. while SHBG·bound T is not 
(13). Considering the fact that non~SHBG-T as well as the albumin bound fraction were 
strongly related to the physical characteristics of aging, it is possible that the albumin 
bound fraction of T is available for uptake by tissues and can exert biological effects. 
Furthermore, in agreement with the suggestion of Pardridge. SHBG-bound T was not 
related to any physical characteristic. Serum non-SHBG-T concentrations were stronger 
related to the physical characteristics than TT. as shown by the standardized regression 
coefficients, and slightly stronger than serum calc-FT concentrations. In addition. non-
SHBG-T levels were related to proximal femur B:MD. while TT levels were not. 
There was a considerable difference in the relationships between non-SHBG-bound T 
calculated according to the method described by S6derg&rd et al. on the TT/SHBG ratio 
as a measurement of non-SHBG~bound T on the one hand and the physical 
characteristics on the other hand. The TT/SHBG ratio probably reflects in part the non~ 
testosterone dependent inverse association of SHBG with these characteristics 
(demonstrated in the relation with lean mass, fat mass and BMD). Furthermore, use of 
the ratio obfuscates the absolute levels of the components of the quotient. TT adjusted 
for SHBG as a measure of non-SHBG-bound T. is probably a better parameter than 
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TT/SHBG. because the inverse associations of SHBG are not taken into account. 
However. as judged by the standardized regression coefficients. it shows no clear 
advantage compared to non-SHBG-T. Thus, the calculated bioavailable T concentration 
according the method described by S6derg&rd et al. appears to be an easy, inexpensive 
and informative measure in representing the bioactive fraction of circulating T. 
Most of the E2 and about 20 % of El produced in normal men is formed by 
extraglandular aromatization of circulating androgens. A smaller part of the circulating 
E2 is derived from a direct secretion by the testicles (29). Most of the El in elderly men 
is produced by the adrenals. Recently it has been demonstrated that estrogens play an 
important role in maintaining bone mineral density in healthy older men (5.30). 
Trabecular bone is generally thought to be more responsive to gonadal steroids than 
cortical bone. However. we did not measure spinal BMD, as degenerative arthritis 
influences the outcome of measurements too strongly. In our population serum total E2 
was independent of age, strongly positively related to BMD at all sites measured. Serum 
non-SHBG-bound E2 was slightly stronger related to BMD at all sites measured 
compared to total E2. as shown by the standardized regression coefficients. This 
suggests that the non-SHBG-bound fraction of E2 is the best representation of bioactive 
hormone. although to a lesser extent than is the case for testosterone. possibly because 
E2 is more dissociable from SHBG than T. These findings are in agreement with those 
described by Khosla et al. (12). Also serum El concentrations were related to bone 
density. although to TBBMD only. However, this relation was independent of E2 and T 
and contributed to an even greater extent to the variation in TBBMD than E2 or T 
levels. This might imply that El has an effect on BMD directly. or that it is locally 
converted to E2. Serum T and E2 both contribute equally to the variation in BMD. 
suggesting that the effect of T on bone is not only attributed to the aromatization to 
estrogens (31). 
Although it is generally accepted that estrogens and fat mass. especially trunk fat, are 
strongly related in postmenopausal women (32), we did not find a significant relation 
between El or E2 and (trunk) fat mass in these elderly men. before or after adjustment 
for testosterone. This confirms other findings that aromatase activity is also present in 
other tissues apart from fat (33-36). 
In summary, together v.rith a decline in muscle strength. bone density and body 
composition, bioavailable testosterone, estrone. total estradioL and bioavailable estradiol 
all decrease v.rith age in healthy old men. In this cross-sectional study in healthy elderly 
men, non-SHBG-bound testosterone seems to be the best parameter for serum levels of 
bioactive testosterone. which appears to play a direct role in the various physiological 
changes which occur during aging through its positive relation v.rith muscle strength and 
bone mineral density and its negative relation v.rith fat mass. In addition, both serum 
estrone and estradiol seem to play a role in the age-related bone loss in elderly men, 
although the cross-sectional nature of this study precludes definitive conclusion. Non-
SHBG bound estradiol seems to be the best parameter for serum levels of bioactive 
estradiol in describing its positive relation with bone mineral density. 
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LH as indicator of frailty 
ABSTRACT 
Objective We investigated the possible clinical correlates between the serum LH 
concentration and characteristics offrailty, and determined the presence and concentration 
of a genetic LH variant, in an independently living population of elderly men. 
Methods After exclusion of subjects with severe mobility problems and signs of dementia, 
403 healthy men (aged 73-94 years) were randomly selected from a population based 
sample. Total testosterone (TT). SHBG and leptin were determined by RIA. Non-SHBG 
bound testosterone (non-SHBG-T) was calculated. Luteinizing hormone (LH) and the 
presence of the genetic LH variant were measured using immunofluorometric assays. The 
characteristics of frailty were leg extensor strength (ma'<LES) using dynamometry. bone 
mineral density (BMD) of total body and proximal femur and body composition. including 
lean mass and fat mass, measured by dual energy X-ray absorptiometry. Disability was 
further assessed by the Modified Health Assessment Questionnaire (MHAQ) and by a 
measure of physical performance (PPS). 
Results LH significantly increased with age, and inversely correlated with TT and non-
SHBG-T. LH was inversely related to muscle strength and lean mass and both relations 
were independent of testosterone. LH was positively related to self-reported disability 
(MHAQ). 12.5% of the study population was heterozygous for the LH variant allele. 
Testosterone levels and the degree of frailty were not different in the wild-type LH group 
compared with the heterozygote LH variant group. However, the proportion of heterozygote 
LH variants was significantly higher in those subjects with TT or non-SHBG-T 
concentrations in the lowest 10% of our study population and LH concentrations> 10 IU/l. A 
significant positive relation between LH and fat mass as well as leptin was only present in 
the heterozygote LH variant group. 
Conclusions Serum LH levels increases with age in independently living elderly men and 
correlates inversely with a variety of indicators of frailty. The observed relation between LH 
and frailty, independent of T. suggests that LH reflect serum androgen activity in a 
different way than T. possibly reflecting more closely the combined feedback effect of 
estrogen and androgen. As a relatively higher proportion of subjects heterozygous for the LH 
variant allele had high LH and low T levels, the two LH forms may differ in biological 
response, in favor of wild-tyPe LH. 
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INTRODUCTION 
Physical frailty in the elderly is defined as "a state of reduced physiological reserves 
associated with increased susceptibility to disability" (1). Age~related disability is 
characterized by generalized weakness. impaired mobility and balance, and poor endurance. 
Clinical correlates of physical frailty include falls. fractures. impairment in activities of 
daily living. and loss of independence: falls contribute to 40% of admissions to nursing 
homes (2). Falls are significantly associated with slow gait, poor physical performance and 
lack of muscle strength (3-5). 
In a previous study we demonstrated that low testosterone (T) levels in a population of 
healthy elderly men were associated with reduced muscle strength and bone mineral 
density and increased fat mass (unpublished data). Since a negative feedback relationship 
exists between T and LH. also the circulating LH level may serve as an indicator of frailty. 
Recently a common variant form of LH was detected in apparently healthy individuals. 
caused by point mutation~based substitutions of two amino acids (Trp8Arg and IlelGThr) in 
the LH~ subunit (6~8). Suggestions have been made that the in vivo bioactivity of the LH 
variant is lower than that of the wild~type hormone. due to its shorter circulatory half-time 
(9,10). Raivio et al.(lO) suggested that the occurrence of the variant LH may be a factor 
contributing to delayed pubertal tempo in othel""'Nise healthy boys. No data are available yet 
describing the presence and bioactivity of this LH variant in elderly populations. 
We investigated serum LH levels in relation to characteristics of frailty and determined 
the presence and concentration of the genetic LH variant in an independently living 
population of elderly men. The purpose was to find out whether any of the variable 
alterations in the pituitary~ testicular function with aging could be related to the occurrence 
of a biologically dissimilar variant form of LH. 
METHODS 
Subjects 
A group of 403 independently living men. aged 73 or above. participated in this study. 
Participants were recruited by letters of invitation. which were sent to the oldest male 
inhabitants of Zoetermeer. a medium sized town in the mid~western part of the 
Netherlands. All participants provided informed consent. and the Frail Old Men study was 
approved by the Medical Ethics Committee of the Erasmus University Hospital Rotterdam. 
Participants were judged sufficiently healthy to participate in the study when they were 
physically and mentally able to visit the study center independently. No additional health 
related eligibility criteria were used. 
Hormone measurements 
Blood samples were collected in the morning after an overnight fast. Serum 
concentrations of total testosterone (TT. nmolll). sex hormone binding globulin (SHBG, 
nmolll) were all measured by radioimmunoassay using commercial kits (Diagnostic System 
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Laboratories. Webster. Texas. USA). The intraassay coefficients of variation (CV) were 
respectively 8.1%. 6.2% and 3.0%. The interassay CVs were resp. 10.5%, 9.7% and 4.4%. The 
Free Testosterone RIA uses an [125I]-labeled testosterone analog which has low affinity for 
SHBG and albumin. Non SHBG bound testosterone (non-SHBG-T. nmol/1) was calculated 
according to a method described by SOderg3.rd et al. (11). Leptin (J..I.gll) was also measured by 
radioimmunoassay (Lilly Research Laboratories. Giessen. Germany). Albumin (gil) was 
measured by photometry using a commercial kit (ALB. Boehringer. Mannheim. Germany). 
Luteinizing hormone (LH. IU/l) was measured by an immunofluorimetric assay (Delfia. 
Wallac Oy. Turku. Finland). The LH variant was recognized after calculation of the ratio of 
the results of two LH assays. The Delfia method for LH (LHspec). which uses two LH 13-
subunit-specific monoclonal antibodies (mAb) (12.13) served as a reference method (assay 2). 
In the other assay (assay 1). the capture mAb recognizes a conformational epitope present in 
the wild-type o:./13 LH dimer but not in the variant form of LH or the free subunits. and the 
detection mAb recognizes an epitope in the a. subunit (6). The ratio of LH values measured 
by the two assays (assay 11 assay 2) was used to assess the variant or wild-type LH status. 
Three separate categories of this ratio were obtained: [1] normal ratio (>0.9). [2] low ratio 
(0.2 to 0.9). and [3] zero ratio (<0.15). A normal ratio individual has two wild-type LH-
alleles: a low ratio individual is heterozygous for the LH variant allele: and a zero ratio 
individual is homozygous for the variant LHI3 gene. as confirmed by DNA analysis {9. 14. 
15). The sensitivity of the two immunofluorimetric assays was 0.05 lUll. and the intra-assay 
and interassay coefficients of variation were < 4% and 5%. respectively, at LH 
concentrations at and above the lowest standard concentration (0.6 IU/l ofthe World Health 
Organization International Reference Preparation 80/552). 
Measures of Muscle Strength 
Isometric grip strength (IGS) was measured using an adjustable hand held dynamometer 
(JAJ\!IAR dynamometer) at the non-dominant hand (16). Each test was repeated three times 
and the average was used in the analyses. Leg or knee extensor strength (LES) was 
measured as described previously (17.18) using the Hoggan MicroFET hand held 
dynamometer. To obtain one main outcome measurement for leg extensor strength. 
··maximum leg extensor strength .. (ma.U.ES) was defined as the ma.ximum strength for the 
right or left leg. whichever is largest. in a position of 120° extension. Statistical analyses 
were based on the physical unit momentum (Nm). obtained by multiplying the ma.ximum 
strength (in Newton) and the distance of the dynamometer to the knee joint (in meters). 
Bone mineral density and body composition measurements 
Total body bone mineral density (TBBJ\.ID) was measured using dual energy x-ray absorp-
tiometry (DEXi\. Lunar. Madison. WI). as were hip bone mineral densities at the femoral 
neck, trochanter and Ward's triangle. In addition. total and trunk lean body mass and fat 
mass were measured (19). Quality assurance for DEX..<\. including calibration was performed 
routinely every morning. using the standard provided by the manufacturer. 
Height and weight were measured in standing position without shoes. Body mass index 
(BMI) was calculated as the weight in kilograms divided by the square of the height in 
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meters. 
Physical Performance 
Lower eA"tremity function. or physical performance score (PPS). was assessed as described 
by Guralnik et al. (20). including measurements of standing balance. walking speed and 
ability to rise from a chair. Three tests of standing balance were considered in hierarchical 
difficulty in assigning a single score of 0 to 4 for standing balance. For the 8-foot walk and 
repeated chair stands. those who could not complete the task were assigned a score of 0. 
Those completing the task were assigned scores of 1 to 4. corresponding to the quartiles of 
time needed to complete the task. v.rith the fastest times scoring as 4. A summary 
performance scale was created by summing the category scores for the walking. chairstand. 
and balance test. 
Satisfaction in performing activities of daily living (i\DL) was assessed by using a self-
administered questionnaire from the Stanford Modified Health Assessment Questionnaire 
(MHAQ) as described by Pincus eta! (21), in which high score means low ability, The final 
score of the MHAQ was not normally distributed. Analyses were done after logarithmic 
transformation. 
Data analyses 
Results were expressed, unless otherwise stated. as mean and standard deviation with 
the interquartile (IQ) range. Relations between variables were assessed using linear 
regression for continuous variables and logistic regression for binary variables, and 
described as the linear regression coefficient (j3) and its S.E .. Multiple regression analysis 
was used to adjust for age and BML as well as to assess the contribution of different 
independent variables to the dependent variable. Correlations between variables were 
assessed by using Pearson's correlation coefficient r. Pearson chi-square test was used to 
assess differences of variables between groups. If not mentioned otherwise all analyses were 
done after adjustment for age. 
RESULTS 
Descriptive data of all parameters measured are shown in Table 1. Their relations v.rith 
age are shown in Table 2. LH was significantly positively related with age and SHBG 
(Table 3). An inverse relation existed between LH and the different testosterone (T) 
measurements (Figure 1 and Table 3). Albumin and leptin levels were not related v.rith LH. 
Testosterone and frailty 
Testosterone (f) was independently related to muscle strength, bone mineral density and 
fat mass. Linear regression coefficients for relations between non SHBG bound T (non-
SHBG-T) and ma."ci.mum leg extensor strength (maxLES), respectively. total body bone 
mineral density (TBBMD) were B= L93 ± 0,53 and B= 0,01 ± 0,002 (P<O,OOl), Twas not 
related to lean mass or the physical performance score. 
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Table 1. Descriptive Data of the study population (n::;4Q3) 
Mean ±SD Interquartile range 
Age (_vr) 77.8 3.58 75 so 
BMI 25.5 3.04 23.32 27.25 
Total Testosterone (nmo111) 8.83 2.98 7.19 10.66 
SHBG (nmolll) 31.5 14.4 23.2 37.5 
Non SHBG bound T (nmolll) 5.68 1.89 4.62 6.76 
Luteinizing Hormone (lUll) 9.38 8.41 4.57 11.15 
Leptin ("gil) 5.35 4.21 2.45 6.90 
Albumin (g/1) 45.6 2.76 43.8 47.5 
IGS (kg) 34.3 6.9 30.0 38.7 
MaxLES (Nm) 103.2 20.9 89.4 117.1 
Total Fat Mass (kg) 21.2 6.4 17.4 24.5 
Total Lean Mass (kg) 51.7 5.6 47.8 55.5 
Total Body BMD (g/cm2) 1.17 0.10 1.11 1.23 
Femoral Neck B:MD (g/cm2) 0.88 0.14 0.78 0.97 
Femoral Ward BMD (g/cm2) 0.72 0.16 0.60 0.82 
Femoral Trochanter BMD (g/cm2) 0.85 0.15 0.76 0.94 
Physical Performance (points) 8.45 2.43 7 10 
MHAQ (points) 10.7 4.30 8 12 
IGS denotes Isometric Grip Strength. MaxLES denotes Ma.ximum Leg Extensor Strength. MHAQ 
denotes Modified Health Assessment Questionnaire. Normative values for healthy young men are 
9.72- 30.54 nmolll for Total Testosterone. 10- 55 nmolll for SHBG. and 3.6- 17.1 lUll for 
Luteinizing Hormone. 
Table 2: Relationship between age and the hormones and the characteristics of Frailty 
Age (yr) 
~ ±S.E. P-value 
Luteinizing Hormone (lUll) 0.06 ± 0.01 <0.001 
Total Testosterone (nmolll) -0.04 ±0.04 0.37 
SHBG (nmolll) 0.92 ±0.20 <0.001 
Non SHBG bound Testosterone (nmolJl) -0.07 ± 0.03 O.Dl 
Leptin (J..Lgll) -0.02 ± 0.01 0.04 
Albumin (gil) -0.07 ±0.04 0.06 
~coefficient denotes changes in unit per year. For example: LH increases with 0.06 lUll per year 
71 
Chapter 4 
Table 3. Associations ofLH with hormones. SHBG. albumin and characteristics of frailty. 
LH (IU!l) (n=403) 
~ ±S.E. p 
Hormones (dependent variables) 
Total Testosterone (nmol!l) -0.12 0.02 <0.001 
SHBG (nmolfl) 0.31 0.09 <0.001 
Non SHBG-Testosterone (nmol!l) ·0.09 0.01 <0.001 
Leptin Oog) ("gil) 0.002 0.005 0.63 
Albumin (gil) ·0.002 0.02 0.91 
Characteristics of Frailty (dependent variables) 
Ma:cimum Leg Extensor Strength (Nm) -0.41 0.12 <0.001 
Isometric Grip Strength (kg) ·0.09 0.04 0.03 
Lean mass (kg) ·0.11 0.09 <0.001 
Fat mass (kg) ·0.03 0.04 0.43 
Total Body Bone Mineral Density (g/cm2) ·0.0005 0.005 0.38 
Physical Performance Score (points) ·0.001 0.001 0.17 
MHAQOog) (points) 0.01 0.002 <0.001 
f) denotes linear regression coefficient. For example: Total Testosterone (TT) decreases 0.12 
nmol!l per IU!l Luteinizing Hormone (LH). Modified Health Assessment Questionnaire (MHAQ). 
Bone density is also adjusted for body mass index. 
Figure 1. Relation between Total Testosterone and Luteinizing Hormone (LH) (logarithmically 
transformed) of Wild-type LH variant subjects. Heterozygote LH variant subjects and Homozygote 
LH variant subjects. 
Ci g 
§ 
I 
...J 
72 
60 • 
40 
• 
20 'C 8 
10 
8 
6 
4 
z 
2 
1 
0 
rr 
+ 
~? 
.e"'• 
+ 
4 
• • ~T 
s 
" z z 
G 
' " 
7! 
-:t::< ., 
·s 
' 
8 12 
Total Testosterone (nmolll) 
c 
• = z 
= 
= 
' 
z 
• z 
Ill Homozygous 
' Wild·Type 
• Heterozygous 
16 20 
LH as indicator of frailty 
Luteinizing Hormone and frailty 
The relations between LH and the measures of frailty are shown in Table 3. LH was 
inversely related to maxLES (Figure 2a). LH was also inversely related to lean mass, 
independent of ma..U.ES (Figure 2b). LH was not associated with bone mineral density or fat 
mass in the whole group. A positive relation existed between LH and MHAQ. MHAQ and 
ma..'XLES were strongly related, but the relation between LH and MHAQ was independent of 
ma..-xLES. Subjects with LH values in the highest quartile had 10.1% lower ma.."{LES values 
and 18.7% higher MHAQ values compared to subjects with LH levels in the lowest quartile 
(after adjustment for age and BMI). 
Because we demonstrated that low T levels were accompanied by reduced muscle 
strength, a multiple regression analysis was performed including LH and T. Both T (total 
and non-SHBG bound) and LH were significantly, but independently, related to maxLES 
and isometric grip strength. Multiple regression coefficients of the relations between 
maxLES and, respectively, LH andnon-SHBG-Twere ~= -0.29 ± 0.13 (P=0.03) and~= 1.42 ± 
0.56 (P=O.Ol). Non-SHBG-T and LH were also both related to MHAQ. However, in a 
multiple regression analysis including LH and non-SHBG-T, only LH remained 
significantly. inversely related to MHAQ (~= 0.007 ± 0.002; P<O.OOl and~= -0.008 ± 0.009; 
P=0.40, respectively). 
Luteinizing Hormone variants 
The heterozygote form of the LH variant was present in 12.5% (50 men) in this study 
population of elderly men. Mean concentrations ofTT. non-SHBG-T, LH. SHBG.leptin and 
albumin were not different in the wild-type LH group compared with the heterozygote LH 
variant group. The homozygote form of the LH variant was present in only 2 subjects (0.5%). 
Their TT values were 6.32 nmolll and 9.97 nmolll 
The relations between LH and T and age, respectively. were not different in the two LH 
groups (Table 4). 
None of the characteristics of frailty was different in the heterozygote LH variant group 
compared to the wild-type LH group. Mean values of the measures of frailty of the two 
variant LH homozygote individuals were also within the ranges of the other groups. The 
relations between LH on one hand, and the different measures of frailty on the other. in the 
two LH variant groups are shown in Table 4. Interestingly. LH was positively associated 
with fat mass and leptin only in the heterozygote LH variant group. This remained after 
adjustment forT (TT or non-SHBG-T). 
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Figure 2. Relation between Luteinizing Hormone (LH) in units per litre (IU/l) and A) maximum leg 
e::-...-tensor strength (maxLES) in newton meters (Nm) and B) Lean Body Mass in kilograms. Coef 
denotes coefficient of linear regression. 
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Table 4. Age adjusted linear regression analysis between LH and hormones respectively 
characteristics of frailty in the wild-type LH group and in the heterozygote LH variant group 
Wild-type LH Heterozygote LH variant 
(n=347) (n=50) 
~± S.E. p ~±S.E. p 
Hormones and SHBG 
Age (yr) 0.44 0.11 <0.001 1.73 0.39 <0.001 
Body Mass Index -0.0.5 0.02 0.02 0.06 0.04 0.14 
Total Testosterone (nmol!l) -0.11 0.02 <0.001 -0.16 0.04 <0.001 
Non-SHBG-Testosterone (nmol!l) -0.0004 0.0001 <0.001 -0.0005 0.0001 <0.001 
SHBG (nmolfl) 0.45 0.10 <0.001 0.05 0.13 0.69 
Leptin (log) (!!gil) -0.004 0.006 0.46 0.03 0.01 0.02 
Characteristics of frailty 
MaxLES (Nm) -0.49 0.14 <0.001 -0.46 0.28 0.11 
Isometric Grip Strength (kg) -0.09 0.05 0.05 -0.15 0.11 0.17 
Lean mass (kg) -0.16 0.04 <0.001 0.022 0.070 0.75 
Fat mass (kg) -0.03 0.04 0.43 0.23 0.07 0.001 
TBBMD (g/cm') -0.0001 0.001 0.92 -0.002 0.001 0.19 
Physical Performance (points) -0.001 0.001 0.26 -0.001 0.001 0.26 
MHAQ (log) (points) 0.006 0.002 0.007 0.012 0.004 0.004 
~ denotes linear regression coefficient. Maximum Leg Extensor Strength (Ma.xLES), total body 
bone mineral denisty (TBBMD). and Modified Health Assessment Questionnaire (MHAQ). 
DISCUSSION 
In an independently living population of healthy elderly men. LH significantly increased 
with age. This gonadotropin was inversely associated with testosterone (TT and non-SHBG-
T). LH was, independent of T, negatively related to several characteristics of frailty, i.e. 
maxLES and lean mass and positively with self-reported disability. In this population, 
12.5% were heterozygous for the LH variant allele. In the heterozygote LH variant subjects, 
but not in those with wild-type hormone, LH was positively related to fat mass and leptin. 
Conflicting results have been reported concerning the question whether LH increases 
with age or remains relatively stable (22,23). One reason may be that the aging-induced 
decrease in testosterone is primarily testicular in some men, mainly due to hypothalamo-
pituitary insufficiency in others and of mixed origin in a third group. In our study 
population LH increased significantly with age. The inverse relation we found between LH 
and TT, could be due to the rather low T levels of the subjects in our study population. It is 
likely that in subjects with low T levels. LH cannot increase T, because of a primary 
disturbance of Leydig cell function. 
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The strong inveree relation of LH with muscle strength. lean mass and self· reported 
disability. which is independent ofT. suggests that also LH reflects the process of frailty. 
This association has not been described before. Our observation might imply that LH 
monitors androgen effects in a different manner than testosterone. probably because LH 
levels reflect the sum of systemic testosterone levels as well as locally produced 5a-
dihydrotestosterone and estrogens which are produced via the local conversion ofT. We did 
measure estradiol in this study: however. this hormone could not explain the independent 
relation ofLH to the characteristics of frailty. The mechanism of this relationship remains 
to be elucidated. 
Previously. a common variant form ofLH has been detected in apparently healthy indivi-
duals. due to the point-mutation based substitutions described above. There is a large 
variation in the common frequency of this polymorphism in different populations (0-50%) 
(15). and presently research is performed to investigate its possible clinical correlates. The 
prevalence of heterozygozity for the LH variant allele in the current cohort of subjects is in 
agreement with frequencies measured previously in The Netherlands. which found a mean 
frequency of 14.3% (95% confidence interval5.7-22.9) in 63 men and women aged 15 years 
and older (15). The stability of the prevalence across age groups suggests that there is no 
selection regarding survival of the LH variant. It has been proposed that the in vivo 
bioactivity of the LH variant is lower than that of the wild-type hormone. due to its shorter 
circulatory half-time (9.10). On the other hand. this may be compensated for by the higher 
bio/immuno ratio of the variant hormone at the LH target cell level (8.24). Neither the mean 
T. SHBG and leptin levels nor the mean values of characteristics of frailty differed between 
subjects with the wild-type LH and subjects with the heterozygote form of the LH variant. 
However, from subjective assessment of the findings presented in Figure 1 .. it appears that 
the proportion heterozygous for the LH variant was relatively large in a group of subjects 
with low T and high LH concentrations. This is compatible with a reduced in vivo bioactivity 
of LH in the heterozygous individuals. Further. we observed differences in the relations 
between LH and leptin as well as fat mass between subjects with the different LH forms. 
The nature of these differences remains to be explained. 
In conclusion. in independently living elderly men, LH increases with age and is 
inversely related toT. The observed relation between LH and frailty. independent ofT. 
suggests that LH levels reflect the overall serum androgen activity in a different manner 
from T. possibly reflecting the combined effect of estrogen and androgen feedback action at 
the hypothalamic-pituitary level. The hormone levels and the degree of frailty are not 
different in the wild-t:ype and heterozygote LH groups. However. a difference in biological 
response between the two LH forms. in favor of the wild-type form is suggested. because it 
seems that a relatively high proportion of subjects heterozygous for the LH variant allele 
have high LH and low T levels. In addition. a difference exists in the relation between LH 
and fat mass. respectively leptin. in the heterozygote LH variant subjects versus the wild-
type LH subjects. 
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High rT3 concentrations are associated with a low physical function 
ABSTRACT 
Objective Thyroid hormones regulate the metabolic thermostat by stimulation of the 
basal metabolic rate. Therefore physiological changes in thyroid hormone concentrations 
with aging might influence the overall physical functional status. We determined in a 
cross-sectional setting to what extent thyroid hormone concentrations are related to 
physical functional status in elderly independently living men. 
Methods 403 independently and ambulatory living men (aged 73 to 94 yr) were 
randomly selected from a population-based sample. Thyroid-stimulating hormone (TSH). 
free and total thyroxine (FT4 and T4), triiodothyronine (T3), reverse T3 (rT3), thyro:>-ine 
binding globulin (TBG) and T4 sulfate (T4S) were measured. Physical functional status 
was estimated by the number of problems in activities of daily living (i\DL), a measure of 
physical performance. leg extensor strength and grip strength. bone mineral density and 
body composition. including lean mass and fat mass. Quality of life was assessed using a 
validated questionnaire. Associations were adjusted for age. 
Results Serum rT3 concentrations increased significantly with age and with the 
presence of disease. Thyroid hormone (metabolite) concentrations were related to 
parameters of physical functional status: independent of disease and after exclusion of 
subjects with the low T3 syndrome, lower serum total and free T4 and rT3 
concentrations and a higher T3/TBG ratio were related with a higher grip strength 
(P<0.05). Also independent of disease. higher free T4. rT3 and T4S levels were associated 
with a lower physical performance (P<O.Ol). Higher rT3 levels were also associated with 
more problems in ADL and lower leg ex-tensor strength and bone mineral density and a 
lower quality of life (P<0.05). Some of these relations were partially dependent on the 
presence of disease 
Conclusions In a population of independently living elderly men. serum rT3 
concentrations increase with age and with the presence of disease. Higher free T4 and 
rT3 concentrations are associated with a lower physical functional status. Higher serum 
rT3 concentrations may result from a decreased peripheral metabolism of thyroid 
hormones due to the aging process itseJi and/or to disease. and may reflect a certain 
catabolic state. Remarkably. rT3 levels remain associated with several parameters of 
physical function in the absence of systemic disease and the low T3 syndrome. Serum 
rT3 levels may therefore be a marker of physical function in the elderly. whether or not 
determined by disease or a poor nutritional status. 
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INTRODUCTION 
Features of aging are in part similar to those of hypothyroidism. In both conditions 
basal metabolic rate (BMR) decreases (1). Several changes in th:yroid hormone 
concentrations occur during aging: serum thyroid~stimulating hormone (TSH) 
concentrations decrease in healthy elderly humans. serum total and free 
triiodothyronine (T3) levels demonstrate a clear. age~dependent decline. whereas serum 
total and free thyroxine (T4) concentrations remain unchanged (2). These changes are 
often determined by or occur in parallel with a poor health status (reviewed by Mariotti 
(2)). Serum reverse T3 (rT3). an inactive metabolite ofT4. seems to increase with age (3). 
Together with the decrease in serum T3 levels, this may indicate a decreased peripheral 
metabolism of thyroid hormones during aging. VVhether T4 sulfate, another inactive 
metabolite of T4, changes with age is not known. However. evaluation of normal thyroid 
function in the elderly is complicated by an increased prevalence of non~thyroidal illness 
and by autoimmune subclinical hypothyroidism (4). 
Thyroid hormones are known to regulate the metabolic thermostat by changing the 
basal metabolic rate. One may hypothesize therefore. that physiological changes in 
thyroid hormone concentrations might be related with changes in the overall physical 
functional status in the elderly. 
We determined in a cross~sectional setting to what e>.."'tent thyroid hormone 
concentrations are related to age as well as to several physical characteristics of aging 
in independently living, elderly men. In addition. we determined whether potential 
associations between thyroid hormone concentrations and age and physical status are 
due to the presence of disease. 
METHODS 
Subjects. 
A cross~sectionaL single~centre study was conducted in 403 independently living and 
ambulatory men. aged 73 years and higher. Names and addresses of all male inhabitants 
70 years and older were obtained from the municipal register of Zoetermeer. a medium 
sized town in the mid-western part of the Netherlands. 1567 men were invited. A total of 
886 men did not respond to the mailed invitation in which it was mentioned that only 
subjects who lived independently and had no severe mobility problems could participate. 
After exclusion of subjects who did not live independently and subjects who were not 
physically or mentally able to visit the study centre independently. and subjects with 
severe systemic illnesses. 403 men participated (25.7%). Participants signed informed 
consent. The study was approved by the Medical Ethics Committee of Erasmus Medical 
Center Rotterdam. 
We divided the cohort in four groups according to the number of complaints or 
diseases which were present (0 (n=38), 1 (n=S7). 2 (n=71) and <:3 (n=207)). Present 
diseases included mainly hypertension. cerebral, coronary and peripheral 
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atherosclerosis, mild congestive heart failure. chronic obstructive pulmonary disease, 
diabetes and arthrosis. However, none of the subjects were treated for systemic, 
infectious, inflammatory or malignant disorders at the time of the investigation. 
11 Subjects with known thyroid disease (including subclinical hypothyroidism) or use 
of amiodarone or corticosteroids were excluded from the analyses. A number of 
participants were taking medication for hypertension (n=96), angina pectoris or a 
myocardial infarction more than sLx months ago (n=85), mild congestive heart failure 
(n=28). chronic obstructive pulmonary disease (n=40). and diabetes (n=28). 
Hormone measurements 
Blood samples were collected in the morning after an overnight fast. Serum was 
separated by centrifugation and stored at -40°C. Thyroid-stimulating hormone (TSH) 
was measured using an immunometric technique (Amerlite TSH-30. Ortho-Clinical 
Diagnostics, Amersham. UK). Free thyroxine (FT4). thyroxine (T4), triiodothyronine 
(T3). and reverse T3 (rT3) were all measured by RIA (Amerlite MAE FT4 assay. Ortho-
Clinical Diagnostics, A.mersham. UK; (5)). Thyroid binding globulin was also measured 
by RIA. Intra- and intervariability coefficients of all the assays were below 11%. T4 
sulfate (T4S) was measured according to the method ofWu et al. with slight modification 
(6). It was not possible to measure the T4S concentrations in all samples in a single 
assay. Intra- and intervariability coefficients of the T4S assay were 17% and 19% 
respectively in the low concentration range measured in these elderly men. 
Physical functional status 
Activities of daily living 
Self-reported disability or satisfaction in performing activities of daily living (ADL) 
was assessed by using a self-administered questionnaire modified from the Stanford 
Health Assessment Questionnaire as described by Pincus et al (7). A high score denotes 
high impairment in ADL. 
Physical performance 
Lower extremity function. or physical performance. was assessed as described by 
Guralnik et al. (8). including measurements of standing balance, walking speed and 
ability to rise from a chair. The three tests of standing balance were considered in 
hierarchical difficulty by assigning a single score of 0 to 4 for standing balance. For the 
S-foot walk and repeated chair stands, those who could not complete the task were 
assigned a score of 0. Those completing the task were assigned scores of 1 to 4. 
corresponding to the quartiles of time needed to complete the task, with the fastest times 
scored as 4. A summary performance scale (PPS) was created by summing the category 
scores for the walking. chair stand, and balance test. Mean scores of the three tests as 
well as of the summary performance scale were comparable to subjects of the same age 
group investigated by Guralnik (8). 
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Muscle strength 
Isometric grip strength (IGS) was tested using an adjustable hand-held dynamometer 
(JAJ\tlAR d:ynamometer) in the non-dominant hand (9). Each test was repeated three 
times and the average. expressed in kilo ponds (kp), was used in the analysis. 
Isometric leg e:>.."tensor strength was measured as described by Hsieh and Philips 
using the Hoggan MicroFET hand-held dynamometer (10). The measurement requires 
that the participant. in a seated position. pushes with ma..-cimal strength to the 
dynamometer, which is held at the tibia preferably 33 em below the knee joint. The 
investigator holds the dynamometer in the hand with an extended arm and pushes back 
until the breaking point is reached. To obtain one measure of leg muscle strength. 
''ma..Umum leg extensor strength"" (ma..'XLES) was defmed as the ma..'limum strength for 
the right or left leg in a position of 120°. Statistical analyses were based on the physical 
unit measurement. moments (N*m). obtained by multiplying the maximum strength (in 
Newton) and the distance of the dynamometer to the knee joint (in meters). 
Bone mineral density (BMD) and Body Composition 
Total body bone mineral density (TBBMD) was measured using dual energy X-ray 
absorptiometry (DXA. Lunar. Madison, \iVI). as were hip bone mineral densities at the 
femoral neck. trochanter and Ward's triangle. In addition. total and trunk lean body 
mass and fat mass were measured (11.12). Quality assurance including calibration was 
performed routinely every morning for DXA. using the standard provided by the manu-
facturer. 
Height and weight were measured in standing position without shoes. Body mass 
index (BMI) was calculated as the weight in kilograms divided by the square of the 
height in meters. 
Well-being 
Psychological well-being or quality of life was assessed using a questionnaire with 
questions pertaining to satisfaction in life according to Henrich and Herschbach (13-15). 
The Fragen zur LebenszufriedenheitModule or Questions on Life SatisfactionModule (QLS) 
has been validated for the Dutch population. The questionnaire is divided in a "general" 
and a ''health .. part or module~ each including eight items. All items are evaluated on a 5-
point scale. ranging from 0 to 4. according to their individual importance (I) and degree 
of satisfaction (S). As a measure of evaluation, a combination of importance and 
satisfaction (Lx(2xS-3)) is used. In addition. the sum of the combination values is 
calculated for each module. 
Data analyses 
Results are expressed. unless otherwise stated. as mean and standard deviation. 
Variables which were not normally distributed were logarithmically transformed. 
Comparisons between groups were made by using Student's t-test. Differences are given 
with corresponding 95% confidence-intervals (CI). Relations between variables were 
assessed using linear regression stated as linear regression coefficient (j3) and 95% 
Confidence Interval (95%CI). Multiple regression analysis was used to adjust for age and 
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BMI, and to determine the contribution of dUferent independent variables to the 
dependent variable. Unless otherwise mentioned all analyses are done after adjustment 
for age. 
RESULTS 
Mean age of this population was 77.8 years (range 73 to 94 years). Mean age did not 
differ within the groups with zero to three or more diseases. Summarized values of the 
hormone measurements as well as the values in the groups divided according to the 
presence of disease are presented in Table 1. Serum T3. (free) T4. TSH. TBG. T3/TBG 
and T4/TBG ratio did not differ between the groups divided according to the presence of 
disease. Only serum rT3 concentrations differed between the 4 groups. being the highest 
in the group with 3 or more diseases. 45 subjects had T3 levels below (<1.27 nmo1/l) and 
rT3 levels above (>0.32 nmo1/l) the normal range of healthy adults, which is 
characteristic for the low T3 syndrome. 96 Subjects had T3 concentrations below the 
normal range of healthy adults. independent of the rT3 concentrations. 158 Subjects had 
T3 levels within the normal range and rT3 levels above the normal range of healthy 
adults. Summarized values of the physical characteristics of aging are presented in 
Table 2. 
Relations of the hormones with age 
As shown in Table 3, within the population of elderly men. serum rT3 concentrations 
increased significantly with age, while TSH, free T4 and TBG concentrations did not 
change with age. There was a tendency in this population for T3 levels to decrease with 
age. Although T4 levels increased with age in this population (Table 3), none of the 
subjects had T4levels above the range of healthy adults (>138 nmolll). All the relations 
described in Table 3 were independent of the presence of disease. Serum T4 and rT3 
concentrations were strongly related to one another (r=0.61. P<O.OOl). 
Relations of physical functional status with age 
The relations between the parameters of physical functional status and age are 
demonstrated in Table 4. Problems in performing activities in daily living increased with age, 
while physical performance, muscle strength and bone density decreased. 
85 
Table 1. Descriptive values of the thyroid hormones in a population of 403 elderly men in the total group as well as divided by the number of diseases. 
All subjects 0 diseases 1 diseases 2 diseases ~3 diseases 
!vie an 95% Cl lVIean 95% CI Mean 95% CI f..lean 95% CI Me au 95% CI 
TSH (mU/1) 1.15 1.05-1.24 1.46 0.87-2.05 1.18 0.96-1.39 l.IO 0.92-1.29 1.09 0.99-1.20 
Fl'ee T4 (pmol/1) 16.6 16.3-16.9 16.4 15.5-17.3 15.9 15.3-16.5 17.1 16.3-17.9 16.7 16.2·17.1 
T4 (nmol/1) 80.4 78.8-82.0 75.6 70.5-80.7 78.7 75.0-82.4 81.2 77.3-85.1 81.7 79.6-83.9 
T3 (nmol/1) 1.43 1.41-1.45 1.41 1.33-1.48 1.47 1.42-1.52 1.43 1.38-1.48 1.42 1.38-1.45 
rT3 (nmol/1) 0.33 0.32-0.34 0.31 0.29-0.34 0.31 0.29-0.32 0.33 0.31-0.35 0.35* 0.33-0.36 
TBG (mgll) 27.2 26.5-27.9 26.0 23.2-28.8 27.7 25.7-29.7 26.8 25.2-28.3 27.4 26.5-28.3 
T4 sulfate (pmol/1) 51.9 50.3-53.6 49.6 43.9-55.3 49.9 46.5-53.3 49.5 46.1-52.8 54.1 51.7-56,5 
T4/'l'BG ratio 3.11 3.01-3.20 3.09 2.86-3.33 2.94 2.79-3.10 3.12 2.96-3.28 3.17 3.01-3.33 
T3f'l'BG ratio 0.055 0.05-0.06 0.057 0.053-0.062 0.057 0.054-0.060 0,054 0.053-0.058 0.055 0.052-0.057 
* Differences between gmups P<0.01 
High rT3 concentrations are associated with a low physical function 
Table 2. Summarized values of the physical characteristics in a population of 403 elderly men 
Means SD IQ~range 
Age (yr) 77.8 3.6 75 so 
Body Mass Index (kg/m:;) 25.5 3.0 23.3 27.3 
Physical Performance (points) 8.5 2.4 7 10 
Activities of daily living (points) 10.7 4.3 8 12 
Maximum Leg E:-..-tensor Strength (Nm) 103.2 20.9 89.4 117.1 
Isometric Grip Strength (kp) 34.3 6.93 30.0 38.7 
Total Body Bone Mineral Density (g/cm:;) 1.17 0.10 1.11 1.23 
Femoral Neck Bone Mineral Density (g!cm:;) 0.88 0.14 0.78 0.97 
Femoral Ward Bone Mineral Density (g/cm:;) 0.72 0.16 0.60 0.82 
Femoral Trochanter Bone Mineral Density (g/cm:;) 0.85 0.1.5 0.76 0.94 
Total Fat Mass (kg) 21.2 6.4 17.4 24.5 
Total Lean Mass (kg) 51.7 5.6 47.8 55.5 
Table 3. Relations of the thyroid hormones with age in a population of 403 elderly men 
All subjects 
~ S.E. P~value 
TSH (miDI!) ·0.01 0.01 0.24 
FT4 (pmolll) 0.05 0.04 0.23 
T4 (nmolll) 0.68 0.23 0.003 
T3 (nmolll) -0.006 0.003 0.07 
rT3 (nmolll) 0.00.5 0.001 <0.001 
TBG (mg/1) -0.01 0.12 0.93 
T4S (pmolll) 1..57 0.22 <0.001 
T41TBG ratio 0.03 0.01 0.02 
T3rl'BG ratio -0.003 0.003 0.33 
Relations between the thyroid hormones concentrations and the physical characteristics 
Since T4. T3 and rT3 were all related to age, all analyses including these parameters 
were done after adjustment for age. None of the thyroid hormones were related to body 
mass index. 
An inverse relationship was present between serum total T4 concentrations and 
isometric grip strength and lean body mass (~= -0.06 kp/(nmolll) [95%CI: -0.10:-0.02]. 
P=0.06. and~= -0.05 kg/(nmolll) [95%CI: -0.09;-0.02]. P=0.002. respectively). 
Increasing serum free T4 concentrations were related to lower physical performance 
score (PPS) (~= -0.11 point/(nmolll) [95%CI: -0.18;-0.03]. P=0.006) and isometric grip 
strength(~= -0.24 kp/(nmolll) [95%CI: -0.53;-0.11]. P=0.004). 
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Also serum T3 concentrations were strongly. inversely related to lean mass (~= ·3.84 
kg/(nmolll) [95%CI: -5.88:-1.28]. P<O.OOl). The relation between T3 concentrations and 
lean mass remained significant after adjustment for rT3. TSH, height and muscle 
strength. Serum T3 levels were, apart from lean mass. not related to any of the other 
physical characteristics. The T3/TBG ratio was only strongly positively related to 
isometric grip strength (~=63.2 kp/(nmolll) [95%CI: 20.9:105.5]. P=0.004). This relation 
was independent of lean body mass. 
Higher serum rT3 concentrations were significantly related to lower PPS scores. more 
problems in activities of daily living. lower muscle strength (leg extensor strength as 
well as isometric grip strength). lower bone mineral density of the femoral neck and 
trochanter and lower lean mass. Linear regression coefficients of the relations between 
serum rT3 levels and the physical characteristics are presented in Table 5A (first 
column). All analyses including BMD were done after adjustment for age as well as B:rvii. 
In Figure 1 it is illustrated that. after adjustment for age. subjects with rT3 
concentrations in the highest quartile had significantly lower physical performance 
scores compared to subjects in the lowest quartile. 
Table 4. Associations of physical characteristics with age (years) 
All subjects 
p S.E. P.value 
Physical Performance Score (points) ·0.22 0.03 <0.001 
Problems in Activities of Daily Living (points) 0.011 0.005 0.02 
Isometric Grip Strength (kp) -0.53 0.09 <0.001 
Ma.'Ximum Leg Eextensor Strength (Nm) -1.30 0.28 <0.001 
Total Body Bone Mineral Density (g/cm2) -0.003 0.001 0.006 
Neck Bone Mineral Density (g/cm2) -0.002 0.002 0.25 
Ward Bone Mineral Density (g/cm2) -0.003 0.002 0.17 
Trochanter Bone Mineral Density (g/cm2) -0.004 0.002 0.04 
Lean mass (kg) -0.38 0.08 <0.001 
Fat mass (kg) -0.18 0.08 0.02 
QLS-General (points) -0.21 0.37 0.58 
QLS-Health (points) -0.61 0.52 0.24 
QLS denotes Quality of Life Satisfaction. 
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1st quartile 2nd quartile 3rd quartile 4th quartile 
Reverse T3 
Figure L Quartiles of serum reverse triiodothyronine (rT3) concentrations in relation to physical 
performance (age adjusted). P denotes significancy towards the first quartile. 
Relation between thyroid hormones and physical characteristics and the presence of 
disease 
All the above described relationships between serum rT3 and the physical 
characteristics were adjusted for the presence of disease in a multiple linear regression 
model to illustrate the effect of illness on the described relationships. The results of 
these analyses are shown in Table 5A (second column). In addition, the analyses were 
repeated after exclusion of the 45 subjects with the low T3 syndrome (T3<L27 nmoVl 
and rT3>0.32 nmoVl). These analyses were also performed after adjustment for the 
presence of disease. The results of these analyses are shown in Table 5B. After exclusion 
of subjects with low T3 syndrome. the relationship between rT3 levels and leg extensor 
strength and trochanter BMD were no longer significant. The inverse relations between 
rT3 concentrations and physical performance. isometric grip strength. and lean mass 
and the positive relation between rT3 and disability remained significant. iilier not only 
exclusion of subjects with low T3 syndrome but also adjustment for the presence of 
disease. the direction of the linear regression coefficients of the relations between rT3 
and the physical characteristics remained the same. 
The relationships between total T4 levels and isometric grip strength and lean body 
mass. as well as the relationship between total T3 and lean body mass and the relation 
between T3/TBG ratio and isometric grip strength, were all independent of the presence 
of the low T3 syndrome and the presence of disease. 
Also the relationships between free T4 concentrations and physical performance and 
isometric grip strength remained strongly significant when subjects with the low T3 
syndrome were excluded and when was adjusted for the presence of disease (~= -0.11 
pointl(nmolll) [95%CI: -0.19:-0.03]. P=O.Ol and~= -0.30 kpl(nmolll) [95%CI: -0.53:-0.08]. 
P=O.Ol. respectively). 
89 
Chapter 5 
Table 5A. Linear regression analyses of associations between rT3 (nmol!l) concentrations and 
physical characteristics of aging before and after adjustment for the presence of disease 
Physical Performance Score (points) 
ADL (points) * 
Ma.'\.-imum Leg Extensor Strength 
Isometric grip strength (kp) 
Total Body Bone Mineral Density 
Neck Bone Mineral Density (g/cm2) 
Ward Bone Mineral Density (g/cm2) 
Trochanter Bone Mineral Density 
Lean mass (kg) 
Fat mass (kg) 
QLS-General (points) 
QLS-Health (points) 
Before adjustment 
~ (95% Cl) 
-3.45 (-6.08: -0.82)' 
0.43 (0.07: 0.79)' 
-25.3 (-48.2: -2.37)' 
-8.94 (-16.4: -1.43)' 
-0.04 (-0.14: 0.06) 
-0.14 (-0.31: 0.02) 3 
-0.10 (-0.28: 0.08) 
-0.18 (-0.34: -0.03) ' 
-7.08 (-13.1: -1.03)' 
-1.03 (-7.54: 5.49) 
-7.63 (-38.3: 23.0) 
-61.2 (-103.6: -18.8)' 
After adjustment 
~ (95% Cl) 
-2.72 (-5.36: -0.09) ' 
0.27 (-0.08: 0.63) 
-20.8 (-43.9: 2.28) J 
-7.79 (-15.4: -0.21)' 
-0.03 (-0.13: 0.07) 
-0.11 (-0.27: 0.06) 
-0.07 (-0.25: 0.12) 
-0.16 (-0.33: -0.01)' 
-7.47 (-13.6: -1.34)' 
-1.70 (-8.31: 4.90) 
1.71 (-28.9: 32.3) 
-38.2 (-79.0: 2.67) J 
Table 5B. Linear regression analyses of associations between rT3 (nmolll) concentrations and 
physical characteristics of aging after exclusion of subjects of subjects with low T3 syndrome. 
before and after adjustment for the presence of disease 
Physical Performance Score (points) 
ADL (points) * 
Ma.ximum Leg Extensor Strength 
Isometric grip strength (kp) 
Total Body Bone Mineral Density 
Neck Bone Mineral Density (g/cm2) 
Ward Bone Mineral Density (g/cm2) 
Trochanter Bone Mineral Density 
Lean mass (kg) 
Fat mass (kg) 
QLS-General (points) 
QLS-Health (points) 
Before adjustment 
~ (95% Cl) 
-4.18 (-7.28: -1.09) I 
0.46 (0.05: 0.89) ' 
-17.1 (-43.9: 9.65) 
-9.84 (-18.5: -1.22)' 
-0.02 (-0.13: 0.10) 
-0.12 (-0.31: 0.07) 
-0.07 (-0.29: 0.14) 
-0.15 (-0.33: -0.04) 
-7.14 (-14.2: -0.07)' 
3.38 (-4.18: 10.9) 
-17.0 (-52.5: 18.5) 
-50.4 (-99.9: -0.81) ' 
Mter adjustment 
~ (95% Cl) 
-3.60 (-6.68: -0.51)' 
0.34 (-0.07: 0.76)' 
-12.6 (-39.4: 14.2) 
-8.72 (-17.4: -0.05)' 
-0.01 (-0.12: 0.11) 
-0.08 (-0.27: 0.11) 
-0.04 (-0.25: 0.18) 
-0.13 (-0.31: 0.06) 
-7.28 (-14.4: -0.15)' 
2.74 (-4.88: 10.4) 
-8.75 (-44.1: 26.6) 
-30.3 (-77.7: 17.1) 
For Table SA and SB: J3 denotes linear regression coefficient. 95% CI denotes 95% Confidence 
Interval. ADL denotes Problems in Activities of Daily Living.·~< Logarithmically transformed 
QLS denotes Quality of Life Satisfaction. all analyses are adjusted for age. 
1 P:s::O.Ol z P:S::0.05 ~ P:s::O.lO 
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Relations between the thyroid hormones and well.being 
Serum rT3 and free T4 concentrations were inversely related to the health dimension 
of the quality oflife questionnaire (Table 5A, for free T4: ~=-L79 points/(nmolJI) [95%CI: 
·2.96:·0.53], P=0.004). Subjects 'With the highest rT3 concentrations were significantly 
less satisfied than those subjects 'With the lowest rT3 levels. The relation between rT3 
and health~related quality of life appeared to be partially explained through the presence 
of disease (Table 5B), while the relation between free T4 levels and quality of life was 
independent of the presence of disease (after exclusion of the low T3 syndrome and after 
adjustment for presence of disease~= -L35 points/(nmolJI) [95%CI: -2.59;-0.12]. P=0.03). 
T4 sulfate 
T4 sulfate (T4S) concentrations increased with age (Table 3). Independent of age, T4S 
levels were inversely related to PPS (~= -0.02 points/(pmolJI) [95%CI: -0.03:-0.002]. 
P=0.03) and positively to the number of problems in ADL (~= 0.002 pointsl(pmolJI) 
[95%CI: 0.0002:0.005]. P=0.03). The relation between T4S and PPS remained significant 
when subjects 'With low T3 syndrome were excluded and after adjustement for the 
presence of disease (~= -0.02 points/(pmolJI) [95%CI: -0.04:-0.003]. P=0.02). while the 
relation 'With problems in activities of daily living was no longer significant. 
Serum T4S concentrations were inversely related to general as well as health-related 
quality of life (~= -0.23 points/(pmolJI) [95%CI: -0.41;-0.05]. P=0.01 and ~= -0.42 
points/(pmolJI) [95%CI: -0.67;-0.17], P=0.001). Subjects with the highest T4S 
concentrations were significantly less satisfied with life compared to subjects with the 
lowest T4S concentrations. These relations were independent of the presence of disease. 
DISCUSSION 
We found in a population of independently living, elderly men, aged 73·94 years, that 
rT3 and T4S concentrations increased with age. Serum rT3 levels were higher in a 
subgroup with 3 or more diseases. compared to subjects 'With less or no diseases. Thyroid 
hormone (metabolite) concentrations were related to parameters of physical functional 
status: independent of disease and after exclusion of subjects with the low T3 syndrome, 
lower serum total and free T4 and rT3 concentrations and a higher T3/TBG ratio were 
related with a higher grip strength. Also independent of disease. higher free T4, rT3 and 
T4S levels were associated 'With a lower physical performance. Higher rT3 levels were 
also associated with more problems in activities of daily living and lower leg e::-..-tensor 
strength and bone mineral density and a lower quality of life. However, these relations 
were partially or completely dependent on the presence of disease. Serum T4, T3 and rT3 
levels were, independent of disease. inversely related to lean body mass. And finally, low 
free T4 and T4S were related to a better quality of life. 
In agreement with previous studies. serum rT3 concentrations increased 'With age in 
our population, while there was a tendency for T3 levels to decrease with age (2). 
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Although there was only a tendency of T3 levels to decrease with age. many subjects had 
T3 levels below the range of healthy adults. Serum total T4 levels increased with age in 
our population. This relation could not be explained through an increase in thyroxine 
binding globulin (TBG) levels. It has to be mentioned. however. that T4 levels were not 
above the normal range of healthy adults in our population. 
These changes in thyroid hormone concentrations may be explained by a decrease in 
peripheral (hepatic) thyroid hormone metabolism with aging. First. aging may be 
accompanied by a decreased activity of type I deiodinase (D1) which in turn leads to a 
decrease in serum T3 due to a reduced peripheral conversion of T4 to T3. an increase in 
serum rT3 levels due to a reduced rT3 degradation in the liver and increased serum T4S 
concentrations due to reduced T4S degradation (Figure 2) (16.17). In addition, a reduced 
selenium intake may contribute to a decreased Dl activity in the elderly. since selenium 
deficiency is known to reduce the expression of the D1 selenoprotein (18). Second. the 
obse:nred increase in both rT3 and total T4 levels with aging may in part be explained by 
a reduced hepatic uptake of rT3 and T4. However. both an impaired Dl activity and a 
decreased hepatic uptake of thyroid hormones may also be due to disease or a poor 
nutritional state rather than aging itself. The extent to which the changes in thyroid 
hormone concentrations and their relations with physical characteristics in this elderly 
population were due to the aging process per se or to the presence of (non-thyroidal) 
illness was investigated by examining these relations before and after adjustment for the 
presence of disease (see below). 
T3 (D0 1~3 '\. 
T4 
T2 
~D3 
rT3 
~D1 
T4S 
~1 
rT3S 
T2S 
Figure 2. Schematic reproduction of peripheral thyroid metabolism. T4 (thyroxine). T3 
(triiodothyronine), rT3 (reverse T3). T2 (diiodothyronine). T48 (T4 sulfate). Dl: D2: D3 
(respectively type I . Hand III deiodinase) 
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We determined whether changes in serum thyroid hormone concentrations were 
related to characteristics of the aging process. like physical functional status and quality 
of life. To our knowledge. these relationships have not been investigated previously. 
Thyroid hormones are known to play an essential role in many biological processes in 
nearly every tissue. This is illustrated by the clinical symptoms in hypothyroidism and 
thyreotoxicosis. We hypothesized therefore that a decreased peripheral thyroid hormone 
metabolism in the elderly. might lead to worsening of physical functional status. In this 
study we found that high serum rT3 concentrations were associated with a lower 
physical functional status. represented by the significant inverse relations between 
serum rT3 and physical performance score (PPS). muscle strength and bone mineral 
density (BMD) at the femur as well as by the positive relation of serum rT3 levels and 
the number of problems in activities of daily living. Higher free T4 concentrations were 
associated with a lower physical performance and grip strength, while a high T3/TBG 
ratio. a rough indicator of free T3. was associated with a better grip strength. Further. 
we observed that low serum rT3 as well as low levels of free T4 were associated with a 
better health-related quality of life. 
As mentioned above non-thyroidal illness is associated with an increase in serum rT3 
concentrations (19.20). It needs to be emphasized that the investigated population was 
relatively healthy and that subjects with systemic infectious or inflammatory and 
malignant disorders were excluded. Known morbidity included mainly hypertension. 
atherosclerotic disease. congestive heart failure. chronic obstructive pulmonary disease. 
diabetes and arthrosis. However. to examine the potential influence of disease on the 
associations found. the followi..'t'J.g analyses were made. First, rT3 levels which increased 
with age were independent of the presence of disease. Second. the decrease in physical 
functional status with age was not dependent of disease (data not shown). Third. when 
we adjusted for the presence of disease. similar linear regression coefficients were 
present in the relations between free T4 and rT3 and the physical characteristics. This 
despite that rT3 levels were slightly higher in subjects with the presence of several 
diseases or complaints. Fourth, after exclusion of subjects who met the criteria for the 
low T3 syndrome. i.e. low T3 and elevated rT3 levels. most relations remained the same. 
Only the associations between rT3 and leg extensor strength and bone density became 
non-significant. Finally. we adjusted these associations (after exclusion of the low T3 
syndrome) for the presence of disease. Again. the linear regression coefficients remained 
nearly the same or only slightly decreased for most associations. This may indicate that 
in the absence of the low T3 syndrome rT3 levels may reflect an individual's physical 
functional status, partially independent of disease. Increasing rT3 levels could then 
represent a certain catabolic state, eventually preceding an overt low T3 syndrome. In 
this respect one's nutritional status may also be a determinant of rT3 concentrations as 
caloric deprivation is also accompanied by an increase in rT3 levels (3). 
Serum T3 and T4 concentrations were significantly and negatively related to lean 
mass. Both serum T3 and lean mass were normally distributed, and the relationship was 
therefore not dependent on outliers. This was a very strong association, which as far as 
we could determine. was not dependent on other characteristics. like height or muscle 
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strength. It is possible that a different relation would have been found if free T3 instead 
of total T3 levels were measured. This is suggested by the finding that the T3/TBG ratio 
was not related to lean mass. The bioactive fraction of total T3 is strongly influenced by 
the binding of T3 to TBG. Therefore it has to be questioned whether total T3 
measurements are biologically relevant and whether the relations we observed between 
T3 and the physical characteristics are representative for bioactive T3. 
Sulfation facilitates the inner ring deiodination of T4 and T3 by DL whereas the outer 
ring deiodination of T4S is inhibited. suggesting that sulfate conjugation is a primary 
step leading to the irreversible inactivation of thyroid hormone. Like rT3. T4S 
concentrations may increase during disease due to a decreased activity ofDl in the liver. 
Although borderline of significant, T4S concentrations indeed tended to be higher in 
subjects with more diseases. Assuming that sulfotransferase eA.-pression is relatively 
constant. we hypothesized that T4S levels might reflect a decreased peripheral thyroid 
hormone conversion, probably indicating a catabolic state. similar to rT3 levels. We did 
fmd a few relations between serum T4S concentrations and parameters of physical 
functional ability mostly independent of the presence of disease. However. in our 
population of elderly men, the T4S concentrations measured appeared to be very low. 
and subject to experimental variation in this low detection range. 
In conclusion, in a population of independently living elderly men. serum reverse T3 
concentrations increase with age and with the presence of disease. Higher free T4 and 
rT3 concentrations are associated with a lower physical functional status. Higher serum 
rT3 concentrations may result from a decreased peripheral metabolism of thyroid 
hormones due to the aging process itself andior to disease. and may reflect a catabolic 
state. Remarkably, rT3 levels remain associated with several parameters of physical 
function in the absence of systemic disease and the low T3 syndrome. Serum rT3 levels 
may therefore be a marker of physical function in the elderly. whether or not determined 
by disease or a poor nutritional status. 
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ABSTRACT 
Objective The aging process is characterized by a number of gradual changes in 
circulating hormone concentrations. as well as by a gradual increase in the degree of 
atherosclerosis. We studied whether serum hormone levels are related to atherosclerosis of 
the carotid artery in independently living. elderly men. 
Methods 403 men (aged 73~94 years) were randomly selected from the general population. 
Carotid artery intima~media thickness (IMT) was determined. Serum concentrations of 
testosterone (T). estrone (El). estradiol (E2), dehydroepiandrosterone (DHEA) and its 
sulfate. insulin~ like growth factor~ I (total and free IGF-I), and its binding proteins~ I, ~2, 
and -3 and leptin concentrations were measured. 
Results Serum T. Eland free IGF-1 were inversely related to WT. after adjustment for 
age. The strength of these relations was as powerful in subjects with and without prevalent 
cardiovascular disease. Serum E2. DHEA(S). total IGF-l, !GFBP-1. -2. -3 and leptin showed 
no association. 
Conclusions These findings suggest that endogenous testosterone, estrone and free IGF~I 
levels may play a protective role in the development of atherosclerosis in aging men. 
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INTRODUCTION 
Cardiovascular disease is the prime cause of death among the elderly in industrialized 
countries, and a major determinant of chronic disability (1). The burden of atherosclerosis 
particularly afflicts the increasing older part of the population. Most hormone levels 
decrease with age, coincident with the age-associated increase in atherosclerotic disease. 
Consequently, a role in the pathogenesis of cardiovascular disease has been suggested for 
several hormonal systems. 
In men, a beneficial effect of testosterone and of dehydroepiandrosterone sulfate 
(DHEAS) on cardiovascular risk factors has been described (2-6). Further, in women there is 
substantial evidence for a protective role of endogenous sex hormones and estrogen therapy 
in the development of atherosclerosis (7 -13). 
Also recently. data have been reported to suggest that the insulin-like growth factor 
(IGF)/ IGF -binding protein system is related to cardiovascular risk factors and the degree of 
atherosclerosis in an elderly population (14.15). 
Most of these studies. however. were performed in relatively young subjects, and have 
concentrated on the relation between hormones and cardiovascular risk factors. We studied 
whether serum hormone levels are related to atherosclerosis, as measured by the intima-
media thickness of the carotid artery in a population of independently living. elderly men. 
METHODS 
Subjects 
A group of 403 independently living men, aged 73 or above. participated in this study. 
Participants were recruited by letters of invitation. which were sent to the oldest male 
inhabitants of Zoetermeer, a medium sized town in the mid-western part of the 
Netherlands. All participants provided informed consent. and the study was approved by the 
Medical Ethics Committee of the University Hospital Rotterdam. Participants were judged 
sufficiently healthy to participate in the study when they were physically and mentally able 
to visit the study center independently. No additional health related eligibility criteria were 
used. A number of participants were taking medications for chronic illnesses. including 
hypertension (n=98). angina pectoris (NYHA class 1 to 3) or a recent myocardial infarction 
(n=S5), mild congestive heart failure (n=28), chronic obstructive pulmonary disease (n=40). 
and diabetes mellitus (n=33). We divided the cohort by presence (n=139) or absence (n=263) 
of prevalent cardiovascular disease. Presence of cardiovascular disease was defined as 
having symptoms of or being treated for angina pectoris. congestive heart failure. 
claudicatio intermittens. or having a myocardial infarction or cerebra vascular accident in 
the medical history. Subjects with hypertension were not included in this group. since 
hypertension is regarded as being a risk factor for cardiovascular disease and not as 
cardiovascular disease itself. In addition. we divided the cohort by the use (n=123) or none 
use (n=279) of cardiovascular drug therapies. Cardiovascular drug therapy was defined as 
using one or more of the following drugs; ACE-inhibitors, calcium antagonists, diuretics.~-
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inhibitors (these previous four were not included when they were only used as an 
hypertension lowering drug). glycosides. nitrates, cordaron. cholesterol lowering drugs and 
anti-coagulates. 
70 subjects smoked at the time of investigation. while 281 subjects did not smoke at 
present time but had smoked previously. 51 subjects had never smoked. 
Height and weight were measured in standing position without shoes. Body mass index 
was calculated as the weight in kilograms divided by the square of the height in meters. The 
waist circumference was measured at the level of the umbilicus and the hip circumference 
was measured at the level of the greater trochanter. The average of two readings was used 
in the analyses. Waist I hip ratio (WHR). which represents a measure of upper body 
adiposity. was calculated from these two measurements. 
Measures of atherosclerosis 
To determine carotid artery intima-media thickness as a quantative measure of 
generalized atherosclerosis (16). ultrasonography of the left and right common carotid a..rtery 
and the bifurcation was performed with a 7.5-MHz linear array transducer (ATL illtramark 
IV. Advanced Technology Laboratories). A careful search was performed for all interfaces of 
the near and far wall of the distal common carotid artery and the far wall of the carotid 
bifurcation (17). The actual measurements of the intima-media thickness were performed off 
line as described previously (18). A composite measure that combined the mean common 
carotid artery intima-media thickness and the mean carotid bifurcation intima media 
thickness (Z-score) was obtained by averaging these two measurements after 
standardization (subtraction of the mean and division by the standard deviation). 
The common carotid artery. carotid bifurcation and internal carotid artery were also 
evaluated for the presence (yes I no) of atherosclerotic lesions on both the near and far wall 
of the carotid arteries. Plaques were defined as a focal widening relative to adjacent 
segments, with protrusions into the lumen composed of only calcified deposits or a 
combination of calcification and non-calcified material (17). The size of the lesions was not 
quantified. The number of plaques was used as an indicator of the presence of 
atherosclerosis. 
Lipids 
Serum total cholesterol, low density lipid cholesterol. high density lipid cholesterol and 
triglycerides concentrations were all measured by commercially available 
radioimmunoassay kits. 
Hormone measurements 
Blood samples were collected in the morning after an overnight fast. Serum 
concentrations of total testosterone (nmoJJl) and sex hormone binding globulin (nmoJJl) were 
measured by radioimmunoassay using commercial kits (Diagnostic System Laboratories. 
Webster. Texas. USA). The intraassay coefficients of variation (CV) were 8.1% and 3.0% 
respectively. The interassay CVs were 10.5% and4.4% respectively. Serum concentrations of 
estrone (nmol!l), estradiol (pmol!l), dehydroepiandrosterone (DHEA nmol!l), and DHEA 
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sulfate ().J.lllolJl) were also measured by radioimmunoassay using commercial kits (Diagnostic 
Systems Laboratories). The intraassaycoefficients of variation (CV) were 5.6%, 5.3%, 3.8%, 
and 2.1% respectively. The interassay CV were 10.2%, 8.1 %, 8.6%, and 5.1% respectively. 
Dissociable free insulin-like growth factor (IGF) -I was measured with a commercially 
available noncompetitive two-site immunoradiometric assay (Diagnostic System 
Laboratories). Total IGF-I was measured by an IGF binding protein (IGFBP) blocked 
radioimmunoassay (RIA) as described previously (19) (Ivledgeni"{ Diagnostics; intra-assay 
and interassay CV: 6.1% and 9.9%). IGFBP-1. IGFBP-2 and IGFBP-3 were determined by 
RIA as described previously (19.20) (respectively Diagnostics System Laboratories Inc: 
intra-assay and interassay CV: 3.4%. 2.9% and 1.9% and 8.1 %. 10.3% and 9.2%). Insulin was 
measured by a commercially available RIA (Farmacia. ThreibeL Germany, intra-assay and 
interassay CV: 8.0% and 13.7%).). Leptin (f.lg/l) was also measured by radioimmunoassay 
(Lilly Research Laboratories, Giessen. Germany). 
Data analyses 
Results are expressed as mean and standard deviation, unless otherwise stated. 
Relations between variables were assessed using linear regression for continuous variables, 
and described as the linear regression coefficient (]3) and its standard error as well as the 
95% confidence interval (CI). Since an association was present between several hormone 
concentrations and age, multiple regression analysis was used to adjust for age, as well as to 
assess the independent contribution of different variables to the dependent variable. We 
used at-test to compare continuous characteristics. Differences between groups were stated 
together with the 95% CI. 
RESULTS 
Mean age of the population was 77.8 years (range 73-94 years). Descriptive values of the 
measures of atherosclerosis as well as general characteristics are presented in Table 1. 
Descriptive values of the hormone levels are presented in Table 2. Mean intima-media 
thickness (IMT) of the carotid bifurcation (~= 0.05 ± 0.01 mmlyear. P=O.OOl) and the 
combined IMT of carotid artery (~= 0.05 ± 0.02 mmlyear. P=0.01) were both directly 
associated with age. In our population, serum total testosterone and insulin were not 
significantly associated with age. Serum estradioL estrone, DHEA and DHEAS were 
significantly inversely related with age (respectively~= -1.99 ± 0.80. (pmolll)/yr, ~= -4.90 ± 
0.50 (pmolll)/yr.log transformed~= -0.02 ± 0.006 (nmolll)/yr and~= -0.04 ± 0.01 (fUllolll)iyr. 
all P<O.Ol) . .Also serum IGF-L IGFBP-3 and leptin concentrations were inversely related 
with age (respectively~= -0.85 ± 0.41 (nmolll)/yr. P=0.04: ~=-0.07 ± 0.01 (f'Illolll)iyr. P<0.001 
and~= -0.02 ± 0.01 (nmol!l)/yr. P=0.04). IGFBP-1 andiGFBP-2levels were positively related 
with age (respectively log transformed ~= 0.03 ± 0.006 (nmolll)/yr and ~= 0.03 ± 0.004 
(fUllolll)iyr. both P<0.001). 
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Table 1. Baseline characteristics of 403 ambulatory elderly Dutch men 
Variable Obs. (n) Mean 
Atherosclerosis 
Mean Intima. Media Thiclmess of the carotid artery (mm) 
Common Carotid (CCA) 
Bifurcation (BIF) 
Risk Factors 
Cholesterol (nmol/1) 
Total cholesterol 
LDL·cholesterol 
HDL.cholesterol 
Triglycerides 
General characteristics 
Age (years) 
Weight (kg) 
Body Mass Index (kg/cm2) 
Waist·to·Hip Ratio 
Medical History 
Variable; Presence 
Angina Pectoris 
Congestive Heart Failure 
Myocardial Infarction 
CerebroVascular Accident 
Claudication Intermittens 
Cardiovascular Disease 
Hypertension 
Diabetes Mellitus 
Cardiovascular Medication 
Smoking 
Atherosclerosis, gonadal and adrenal hormones 
397 0.97 
297 1.33 
403 5.75 
403 3.77 
403 1.34 
403 1.39 
403 77.8 
403 75.9 
403 25.4 
400 0.98 
Obs (n) Yes 
401 60 
402 28 
402 66 
402 37 
402 22 
402 189 
401 98 
402 33 
402 123 
Never 51 Ever 81 
S.D. 
0.15 
0.56 
1.14 
1.02 
0.39 
0.84 
3 . .58 
10.5 
3.04 
0.05 
No 
341 
374 
336 
365 
380 
263 
303 
369 
279 
Now70 
Serum estradiol. dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) 
concentrations were not related to the combined IJV[T of the carotid artery. nor after 
adjustment for age and body mass index (BMI). 
Serum testosterone concentrations, however, were inversely related to the mean llvl:T of 
the bifurcation and the combined IMT after adjustment for age (P:;:0.02. Table 3). Serum 
total testosterone concentrations were inversely related to BMI (~:;: ·0.17 ± 0.05 
(nmolll)/(kg/m2). P<O.OOl). Testosterone levels did not differ between subjects with or 
without hypertension or diabetes. Mean serum testosterone concentrations were 
significantly higher amongst subjects who had never smoked compared to subjects who had 
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(difference:;;;1.01 nmol!l. 95%CI; 0.10 - 1.91 nmo1'l). The associations between serum 
testosterone and IMT were independent of the BMI. WHR the presence of hypertension and 
diabetes, smoking and serum cholesterol levels (total~. LDL~, HDL·cholesterol. and 
triglycerides). 
Serum estrone concentrations were also inversely related to the mean ThfT of the 
common carotid artery and to the combined IMT. also after adjustment for age (P:;;;0.02. 
Table 3. Figure 1). Serum estrone levels were positively related to waist/hip ratio (\VHR) ()3== 
0.13 ± 0.07 (nmol/1)/L P=0.04). Further. subjects with hypertension had significantly higher 
estrone concentrations compared to subjects without hypertension (difference:;;; 0.01 nmol!l, 
95%CI: 0.003 - 0.021 nmol/1). The distribution of estrone concentrations did not dilier 
significantly amongst diabetes and smoking. The association between IMT and estrone 
concentrations was independent of the BMI. WHR. the presence of hypertension and 
diabetes. smoking and serum cholesterol levels. 
Serum estrone and testosterone concentrations were significantly positively related 
(r-=0.28. P<O.OOl). We therefore conducted a multiple regression analysis including both 
estrone and testosterone as the independent variables and IMT of carotid artery as 
dependent variable. The relation with both estrone and testosterone attenuated and became 
statistically non-significant (respectively: )3=~2.31 ± 1.39 nmol!mm. P=O.lO and )3=~0.03 ± 
0.02 nmollmm. P=0.09). 
No significant associations were present between serum testosterone. estrone. estradioL 
DHEA or DHEAS concentrations and the number of plaques present in the carotid artery. 
Table 2. Serum hormone concentrations of 403 ambulatory elderly Dutch men 
Testosterone (nmol!l) 
Estrone (nmoJJ1) 
Estradiol (nmol!l) 
Dehydroepiandrosterone (nmoJJ1) 
Dehydroepiandrosterone Sulfate (J.LmOJJ1) 
Total Insulin-like Growth Factor-I (J.Lgll) 
Free Insulin-like Growth Factor-I (nmol!l) 
Insulin-like Growth Factor Binding Protein-! (.l1gll) 
Insulin-like Growth Factor Binding Protein-2 (mg!l) 
Insulin-like Growth Factor Binding Protein-3 (mg/l) 
Leptin (J.Lg/l) 
Mean 
8.83 
0.102 
0.098 
7.34 
1.97 
100.9 
0.09 
31.7 
0.62 
2.59 
5.35 
Atherosclerosis. somatotropic hormones, insulin and leptin concentrations 
SD 
2.98 
0.039 
0.058 
3.78 
1.38 
29.2 
0.05 
15.5 
0.32 
0.70 
4.19 
Serum total insulin-like growth factor (IGF)-l. IGF binding protein (IGFBP)-1. IGFBP-2, 
IGFBP-3. insulin and leptin concentrations were not significantly related to the IMT of the 
carotid artery, nor after adjustment for age and BMI. 
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Serum free IGF-I was inversely related to the mean IMT of the carotid bifurcation after 
adjustment for age (P=0.05. Table 3, Figure 2). Serum free IGF-I concentrations were not 
related to BMI or WHR. The distribution of free IGF-I levels did not differ between subjects 
with or without hypertension. diabetes or smoking. The relation between serum free IGF-I 
and IMT was independent of the BML WHR, the presence of hypertension and diabetes. 
smoking and serum cholesterol levels. 
No associations were present between IGF-I (free nor total). IGFBP-1. !GFBP-2. IGFBP-
3. insulin and leptin concentrations and the number of plaques present in the carotid artery. 
Table 3. Regression coefficients for intima media thickness of the carotid artery (Z-score CCA + BIF) 
as the dependent variable and endogenous testosterone. estrone and free !GF-1 levels as the 
independent variables in 297 elderly men with and without cardiovascular disease 
Z-score CCA + BIF (mm) 
Complete group (n-297) ~ 95% C! 
Testosterone (nmol!l) -0.041 -0.076 -0.006 
Estrone (nmol/1) -3.07 -5.70 -0.44 
Free Insulin-like Growth Factor-! (nmol/1) -1.82 -3.62 -0.013 
Free of cardiovascular disease (n-197) 
Testosterone (nmol!l) -0.034 -0.077 0.009 
Estrone (nmol!l) -3.26 -6.55 0.02 
Free Insulin-like Growth Factor-! (nmol!l) -2.12 -4.30 0.06 
With cardiovascular disease (n-100) 
Testosterone (nmolll) -0.045 -0.106 0.015 
Estrone (nmol!l) -2.15 -6.52 2.22 
Free Insulin-like Growth Factor-! (nmol!l) -1.33 -4.55 1.90 
Common carotid artery (CCA). Bifurcation (BIF). 13-coefficient of linear regression: an increase of 
the independent variable by 1 unit is associated with an increase of intima-media thickness by a 
factor e13 
Intima-media thickness, serum hormone levels and prevalent cardiovascular disease 
We hypothesized that the above described significant relations between serum estrone. 
testosterone and free IGF-I concentrations and IMT of the carotid artery are due to 
cardiovascular disease (CVD) rather than the cause of disease. Therefore we reassessed 
linear regression between serum hormones and IM:T in two groups. namely with and 
without prevalent cardiovascular disease. The results of these analyses are shown in Table 
3. We also performed the same analyses in the two groups with and without cardiovascular 
drug therapy. Similar results were found as described in Table 3. In addition. serum 
testosterone, estrone and free IGF-I were not differently distributed amongst subjects with 
or without CVD or cardiovascular drug therapy. 
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Figure 1. Mean intima media thickness (ThiT) in mm of the combined score of the common carotid 
artery and the bifurcation in tertiles of A) serum estrone and B) free insulin-like growth factor-1 
(IGF-I) concentrations. p denotes the significancy of the third towards the first tertile. 
P=0.04 P=0.04 
"- "-iii iii 
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DISCUSSION 
In this study among 403 independently living, elderly men. several associations between 
circulating hormone levels and ultrasonographic measures of atherosclerosis were observed. 
An increased wall thickness of the carotid artery was related to lower serum testosterone, 
estrone and free IGF -I concentrations in subjects with prevalent cardiovascular disease as 
well as in subjects free of cardiovascular disease. 
Thickening of the intima-media of the carotid artery is generally considered to be an 
early marker of generalized atherosclerosis and has been associated with an unfavorable 
cardiovascular risk profile. other localizations of atherosclerosis (9) and an increased risk of 
myocardial infarction and stroke (16.21.22). The combined carotid artery intima-media 
thickness (IMT) measure provides a more precise IJY.[T measurement compared to only 
common carotid IJY.[T or the carotid bifurcation IMT (21). 
Although it is known that testosterone levels influence lipoprotein patterns (3.23), only 
few studies have directly examined the relation between testosterone and markers of 
atherosclerotic cardiovascular disease. A study performed by Philips et al. in 55 men (aged 
39 to 89) found an inverse relation between serum testosterone and the degree of coronary 
artery disease (2). We observed that high testosterone concentrations are associated with a 
reduced intima-media thickness of the carotid artery. It is not possible to discriminate 
between cause and effect in this cross-sectional study. Low testosterone levels might lead to 
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an mcrease in intima-media thickness. On the other hand, atherosclerosis could be 
widespread and have caused a decrease in testicular blood flow and function. Alternatively, 
the blood flow to the pituitary could be impaired, leading to low luteinizing hormone 
concentrations and a degree of secondary hypogonadism, i.e. the hormone changes were the 
result not the cause of the findings. In addition, high estrone concentrations are associated 
with reduced intima-media thickness in our population of elderly men. The reason that both 
estrone and testosterone lost their significant relationship with the intima-media thickness. 
when adjusted for one another. might be due to the fact that their serum levels were 
strongly linked. However. the major source for testosterone is from direct testicular 
secretion. 
Few studies have examined the relation between estrogens and atherosclerosis in men 
(24). In women, estrogen replacement therapy is associated with plaque regression in the 
carotid artery (10), as well as a delay in thickening of the intima layer of the carotid artery 
(11). Also in men estrogens may offer some degree of protection against cardiovascular 
disease by influencing the lipid profile (25,26). We could not demonstrate an association 
between endogenous serum estradiol concentrations and measures of atherosclerosis. 
However, it might be that estradiol has a local effect which can not be shown in relations 
between serum estradiol and measures of cardiovascular disease, since estradiol derives 
from the conversion of testosterone and estrone. which were both related to measures of 
cardiovascular disease. In addition. estradiol might change insulin sensitivity of peripheral 
tissues. 
DHEAS has been proposed to be cardioprotective in men (5,6,27). However, its role in the 
etiology and prevention of coronary disease has been challenged (28), as results from other 
studies did not support the cardioprotective hypothesis (29). In agreement with Baulieu et 
al. we did not find supporting evidence for the potential cardioprotective role ofDHEA(S), 
since DHEA(S) concentrations were not associated with the intima-media thickness or the 
number of plaques in the carotid artery in our population (30). 
Recently, data have been reported to suggest that the insulin-like grovrth factor (IGF) I 
IGF-bindingprotein system is related to atherosclerosis in the elderly population (14.31). In 
several studies it has been demonstrated that grovrth hormone (GH) deficient adults have 
an increased intima-media thickness (32). and a high prevalence of hypertension (33). High 
fasting serum free IGF-I levels have been associated with a reduced number of 
atherosclerotic plaques. symptomatic cardiovascular disease and lower serum triglycerides 
levels (31). In the present study, free IGF-I, rather than total IGF-I, was independently 
related to the mean intima-media thickness of the carotid bifurcation, suggesting that it is 
the easily dissociable IGF-I fraction which may be able to act on the vascular wall. In 
diabetic and non-diabetic populations, higher IGFBP-llevels have been associated with an 
advantageous cardiovascular risk profile (31,34). IGFBP-1 and -2 are capable of both 
inhibition and augmentation of IGF-I bioactivity (35). No significant relationships were 
observed between IGFBP-1 and -2 and atherosclerosis in our elderly population. 
It is well established that leptin is positively associated with fat mass. insulin resistance 
and insulin levels (36). Whether leptin itself. apart from fat mass and insulin levels, is a 
cardiovascular risk factor is subject to debate (37). Leptin levels in our population were not 
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related to measures of atherosclerosis. 
As already has been touched lightly on. an important question is whether the elevated 
levels of testosterone, estrone and free IGF~I that are inversely related to carotid intima-
media wall thickness are cause or effect. In an attempt to answer this question, we 
subdivided the cohort by presence or absence of prevalent cardiovascular disease. Although 
power to infer conclusions is limited, it is shown that the associations between IMT and 
respectively testosterone, estrone and free IGF ~I in subjects free of symptomatic 
cardiovascular disease were as powerful as in subjects with prevalent cardiovascular 
disease. This is illustrated by the same direction of the linear regression coefficient as well 
as by the fact that there was no significant difference between these associations. Similar 
results were found for subjects with and without cardiovascular drug therapy. These results 
suggest that the findings are not due to cardiovascular disease, but give a hint that low 
hormone levels are indeed cause of disease. Of course follow~up studies and preferably 
intervention studies should be performed to confirm these preliminary conclusions. 
In summary, testosterone, estrone. and free IGF~I concentrations, appear to be linearly, 
inversely related to atherosclerosis as measured by the intima~media thickness of the 
carotid artery in elderly men. The fact that the associations were as strong in the group free 
of cardiovascular disease as in the group with prevalent disease, suggest that testosterone. 
estrone and free IGF~I levels may play a protective role in the development of 
atherosclerosis in aging men. 
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ABSTRACT 
Objective To assess which health. physical and hormonal factors are related to quality of 
life. and to assess whether quality of life is predictive of mortality in a population of 
independently living elderly men. 
Methods 403 men (aged 73~94 years) were randomly selected from the general population. 
Four years after the initial investigation. data of death were recorded. At baseline. Quality 
of Life (QoL) was assessed using a validated questionnaire. which consists ofthree modules 
directed at general factors (QLS-General). health factors (QLS-Health). and factors related 
to hormone deficiency (QLS~Hormone). Physical characteristics of aging included problems 
in activities of daily living. a measure of physical performance, muscle strength. bone 
mineral density and body composition. Testosterone. estrone. estradioL 
dehydroepiandrosterone (DHEA). DHEAS. sex hormone binding globulin (SHBG). insulin-
like growth factor-I (IGF-I). IGFBP-l. IGFBP-2. IGFBP-3 and insulin were all determined 
by RIA. 
Results QoL did not change with age. QLS-Health was closely related to prevalent 
morbidity at baseline. like prostate disease and congestive heart failure. Muscle strength. 
physical performance and subjective functional ability were strongly positively related to 
QLS-Health. Serum bioavailable testosterone weakly correlated to QLS-Health. while 
DHEA(S) did not. Estradiol and IGFBP~3 concentrations were strongly positively associated 
to all QLS modules. while cortisol and IGFBP-l were inversely related with QLS-General 
and QLS-Hormone. IGFBP-l was also inversely related to QLS-Health. Serum IGF-I 
concentrations were weakly positively associated with QLS-Hormone only. QLS-Health and 
QLS-Hormone were both predictive of mortality (OR=0.99 ± 0.003. P=0.003 and OR=0.99 ± 
0.004. P=0.05). In addition. subjects with scores in the lowest quartiles of the questionnaire 
(the least satisfied) died significantly earlier compared to the subjects with scores in the 
highest quartiles (P=O.OOl and P=O.Ol respectively). 
Conclusions Irrespective of the health status, physical and psychological well-being are 
strongly related in independently living, elderly men. In this population. estradiol and 
IGFBP-3levels are powerful direct predictors ofQoL. Cortisol andiGFBP-llevels. however. 
are inverse predictors. These data, although collected in a cross-sectional study indicate that 
exercise in order to improve muscle strength andlor functional ability. but perhaps also 
hormonal intervention, which aims at increasing estradiol bio-availability and/or IGFBP-3 
levels might further improve quality of life in elderly men. The importance of defming 
determinants of quality of life is shown by the fact that quality of life itself is an important 
predictor of mortality. 
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INTRODUCTION 
Psychological well-being and quality of life are important determinants of successful 
aging (1). Health and socioeconomic factors in association with psychological well-being have 
been studied extensively (2-5). Modest reductions in the capacity to perform common 
physical functions may already prevent full participation in productive and recreational 
activities of daily life. Although a strong positive relation is expected between physical and 
psychological well-being, this relation has hardly been directly examined in healthy elderly 
subjects. Furthermore hormonal activity might be related to quality of life. Some studies 
have reported improvement in the sense of well-being during testosterone supplementation 
in elderly men (6-8). In addition. several studies have reported that estrogen replacement 
therapy of post-menopausal women improves quality of life (9-12). Controversy exists 
concerning the potential beneficial effects of dehydroepiandrostenedione (DHEA) 
administration on well-being in elderly men (13-15). Finally, it has been demonstrated that 
growth hormone treatment of adult patients with growth hormone deficiency increases 
psychological well-being (16-18). 
Some studies have shown that quality of life is a predictor of mortality after coronary 
artery bypass surgery (19). in patients with congestive heart failure (20) and in patients 
with metastatic colorectal cancer (21). With regard to quality of life as predictor of mortality 
in relatively healthy older populations. only one study recently demonstrated that in a large 
study amongst older Mexican Americans. subjects (men and women) with low scores on an 
emotional well-being questionnaire had a significant higher risk of mortality compared to 
subjects with high scores (22). 
In the present study we have investigated which health factors. physical and hormonal 
factors are related to psychological well-being in a population of independently living elderly 
men. In addition. in this same population. we investigated whether quality of life by itself 
might be a predictor of mortality. 
METHODS 
Subjects 
A cross-sectional. single-centre study was conducted in 403 independently living men. 
aged 70 years and older. Names and addresses of all male inhabitants 70 years and older 
were drawn from the municipal register of Zoetermeer, a medium sized town in the mid-
western part of the Netherlands. 1567 men were invited. A total of 886 men did not respond 
to the mailed invitation in which it was mentioned that only those subjects who lived 
independently and had no severe mobility problems could participate. After exclusion of 
subjects who did not live independently and who were mentally not fit to visit the study 
centre independently and undergo the investigations. eventually 403 men participated 
(25.7%), aged between 73 and 94 years. The main reason not to participate among the 
respondents was because they were ill and currently seen by a specialist or general 
practitioner (28%), while 16% was excluded on the basis of physical (10%) or mental (6%) 
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problems. Participants signed an informed consent. The study was approved by the Medical 
Ethics Committee of the Erasmus University Hospital Rotterdam. No additional health-
related eligibility criteria were used. 
A 21 item medical history was obtained by questionnaire according to following groups: 
musculoskeletal impairments (including arthrosis and fractures): cardiovascular 
impairments (including symptoms or treatment of angina pectoris. congestive heart failure. 
hypertension, arythmias. myocardial infarction. cerebrovascular accidents and shortness of 
breath): prostate problems (hyperplasia and cancer):other malignancies: endocrine disorders 
(diabetes mellitus and thyroid disease): and symptoms like dizziness and impaired vision 
which limits mobility. Further a physical examination was performed. From the results of 
these questions it appeared that a number of participants were taking medications for 
chronic illnesses. including hypertension (n=98) and mild congestive heart failure (n=28). 
However. in retrospect. the use or no use of these medications did not influence the relations 
described in this study. 
Four years after the initial investigation, 75 men had died (8 in the first year, 16 in the 
second year. 21 in the third year and 30 men in the fourth year after the initial investigation 
had taken place). For the subjects who had died during the four year follow-up. the number 
of months between death and the initial investigation was recorded. 
Psychological well-being 
Psychological well-beingor quality ofhle was assessed using a questionnaire "With questi-
ons pertaining to satisfaction in life according to Henrich and Herschbach (23-25). The 
Fragen zur LebenszufriedenheitModuk or Questions on Life SatisfactionModull· (QLS) combines 
three features: economy. modular structure. and individual weighting of items. The 
questionnaire used consisted of three modules. The three modules of the questionnaire used 
consist of a single sheet of paper each. containing both instructions and S items. They can be 
completed in a few minutes, and no difficulties in understanding were observed in the group 
of elderly men studied. The first module addressed 8 general questions (''general''-module), 
the second module consists of S questions regarding general health (''health~ -module). and 
the third module, with 9 questions. was developed on the basis of a number of interviews in 
adults with hypopituitarism ("hormonal"-module) (Table 1). All items are evaluated on a 5 
point scale. ranging from 0 to 4, with the highest score indicating e)..-tremely important and 
respectively very satisfied. Of the 8 items asked first the individual importance is asked and 
subsequently, the personal degree of satisfaction is being asked of these same 8 items. As a 
measure of evaluation, a combination of importance (I) and satisfaction (S) (h::[(Sx2)-3]) is 
used for each item. In addition. the sum of the combination is calculated for each module. 
Physical characteristics of successful aging 
Muscle Strength 
Isometric leg e).."tensor strength was measured as described previously using the Hoggan 
MicroFET hand held dynamometer (26.27). The measurement requires that the participant. 
in a seated position. pushes with maximal strength to the dynamometer. which is held at 
the tibia. The investigator holds the dynamometer in the hand and pushes back until the 
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breaking point is reached. The measurements were done three times and the ma..Timum 
performance at each position was recorded. To obtain one measure of leg muscle strength, 
'maximum leg extensor strength' (maxLES) was deflned as the maximum strength for the 
right or left leg in a position of 120°. 
Bone mineral density (BMD) and Body Composition 
Total body bone mineral density (TBBMD) was measured using dual energy x.ray 
absorptiometry (Lunar, Madison. WI), as were hip bone mineral densities at the femoral 
neck, trochanter and Ward's triangle. In addition total and trunk lean body mass and fat 
mass were measured (28.29). Quality assurance including calibration was performed 
routinely every morning for DEXA. using the standard provided by the manufacturer. 
Height and weight were measured in standing position without shoes. Body mass index 
(BMI) was calculated as the weight in kilograms divided by the square of the height in 
meters (kglm2). 
Physical Performance 
Lower extremity function. or physical performance. was assessed as described by 
Guralnik et al. (30). including measurements of standing balance. walking speed and ability 
to rise from a chair. A summary performance scale (PPS). ranging from 0 to 12 points. was 
created by summing the category scores for the walking. chairstand. and balance test. 
Activities of daily living (ADL) 
Satisfaction in performing activities of daily living (ADL) was assessed by using a self· 
administered questionnaire modified from the Stanford Health Assessment Questionnaire 
(MHAQ) as described by Pincus eta! (31). All items are evaluated on a 4 point scale. A high 
score denotes high impairment in ADL. 
The Mini·Mental State Examination (J\111.SE) was used to assess cognitive function (32). 
Hormone measurements 
Blood samples were collected in the morning after an overnight fast. Serum was 
separated by centrifugation and stored at ·40°C. Serum concentrations of total testosterone 
(TT, nmo1'l). and sex hormone binding globulin (SHBG. nmo1'l) were measured by 
radioimmunoassay using commercial kits (Diagnostic System Laboratories. Sinsheim. 
Germany). The intra·assay coefficients of variation (CV) were respectively 8.1% and 3.0%. 
The inter·assay CVs were respectively 10.5% and 4.4%. In addition. serum concentrations of 
estrone (El. nmolfl). estradiol (E2. nmol!l). DHEA (nmol!l). and DHEAS (j.lmolfl) were also 
measured by radioimmunoassay (RIA) using commercial kits (Diagnostic System 
Laboratories). The intra·assay coefficients of variation (CV) were respectively 5.6%. 5.3%. 
3.8%. and 2.1%. The inter·assay CV were respectively 10.2%, 8.1%, 8.6%. and 5.1%. Non 
SHBG bound testosterone (nmo1'l) and non SHBG bound E2 (nmoVl) were calculated 
according to a method described by S6derg3.rd et aL (33). Cortisol (nmo1'l) and insulin 
(miU!l) were measured by RIA (Diagnostic System Laboratories). Albumin (gil) was 
measured by photometry using a commercial kit (ALB. Boehringer·Mannheim). 
Total IGF.I was determined by a IGFBP·blocked RIA in the presence oflarge excess of 
IGF·II as described (34). Intra· and interassay CVs were 1.6% and 6.4% respectively. 
IGFBP-l. IGFBP-2. and IGFBP-3 were all measured with inhouse RL-"'s as described 
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previously with intraassay CVs of 3.4%, 2.9% and 1.9% and interassay CVs of 8.1 %. 10.3% 
and 9.2% respectively (34). Insulin was measured by a commercially available 
radioimmunoassay (Medgeni-x: Diagnostics. intra-assay and inter-assay CV: 8.0% and 
13.7%). 
Data analyses 
Results are expressed. unless otherwise stated, as mean and standard deviation with the 
interquartile (IQ) range. Variables which were not normally distributed were 
logarithmically transformed. Comparisons between groups were made by using Students t-
test. Differences are given with corresponding 95% confidence-intervals (CI). Relations 
between variables were assessed using linear regression for continuous variables and 
logistic regression for binary variables. stated as linear regression coefficient (~) or Odds 
ratio and standard errors. Multiple regression analysis was used to assess the contribution 
of different independent variables to the dependent variable. Partial correlations between 
variables were assessed by calculating Pearsons product r. Cox regression was done to 
analyse the relative risk of mortality. stated as B and its standard error. Analyses were 
performed using Stata statistical package (StatCorp 1997. Stata Statistical Software: 
Release 5.0). 
RESULTS 
Summarized values of the quality oflife questionnaire (QLS) are described in Table 1. 14 
subjects which did not fully complete the questionnaire were excluded from the analyses. 
since the combination of the modules of QLS-questionnaire is not representative if not all 
the items have been answered. No differences in health. physical characteristics or serum 
hormones were found between these 14 excluded and the included subjects. Three of the 
subjects who did not fill in the questionnaire had died after 4 years. while 11 subjects were 
still alive. Summarized values of the physical characteristics have been previously described 
(35). Mean age of this population was 77.8 ± 3.6 years (range 73-94). 
None of the summarized scores of the general, the health or the hormonal module were 
related to age. Only the question about leisure time of the general module (QLS-General) 
and the questions concerning mobility and vision/hearing of the health module (QLS-
Health) were inversely related with age (~= -0.15 ± 0.08 points/year. P=0.05: ~= -0.28 ± 0.10 
points/year. P=0.005 and~= -0.36 ± 0.10 points/year. P<O.OOl. respectively). 
Relations with medical history 
Mean scores especially of QLS-Health, were significantly lower in subjects which 
answered yes on several questions in the medical history (for example: angina pectoris. 
dyspnea. subjects with a cerebral vascular accident, dizziness). Subjects with complaints of 
prostatism had a mean score of the health module which was 14.07 ± 4.03 points lower than 
subjects which did not have complaints of prostatism (P<O.OOl). Prostate cancer seemed to 
interfere most in all three modules of the quality of life questionnaire. In Figure 1 is 
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illustrated that subjects with 5 or more complaints or diseases (established by the 21 item 
Table 1. Summarized values Quality of Life questionnaire (QLS) 
QLS-General Obs. (n) Mean (points) ±S.D. Min. Max. 
Friends I acquaintances 389 8.02 5.38 -9 20 
Leisure time I hobbies 389 8.21 5.50 -9 20 
Health 389 10.35 7.53 -12 20 
Income I financial security 389 8.86 5.24 -12 20 
Occupation I work 389 5.40 5.78 -12 20 
Housing I living conditions 389 10.95 5.07 -9 20 
Family life I children 389 12.54 5.77 -6 20 
Partner relationship I sexuality 389 9.02 6.96 -12 20 
Total score general module 389 67.97 26.18 -.56 140 
QLS-Health Obs. (n) Mean (points) ±S.D. Min. Max. 
Physical condition I fitness 388 6.40 6.26 -12 20 
Ability to relax I stay on an even 388 7.73 5.59 -12 20 
Energy I zest for life 388 9.23 6.14 -12 20 
Mobility (e.g. walking. driving) 388 8.06 6.92 -12 20 
Vision and hearing 388 7.01 7.52 -12 20 
Freedom from anxiety 388 9.02 6.25 -12 20 
Freedom from aches and pains 388 8.40 7.09 -12 20 
Independence from help I care 388 11.77 6.55 -12 20 
Total score health module 388 67.62 36.73 -54 160 
QLS-Hormone Obs. (n) Mean (points) ±S.D. Min. Max. 
Ability to withstand stress 386 5.52 5.06 -9 20 
Figure/ appearance 386 5.59 4.46 -9 20 
Self-confidence 386 8.77 5.42 -12 20 
Ability to become sexually 386 3.62 5.11 -12 20 
Ability to concentrate 386 7.26 6.50 -12 20 
Physical endurance 386 5.27 6.50 -12 20 
Initiative/ activity 386 5.72 5.56 -9 20 
Coping with anger 386 5.16 5.84 -9 20 
Coping with bustle 386 4.27 6.54 -12 20 
Total score hormonal module 386 54.18 .15.48 -.50 142 
questionnaire) were significant less satisfied with life compared to subjects with zero or one 
complaint or disease. Interestingly all anamnestic aspects in the medical history which were 
found to be lowering quality of life turned out to be statistically most significant in the 
'"health'"-module. with the '·general"- or "hormonal''-module not adding information in any 
instance. 
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Figure 1. Sores of the quality of life questionnaire according to the number of diseases of A) the 
health module and B) the hormonal module. p denotes the significancy of 5 towards 0 diseases. 
Relations with physical characteristics 
These relations are described in Table 2. Since age was not related to QLS, we did not 
adjust for age. Body Mass Index (BMI) was not related with QLS. Isometric grip strength 
(IGS) and ma.\.-imum leg extensor strength (ma..TI.ES) were both positively related to all 
modules of the QLS questionnaire. MaxLES was 19%, 45% and 44% higher. respectively in 
subjects which scored in the highest compared to the lowest tertile of QLS-GeneraL QLS-
Health and QLS-Hormone. respectively (Figure 2). 
Bone mineral density (BMD) was positively related to all three modules. BMD and 
muscle strength were positively related (r=0.2.5. P<O.OOl). Therefore. a multiple regression 
analysis was performed. After adjustment for ma.ThES, BMD was no longer significantly 
related to QLS. Body composition, including lean body mass and fat mass, were not related 
to QLS. 
Physical performance was positively related to QLS-Health and QLS-Hormone. 
Impairments in activities of daily living (ADL) were inversely related to all three modules. 
This implies that in our population of elderly men, subjects with more problems in activities 
of daily living were less satisfied with llie. ADL was independently. inversely related to 
physical performance (r=-0.54. P<O.OOl) and maxLES (r=-0.34. P<O.OOl). Physical 
performance and ma.-d.ES were also strongly associated (r=0.40. P<O.OOI). ADL and 
ma.ThES were both independently related with QLS. However. part of the relation between 
QLS-Health and physical performance was eA-plained through ma."XLES (linear regression 
coefficient decreased from 3.46 ± 0.76 to 1.67 ± 0.81). while physical performance was no 
longer associated with QLS-Hormone after adjustment for ma.ThES. Interestingly. as was 
the case for the relationship with the anamnestic variables. the QLS-Health module turned 
out in all instances to have the closest relation with the physical characteristics measured. 
without the QLS-General or -Hormone modules adding any information. 
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To be certain that the association between muscle strength and quality of life was 
independent of physical complaints and diseases, we adjusted for the number of presence of 
these diseases (0. 1. 2, 3. 4 or~ 5).The number of diseases as well as ma..xLES remained 
independently related to QLS-Health (respectively B= -7.22 ± 0.98 point/number. P=<O.OOl 
and B= 0.48 ± 0.08 point!Nm. P<0.001). 
Table 2. Results from linear regression of Quality of Life on physical characteristics. 
QLS-General (points) QLS-Health (points) QLS-Hormone (points) 
~ S.E. p ~ S.E. p ~ S.E. p 
Age (years) -0.21 0.37 0.58 -0.61 0.52 0.24 -0.62 0.50 0 ")") 
BMI 0.81 0.44 0.06 0.58 0.62 0.34 1.48 0.59 0.01 
Muscle Strength 
IGS (kg) 0.44 0.19 0.02 1.11 0.26 <0.001 0.59 0.26 0.02 
MaxLES 0.31 0.06 <0.001 0.59 0.09 <0.001 0.44 0.09 <0.001 
Bone Mineral Denisty (g I cm2) 
TotalBody 31.2 13.4 0.02 40.5 19.0 0.03 36.6 18.4 0.05 
Neck 22.9 9.20 0.01 37.8 12.9 0.004 34.2 12.5 0.007 
Ward 23.6 8.18 0.004 31.5 11.6 0.007 28.1 11.2 0.01 
Trochanter 25.2 9.04 0.006 37.2 12.7 0.004 28.7 12.4 0.02 
Body Composition O~g) 
Lean Body 0.36 0.23 0.12 0.49 0.33 0.13 0.45 0.32 0.16 
Fat Mass -0.01 0.23 0.98 -0.03 0.33 0.93 0.23 0.32 0.-16 
Functional ability (points) 
PPS 0.94 0.54 0.07 3.46 0.76 <0.001 1.67 0.75 0.03 
MHAQ -1.47 0.30 <0.001 -3.45 0.42 <0.001 -1.88 0.42 <0.001 
j3:::; linear regression coefficient. For example: QLS-General increases 0.31 point per Nm Maximum 
Leg Extensor Strength (1\1a.'<LES). IGS:::;Isometric Grip Strength, PPS:::;Physical Performance Score. 
MHAQ::: Modified Health Assesment Questionnaire. which reports on the activities of daily life. 
Relations with hormones levels 
These relations are described in Table 3. Only serum non-SHBG-bound testosterone 
levels were just related to QLS-Health. but not to QLS-Hormone. Serum estradiol (total and 
non-SHBG bound E2) was very significantly associated to all three modules tested. Subjects 
with serum non-SHBG-bound E2 levels in the highest tertile scored 9.9% higher in QLS-
General. 20% higher in QLS-Health and 31% higher in QLS-Hormone compared to subjects 
with serum non-SHBG-bound E2levels in the lowest tertile (Figure 3a). Serum DHEA levels 
were not related to quality of life. DHEAS was positively related to QLS-Health only. 
However. DHEAS and E2 were strongly related and after adjustment for E2, DHEAS was 
no longer associated with the health module. An inverse association was present between 
serum cortisol and QLS-General and QLS-Hormone (Figure 4a). Cortisol was not associated 
with QLS-Health. 
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Figure 2. Scores of the quality of life questionnaire in tertiles of maximum leg extensor strength of 
A} the general module. B) the health module and C) the hormonal module.p denotes the significancy 
of the third towards the first tertile. 
Serum IGF-I was not associated with QLS measured in the general and the health 
module. It was. however. positively related to QLS-Hormone. Its binding proteins were 
related to all three QLS modules. but most significantly to QLS-Health. Serum IGFBP-3 
positively. and IGFBP-1 and -2 inversely. IGFBP-3 concentrations were independentofiGF-
I. IGFBP-l. -2 or insulin levels related to QLS (Figure 3b). Also serum IGFBP-llevels were 
independent of physical characteristics and insulin levels related to QLS (Figure 4b). The 
relation between IGFBP-2 and QLS. however. seemed to be dependent on the relation of 
ma.-..::LES and QLS. Serum IGFBP-2 concentrations and muscle strength were strongly 
inversely related. In view of these findings. a multiple regression analysis was performed 
including QLS as the dependent variable and maxLES and IGFBP-2 as the independent 
variables. Ma.U.ES remained significantly related to QLS. while IGFBP-2 did not. Leptin an 
albumin levels were not associated with quality of life. 
121 
Chapter 7 
Table 3. Results from linear regression analyses of Quality of Life on hormones. 
QLS·General (points) QLS-Health (points) QLS-Hormone (points) 
~ ±S.E. p ~ ±S.E. p ~±S.E. p 
Androgens 
TT (nmolll) 0.68 0.44 0.13 0.90 0.62 0.1.5 0.11 0.60 0.85 
FT (pmoi!D 38.8 100.6 0.70 ·35.6 140.6 0.80 34.9 28.4 0.22 
SHBG (nmolll) -0.04 0.09 0.65 -0.14 0.13 0.29 -0.21 0.03 
Non-SHBG-T 1.26 0.70 0.07 1.91 0.98 0.05 1.16 0.95 0.23 
DHEA (nmolll) -0.42 0.35 0.23 0.30 0.49 0.53 -0.37 0.43 
DHEAS (mmolll) 0.40 0.97 0.68 3 99 1.34 0.02 1.05 1.31 0.43 
Estrogens 
Estrone (nmoVJ.) 1.82 33.9 0.96 63.5 47.2 0.18 33.3 46.6 0.47 
E2 (nmoVJ.) 60.1 22.8 0.009 86.0 31.8 0.007 92.3 30.8 0.003 
Non-SHBG-E2 77.4 28.9 0.008 109. 40.3 0.007 128.6 39.0 0.001 
Insulin-like Growth Factor and its binding 
IGF-1 ("gil) 0.03 0.05 0.48 0.12 0.06 0.06 0.14 0.06 0.02 
IGFBP-1 ("g/1) -0.20 0.08 0.02 -0.39 0.12 0.001 -0.38 <0.001 
IGFBP-2 (mg/1) -9.68 4.24 0.02 -16.3 5.94 0.006 -17.2 0.003 
IGFBP-3 (mg/1) 3.81 1.90 0.05 7.60 2.64 0.004 6.32 2 . .59 0.02 
Insulin (lUll) -0.12 0.31 0.69 0.10 0.44 0.81 -0.13 0.76 
Other 
Cortisol (nmoVl) -0.02 0.01 0.03 -0.008 O.Ql 0.41 -0.02 0.04 
Albumin (g/1) -0.21 0.48 0.67 0.73 0.68 0.28 0.28 0.65 0.67 
P denotes linear regression coefficient. For example: QLS-General increases 60.11 point per nmoVl 
Estradiol. TT=Total Testosterone. FT=Free Testosterone. SHBG =sex hormone binding globuline. 
Non-SHBG·T= non SHBG bound Testosterone (nmoVl). E2=Estradiol. Non-SHBG-E2 =non SHBG 
bound Estradiol. IGF-I = Insulin·like Growth Factor·!. IGFBP= Insulin-like Growth Factor Binding 
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Figure 3a. Scores of the quality of life 
questionnaire in tertiles of serum 
(non-SHBG-bound) estradiol concentrations 
of a) the general module, b) the health module 
and c) the hormonal module. 
Figure 3b_ Scores of the quality of life 
questionnaire in tertiles of serum IGFBP-3 
concentrations of a) the general module. 
b) the health module and c) the hormonal 
module. 
"),·"),·denotes significancy ofp<0.05 of first towards third tertile 
"!.· denotes significancy ofp<O.Ol of first towards third tertile 
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Figure 4a. Scores of the quality of life 
questionnaire in tertiles of serum 
cortisol concentrations of a) the 
general module. b) the health module 
and c) the hormonal module. 
Figure 4b. Scores of the quality oflife 
questionnaire in tertiles of serum IGFBP~l 
concentrations of a) the general module. 
b) the health module and c) the hormonal 
module. 
""* denotes significancy of p<0.05 of first towards third tertile 
* denotes significancy of p<O.Ol of first towards third tertile 
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Quality of life and mortality 
The health·related and hormone· related QLS modules were significant predictors of 
mortality (respectively OR=0.99 ± 0.003. P=0.003 and OR=0.99 ± 0.003. P=O.Ol). Subjects 
which had scores in the lowest quartile of the health-related part of the questionnaire (the 
least satisfied) had a significantly higher risk of mortality compared to subjects with scores 
in the highest quartile (respectively OR=3.81 ± 1.67 versus OR=l. P=0.002). In addition. 
subjects which scored in the lowest quartile of the health- as well as of the hormone· related 
module of the questionnaire died significantly earlier compared to subjects who scored in the 
highest quartile (the most satisfied) (Figure 5). QLS-General at baseline did not 
differentiate between deceased and survivors. Since the presence of certain diseases was 
related to quality of life, we adjusted for the presence of co-morbidity. Quality of life 
remained an independent predictor of mortality. We also adjusted for physical 
characteristics of aging. like muscle strength and physical performance. as well as serum 
hormone and albumin levels. Again. quality of life remained an independent predictor of 
mortality. 
Figure 5. Cumulative survival during 48 months of quartile of the A) health module and the B) 
hormonal module 
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DISCUSSION 
In a population of independently living elderly men. aged between 73 and 94 years. 
quality of life did not decrease with age. Several (pre)-existing diseases. however. were 
associated with a reduced quality of life. Maximum leg extensor strength and functional 
ability were strongly positively associated with the general part. the health part, as well as 
the hormonal part of the questionnaire on life satisfaction. Of the endocrine parameters we 
measured. estradiol and IGFBP-3 were strongly positively associated with general. health 
and hormonal related quality of life, while IGFBP-1 and cortisol were negatively related. 
Non-SHBG-bound testosterone was slightly. but significantly related to health-related 
quality oflife. IGF-I was weakly positively related to the hormonal module of the quality of 
life questionnaire. Health- and hormonal-related quality of life are both predictors of 
mortality. 
Psychological well-being is an important factor of successful aging (1). Quality of life 
(QoL) is viewed as a major outcome in its own right (25). Numerous general and illness-
specific questionnaires on QoL exist (36.37). We used the questionnaire Questions on Life 
Satisfaction Module~ because it is designed to assess general. health and hormone-related QoL 
(24.25.38). It is a standardised, economical questionnaire in which subjective QoL is 
reflected by weighting the response to each item for its importance to the respondent. The 
questionnaire used was previously demonstrated to have high correlations with other 
instruments used to assess mainly psychological aspects of well-being. such as the General 
Well-Being Schedule-GWB (39). the Beck Depression Inventory-BDI (40) and the general 
symptomatic index and the scale 'Depression" of the SCL-90-R Symptom Checklist (41). In 
studies in healthy adult individuals correlation coefficients between the total score of 
health-module and these questionnaires were 0.63. -0.51. -0.31 to -0.66. respectively (25). 
Summarized scores of the three modules found in our study were slightly higher than 
scores of male respondents aged 65 and over previously investigated by Hersch bach et al. 
(25). Furthermore cultural differences between Germans and Dutch cannot be excluded. 
This difference was to be ex"})ected since this study was carried out in a selected group of 
independently living elderly men with relatively good physical performance. as well as 
cognitive function. We excluded subjects that were unable to reach the study centre 
independently. as well as subjects with signs of dementia. Only 30 out of the 403 men 
investigated had a slightly impaired score in the mini-mental state examination. between 18 
and 24 points. These 30 subjects did not have different mean quality oflife scores. however. 
The fact that we investigated a rather selected population. is also reflected in the relatively 
high mean score of the 'health' item in QLS-General and the 'independence of help' item in 
QLS-Health. In less selected populations with a broader range of functional ability. if 
anything. associations are likely to be stronger. The fact that quality of life did not change 
with age in this population. while physical well-being did decrease with age may appear as a 
paradox. as physical well-being and quality of life were closely related. However. in this 
relatively healthy group of elderly men, the oldest individuals might have a more positive 
outlook on life. simply due to the fact that they have became this old in a relatively healthy 
condition. 
Various authors have associated psychological well-being with physical health, measured 
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by a number of organic impairments (3.42-45). Larson et al. observed that physical health 
seemed the most crucial factor in life satisfaction (4). Our results, with regard to physical 
health. are in agreement with these previously reported studies. In particular, in our study. 
we linked physical health. measured by a number of questions with regard to musculo-
skeletal or cardiorespiratory problems, to quality of life. 
Few data have been reported with regard to the relations between measurements of 
physical functional capacity and life satisfaction in healthy elderly men. Functional 
independence is known as a predictive factor of life satisfaction (5). On the other hand. 
depressive symptoms might lead to physical disability (46.4 7). Not unexpectedly. scores of 
the modified health assessment questionnaire (MHAQ) which reports activities of daily 
living correlated closely with QLS. The better one can perform activities of daily living, the 
more satisfied one is with regard to general aspects of life. Some overlap exists between 
QLS-Health and the MHAQ (indeed the QLS-Health module related better with the physical 
characteristics than the two other QLS modules). Questions on physical performance. 
mobility and independence overlap with questions asked in the MHAQ. This confirms that 
the QLS questionnaire provides reliable information concerning these items. 
Further. subjects with the best physical performance, measured objectively, have the 
highest life satisfaction. measured subjectively. In addition. it is interesting to note that we 
found a strong independent relation between muscle strength and quality oflife. It might be 
that subjects with the highest muscle strength are better able to undertake leisure. social 
and physical activities and to maintain a social network. As a consequence. they may 
perceive a high quality oflife (44). Alternatively, subjects who perceive a high quality of life, 
may undertake a lot~ and as a consequence of this high activity level, have increased muscle 
strength. Importantly. the relation between muscle strength and QLS is independent of 
other health factors. as assessed by the medical history. Thus. physical well-being, not only 
measured by health factors. but also as functional ability and muscle strength. is strongly 
related to psychological well-being. 
Hormonal activity might also be related to quality of life. In older men. the effects of 
androgens on mood. aspects of cognition, and sexual behaviour have not been extensively 
evaluated. Some studies reported improvement in the sense ofwell-beingwith testosterone 
supplementation (6-8). We demonstrated a weak relation between serum non-SHBG-bound 
testosterone levels and QLS-Health. Testosterone (mainly non-SHBG-bound) was especially 
related to three questions of QLS-Health (physical condition. mobility. and independence 
from help), suggesting that testosterone plays a role in maintaining physical function. which 
in turn is related to a higher life satisfaction. Controversy exists concerning the potential 
beneficial effects ofDHE..A...administration on well-beingin elderly men (13-15). We observed 
a positive relation between DHEAS and the health module of the QLS questionnaire. This 
relation, however. was explained through the positive relation between estradiol and QLS. 
To our knowledge, the strong relationship between serum estradiol levels and quality oflife. 
has only been described in women. insofar that several studies have reported that estrogen 
therapy of post-menopausal women improves disease-specific aspects of quality of life. as 
well as more general aspects of quality of life (9-12). In our study. elderly men with the 
highest estradiol (E2) levels had the highest degree oflife satisfaction. This relation might 
127 
Chapter 7 
be direct. through an effect of E2 on central neurotransmission in the brain (reviewed by 
Fink et al.(48)). The relation between E2 and life satisfaction might also be indirect by 
increasing physical well-being. In this study. however. the relation between E2 and QLS 
was independent of the physical characteristics measured. 
Serum cortisol was inversely related to QLS-General and QLS-Hormone. Single 
measurements of total early morning cortisol levels are only oflimited informative value. 
because cortisol is secreted in a highly episodic manner. and serum cortisol levels therefore 
might not represent the total 24 h production of the hormone. However. elevated serum 
levels of cortisol have been found to be associated with a higher degree of atherosclerosis 
(49.50) and increased incidence of diabetes (51.52). while they have also been associated 
with decreased immune function (53.54) and greater cognitive impairment (55·.57). The 
negative influence of cortisol on the QoL might therefore represent a cumulative deleterious 
effect oflongterm exposure of the human body to relatively high cortisol concentrations. as 
suggested by McEwen et al. (58). 
It has been demonstrated that growth hormone (GH) treatment of adult patients with 
GH-de:ficiency increases psychological well-being (16·18). In our study serum IGF-I 
concentrations were found to be only weakly positively associated to the hormonal module of 
the quality of life questionnaire. In our study serum IGFBP-3 concentrations were strongly 
positively related to the general. the hormonal and especially the health related part of 
QLS. This relation further supports a potential role of GH on psychological well-being. since 
IGFBP-3 is mainly regulated by GH. Both IGFBP-1 and IGFBP-2. were significantly 
inversely related to mainly QLS-Health. The relation between IGFBP-2 and QLS appeared 
to be dependent on the physical condition and/or muscle strength. but the relation between 
IGFBP-1 and QLS, on the other hand. was not dependent on factors determining physical 
well-being. These results are in agreement with previous findings that mean IGFBP-1levels 
were significantly higher in elderly subjects who reported a decreased quality of health 
compared to their peers (.59). An explanation for this remains unknown. but was not 
influenced by insulin or glucose levels in our study. 
The importance of defining determinants of quality of life is shown by the fact that 
quality of life itself turned out to be an important independent predictor of mortality. As 
mentioned previously. it has been reported that quality of life and depression predict 
physical ability in older persons. Some studies have shown that quality of life is a predictor 
of mortality in patients after coronary artery bypass surgery (19), with congestive heart 
failure (20) and with metastatic colorectal cancer (21). With regard to quality of life as 
predictor of mortality in relatively healthy older populations. as far as we know. only one 
study has been described (22). In our population of elderly men. we demonstrated that. 
independent of age. subjects with the lowest life satisfaction at baseline had a signiticant 
higher risk of mortality in the following four years. compared to subjects with the highest 
life satisfaction. In addition. we demonstrated that this significant higher risk was already 
present after a few months (Figure 5). Subjects with a high life satisfaction might be in 
good physical shape and in good health. which in turn might be the reason of an increased 
chance of survival. However. after adjustment for physical performance. disability and 
muscle strength as well as the presence of diseases in our population. life satisfaction 
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remained an independent predictor of mortality. Also. subjects with a higher life satisfaction 
might have a better social environment. which might give the support needed to maintain a 
good health and physical functional status. However. in our study the general part of the 
quality of life questionnaire, which includes questions concerning family. friends, partner 
and leisure time was not predictive of mortality. 
In summary. in elderly men the presence of several health problems is associated with a 
reduced quality of life. Irrespective of the health status. physical and psychological well-
being are strongly related. Muscle strength and functional ability appear to be important 
predictors of quality of life in independently living elderly men. In this same population. 
serum estradiol and IGFBP-3levels were powerful positive predictors, while fasting early 
morning cortisol and IGFBP-llevels turned out to be independent negative predictors of 
quality of life. Low quality of life itself is a predictor of mortality. These data. although 
collected in a cross-sectional study indicate that exercise in order to improve muscle 
strength and! or functional ability. but perhaps also hormonal intervention which aims at 
increasing estradiol bio-availability and! or IGFBP-3levels might further improve quality of 
life in elderly independently living men. The importance of defining determinants of quality 
of life is shown by the fact that quality oflife itself is an important independent predictor of 
mortality. 
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ABSTRACT 
Background ··successful aging" has been used to differentiate between normal aging 
and a more desirable form of aging. One aspect of successful aging is a better health-
related quality of life (HRQOL). 
Objective To map the relationships between HRQOL, various physical and 
psychological characteristics and hormone levels. 
Subjects 244 men aged 77-95 years who had been living independently in the 
community four years earlier. 
Methods Interviews and physical examinations to collect data on hormone levels, 
muscle strength, physical performance, activities of daily living (ADLs), cognitive 
function, loneliness. and HRQOL (EQ-5D instrument). Linear regression analysis was 
used to examine the relationships between these parameters. 
Results Despite various associations on bivariate analysis, HRQOL was associated 
with only ADL, loneliness and serum IGFBP-3 and testosterone levels on multiple 
regression. ADLs and loneliness in turn were both associated with physical performance 
leveL 
Conclusions Physical performance is associated with HRQOL, exerting its influence 
along both the physical and psychological pathways. The challenge remains as to 
whether or not physical performance can be improved well enough using exercise 
therapy to have a substantial impact on HRQOL. given problems with dropout and 
motivation. Improvements to HRQOL may be possible by hormone therapies and by 
social therapy to reduce loneliness. 
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INTRODUCTION 
A differentiation has been made between normal aging and successful aging (1) and 
the definition of normal plays a pivotal role in this discussion. If normal is viewed as 
that which is usually seen as opposed to that which is desirable, it is clear that the aging 
process can be improved upon. For this reason, the term successful aging has been 
adopted. It is not surprising that there is growing interest in determining how the 
chance to age successfully can be increased. However the primary problem one faces 
initially is the definition of 'successful aging'. It is clear that the definition depends on 
one's perspective and value system. and in the literature. one can find various 
definitions for successful aging (2.3) . As a result, it is difficult to create one universally 
acceptable definition. We chose the model described by Rowe & Kahn (4) which contain 
the following components: a) a reduced chance of disease and disease· related handicap: 
b) maintenance of a high level of cognitive and physical function: and c) active 
engagement with life. 
The main study objective was to examine the factors associated with successful aging 
amongst older. predominantly self-sufficient Dutch men. By means of different 
instruments and questionnaires. we operationalised selected aspects of Rowe and Kahn's 
model of successful aging. We focused on health-related quality of life (HRQOL). since 
HRQOL can be viewed as one important aspect of successful aging. In fact. since HRQOL 
cannot easily fit into only one of the components described by Rowe and Kahn. it can 
therefore be positioned above these three components. In addition. we studied the 
relationship between health-related quality of life and the factors of muscle weakness 
and physical performance, since for older-aged adults. the loss of muscle strength results 
in weakness. an important limiting factor for the chance to live an independent life. The 
association between muscle weakness and morbidity and mortality has been noted in the 
past (5). We were particularly interested in exploring the interrelationships between 
hormone levels. muscle strength. physical performance. and health-related quality of 
life. 
MATERIALS AND METHODS 
The men included in this study stemmed from a larger study population created in 
1996 when all males 70 years or older living in Zoetermeer (Netherlands) were invited to 
participate (n=1585). In total 403 men (25.9%) were both eligible and willing to take part 
in the study. Since an important inclusion criterion was the ability to travel to a health 
research center on their own. a relatively healthy group of elderly men was included in 
the study (6). For the present study. all survivors from this original cohort were invited 
to participate. Official approval to conduct this study was received by the medical ethics 
committee of the Erasmus Medical Center Rotterdam. 
All men were invited to visit a health research center to be interviewed and receive a 
physical examination. If necessary. the men were visited at their home. Various 
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demographic and clinical characteristics were studied for their association with health-
related quality oflife (Table 1). 
Instruments 
Health-related quality of life was measured using the EuroQol EQ-5D instrument (7). 
a widely used and validated generic quality of life instrument with 5 dimensions: 
mobility. self care. usual activities. pain/discomfort and an.'l(iety/depression. Each 
dimension has three levels: no limitations. some limitations and severe limitations. All of 
the 243 (i.e., 53) possible health states have been valued by the general public in the 
United Kingdom using the so called York A-1 tariff, by means of a large-scale time trade-
off study (8). These '"valuations .. of the health states represent utility values. an 
indication of their level of desirability or undesirability. The set of possible values has a 
range of -0.549 to 1. where 1 indicates perfect health. 0 indicates death and -0.549 
indicates the worst possible health state. The utility values found in the UK study have 
since been validated for the Netherlands (9). In addition. the study participants were 
asked to describe their overall actual health state using the EuroQol visual analogue 
scale (\lAS). where 0 represents the worst imaginable health state and 1 indicates 
perfect health. 
The ability to perform activities of daily living (ADLs) and the satisfaction with this 
ability was measured using the 'Staniord Health Assessment Questionnaire' (MH..-\Q) as 
described by Pincus et al. (10). Scores range from 0 to 36. where a higher score indicates 
more problems with performing ADLs. Loneliness was measured using the Loneliness 
Questionnaire where possible scores range from 0 (not lonely) tot 11 (extremely lonely) 
(11). This questionnaire bas previously been shown to be reliable and valid (12.13). The 
Mini-Mental State Examination (MMSE) was used to determine the level of cognitive 
function (14). Physical performance was assessed using the method described by 
Guralnik et al. (15). A physical performance score was determined based on balance. 
walking speed and the ability to rise from a chair (range: 0-12. where a higher score 
indicates better performance). Muscle strength. and specifically isometric leg eA-tensor 
strength. was measured in Newton-meters as described by Hsieh en Phillips (16). using 
a Hoggan MicroFET hand-held dynamometer. 
Hormone measurements were performed in the following manner. Blood samples 
were collected in the morning following an overnight fast. Serum was separated by 
centrifugation and stored at -40°C. Serum concentrations of total testosterone (TT. 
nmolll). and sex hormone binding globulin (SHBG. nmolll) were measured by RIA using 
commercial kits (Diagnostic System Laboratories. Sinsheim. Germany). The intra-assay 
CVs were 8.1% and 3.0% respectively. The inter-assay CVs were respectively 10.5% and 
4.4%. Total IGF-I was determined by a IGFBP-blocked RIA in the presence of large 
excess of IGF-II (17). Intra- and interassay CVs were 1.6% and 6.4% respectively. 
IGFBP-1. IGFBP-2. and IGFBP-3 were measured using in-house RIAs with intra-assay 
CVs of 3.4%. 2.9% and 1.9% and interassay CVs of 8.1%. 10.3% and 9.2% respectively 
(17). 
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Statistical analyses 
.All characteristics of the men were studied for their association with health· related 
quality of life (see Table 1). Bivariate and multivariate analyses were performed using 
linear regression analysis where HRQOL (i.e., EQ·5D utility score) was the dependent 
variable. Multivariate analysis was used to establish which patient characteristics were 
statistically significantly associated with HRQOL after adjustment for other 
characteristics. Both stepwise and best subsets analysis were used to create the fmal 
statistical models and a p·value of 0.05 was applied as a guideline for inclusion into the 
model. Associations between patient characteristics and each of the five dimensions of 
the EQ5D scale were analyzed by means of bivariate analysis (Mann-Whitney U test. 
Kruskal-Wallis test. Kendall's tau where appropriate) and stepwise multivariate logistic 
regression analysis (binary and ordinal logistic regression). Correlation between the 
EQ5D utility scores and the EuroQol VAS scores was examined using both the Pearson 
and the Spearman correlation methods. In subsequent analyses we examined the factors 
associated with the outcomes of loneliness and ADLs in a manner similar to that 
described above for the HRQOL. Data were analyzed using SPSS version 8.0. 
RESULTS 
Of the 403 men from the study in 1996, 244 men (60%) participated in the survey. The 
remaining 159 men did not participate for the following reasons: 75 (19%) were deceased: 
21 (5%) had moved. and 63 (16%) were not willing to participate. their reasons including 
"too sick" (n=24). "no reason" (n=22). interview too ta..'\:.ing (n=5). demented (n=4). wife too 
sick (n=4). and other reasons (n=4). Most participants were seen at the research center 
(215. 88%). the others interviewed at home. Characteristics of the study population are 
found in Table 1. The average age was 81 years (range: 77-95 years). Most men were 
married and still living independently at home without assistance. The average score for 
loneliness was 2.5. and approximately 40% of the men were found to be at least 
moderately lonely (i.e., score~ 3). 
Quality of life based on EQ5D instrument 
The average EQ-5D utility score was 0.80 and the average EuroQol VAS was 0.76. In 
a general population of similarly aged men. Kind et al reported an average EQ-5D utility 
score of 0.75 and an average EuroQol VAS score of 0. 73 (18). The HRQOL seen in this 
population was therefore higher than that seen in the general population. The 
correlation between the EQ-5D utility score and the EuroQol VAS score was 0.394 (p < 
0.0001). 
Most men reported having little or no problems with each of the five EQ-5D 
dimensions (Table 2). In fact. 30% of the men scored the highest EuroQol utility score of 
L indicating no problems whatsoever with any of the dimensions. Problems with 
mobility were most frequent in this study group and increased with age (Table 2). 
Interestingly. most men reported no problems with self-care and daily activities. The 
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only statistically significant association between age and limitations was seen with 
mobility (Kendall tau= 0.130. p<0.05). 
Table 1. Description of the study population (n=244) 
Age in years 
Marital status (n. %) 
Married 
Single. never married 
Divorced 
Widowed 
Living situation (n. %) 
Living independently. without assistance 
Living independently. with assistance 
Service center 
Seniors flat 
Home for seniors 
Muscle strength (Newton-meters)* 
Physical performance score (points) 
:MlviSE score (cognitive function)* 
Activities of Daily Living score (points) 
Loneliness score 
Not lonely (score of 0-2) (n. %) 
Moderately lonely (score of 3-8) (n. %) 
Extremely lonely (score of 9-11) (n. %) 
EQ-5D utility score 
EuroQol VAS score 
Mean (SD). 
81.2 (3.3) 
182 (75%) 
7 (3%) 
7 (3%) 
48 (20%) 
101 (41%) 
84 (34%) 
41 (17%) 
8 (3%) 
10 (4%) 
106.04 (23.05) 
8.28 (3.16) 
26.82 (2.74) 
13.00 (6.44) 
2.49 (2.43) 
142 (57%) 
96 (39%) 
6 (3%) 
0.80 (0.21) 
0.76 (0.14) 
Range 
77-95 
0-36 
0-10 
NB: Means with standard deviations in brackets are shown unless otherwise indicated. * - One 
observation missing. 
Table 2. Freguencv of:2roblems with the five E~-5D dimensions :2er age gr:ouE ·~<- E < 0.05 
EQ-5D dimension 75-79 yrs 80-84 yrs 85-89 yrs 90-95 yrs Total Kendall tau 
(n=96) (n = 106) (n= 36) (n= 6) (n = 244) correlation 
coefficient 
Mobility 43% 54% 61% 67% 50% 0.130* 
Self-care 6% 10% 14% 17% 9% 0.050 
Daily activities 11% 14% 17% 17% 13% 0.047 
Pain/discomfort 38% 41% 34% 50% 36% -0.016 
An.xiety/depression 22% 17% 14% 17% 18% -0.055 
Mean EQ-5D utility score 0.82 (0.20) 0.80 (0.23) 0.80 (0.16) 0.78 (0.05) 0.81 (0.21) 
(SD) 
Mean EuroQol VAS (SD) 0.77 (0.14) 0.75 (0.15) 0.76 (0.14) 0.63 (0.12) 0.76 (0.14) 
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Association between HRQOL and personal characteristics 
Table 3 shows the results of linear regression analyses involving the EQ~5D utility 
score and the EuroQol VAS score. Age was not statistically significant associated with 
the EQ-5D utility score but was associated with the EuroQol VAS score. Various factors 
were associated with both EQ-5D utility score and EuroQol VAS score (Table 3). 
Following multivariate analysis. only the ADL score (beta=-0.019. 95%CI: -0.022. -0.015: 
p<0.001) and loneliness (beta=-0.016. 95%CI: -0.024. -0.017: p<0.001) remained in the 
model using the EQ-5D utility score as the dependent variable (R-squared. 40%).The 
majority of the predictive ability in this model was derived from the ADL score (i.e .. 37% 
of the R-square of 40%). 
To explore the mechanisms underlying the associations between HRQOL. ADLs and 
loneliness, we examined their correlations with the five EQ·5D dimensions. The .t\DL 
score was statistically significantly associated with all five dimensions (range of Kendall 
tau correlation coefficients: 0.246-0.639). In contrast. loneliness was statistically 
significantly associated with mobility (Kendall tau=O.l74. p<O.Ol). self-care (Kendall 
tau=0.206. p<0.01) and arD.ietyldepression (Kendall tau=0.267. p<0.01). 
Table 4 shows the correlations between the EQ-5D results and the levels of the 
hormones that were measured. Insulin-like growth factor (IGF) and IGF binding protein 
3 were the only hormones associated with both the EQ-5D utility score and VAS scores. 
Total testosterone was associated with only one of the two EQ-5D scores. When the 
individual EQ-5D dimensions were examined. various associations were statistically 
significant (see Table 4). 
Table 3. Relationships between health-related quality of life (EQ-5D) and personal characteristics 
(univariable linear regression analyses) 
Age (in years) 
Marital status (relative to married men) 
Unmarried 
Divorced 
EQ-5D utility 
Beta coefficient 
-0.003 
0.019 
-0.023 
-0.036 
S.E. 
0.004 
0.080 
0.080 
0.034 
Living situation (relative to men living independently without assistance) 
Living independently with assistance -0.067* 0.029 
Sen.rice center -0.011 0.370 
Seniors flat -0.146* 0.073 
Home for the elderly -0.276** ... 0.066 
ADL score (points) -0.020*** 0.002 
Loneliness score -3.300 ... ** 0.722 
Physical performance (points) 0.030.'"** 0.004 
Muscle strength (in Newton-meters) 0.003*'X-k 0.001 
Cognitive function (using MJ..1SE) 0.013*'1< 0.015 
EuroQol VAS 
Beta coefficient S.E. 
-0.007* 0.003 
-0.022 0.055 
-0.045 0.055 
-0.012 0.023 
-0.056·.(··)< 0.020 
-0.051 0.025 
-0.116* 0.050 
-0.196*** 0.04-5 
-0.010*** 0.001 
-0.011** 0.004 
0.019*** 0.003 
0.002"'.** 0.0004 
0.007"'' 0.003 
NOTE: A positive coefficient indicates a better quality oflife. * p < 0.05: *·!.- p< 0.01: *** p< 0.001 
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Problems with activities of daily living 
Subsequently, we studied the characteristics associated with ADL. Excluding marital 
status, all characteristics were associated with ADL problems (Table 4). The fmal model 
consisted of physical performance (beta=-1.05. 95%CI: -1.27.-0.83: p<O.OOl). muscle 
strength (beta=-0.056. 95%CI: -0.086. -0.026: p<O.OOl). living independently with 
assistance (beta=l.509. 95%CI: 1.303, 2.715. p<0.05) and living in a home for seniors 
(beta=5.805. 95%CI: 2.945. 7.945: p<0.001) This model explained 54% of the variation in 
ADL scores (R-square=54%). owing particularly to the presence of physical performance 
in the model (R-square=47%). 
Table 4. Correlations between hormone levels and EQ-5D health-related quality of life scores and 
dimensions (Values in bold are Pearson correlation coefficients for utility and VAS scores. and 
Kendall tau correlation coefficients for the EQ-5D dimensions)(p-values shown in italics) 
IGF-1 IGFBP-1 IGFBP-2 IGFBP-3 Total 
(ngll) (ng/1) ("g/1) ("gil) Testosterone 
(nmol!l) 
EQ-5D utility score 0.144 -0.059 -0.077 0.194 0.091 
0.024 0.3.58 0.233 0.002 0.1.58 
EQ-5D VAS score 0.129 -0.105 -0.085 0.223 0.286 
0.044 0.101 0.187 0.001 <-0001 
EQ-5D dimensions 
1. Mobility -0.029 0.073 0.124 -0.074 -0.058 
0 . .581 0.167 0.018 0.158 0.269 
2. Self-care -0.104 0.117 0.159 -0.103 -0.096 
0.047 0.025 0.002 0.050 0.068 
3. Usual activities -0.149 0.042 0.034 -0.178 -0.018 
0.00.5 0.424 0.517 0.001 0.726 
4. Pain and discomfort -0.084 0.002 -0.020 -0.111 -0.150 
0.107 0.976 0.706 0.033 0.004 
5. An:ciety and depression -0.047 0.091 0.091 -0.116 -0.090 
0.370 0.080 0.081 0.027 0.086 
Insulin-like Growth Factor-1 (IGF-I). Insulin-like Growth Factor Binding protein (IGFBP)-1.-2.-3 
Loneliness 
We also examined the factors associated with loneliness (Table 5). Widowers. men 
showing poor physical performance, and men with less muscle strength were on average 
lonelier than other men. The final model consisted of widower (beta:::;:l.637. 95% CI: 
0.752, 2.389, p<0.001), physical performance score (beta=-0.220. 95% CI: -0.322,·0.118, 
p<0.001). and age (beta=-0.113. 95% CI: -0.209.-0.017. p<0.05). This model explained 
13.4% of the variation in loneliness scores. 
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Table 5. Relationships between problems with activities of daily living and patient characteristics 
(bivariate analyses using linear regression analysis) 
Age in years 
Marital status (relative to married) 
Single 
Divorced 
Widowed 
Problems with activities 
of daily living 
Beta coefficient Standard 
error 
0.4l"bl••k 0 .. 12 
-2 .. 54 2.49 
0.75 2.49 
0.45 1.05 
Loneliness 
Beta 
coefficient 
0.013 
1.055 
1.484 
1..662*** 
Standard 
error 
0.47 
0.901 
0.901 
0.380 
Living situation (relative to men living independently without assistance) 
Living independently with assistance 3 .. 94*** 0.86 -0 .. 031 0.359 
Service center 1.93 1.08 0.282 0.450 
Seniors flat 7.67*** 2.15 0.999 0.893 
Home for the elderly 11..92*** 1.94 1.024 0.806 
Loneliness score 0.45* ..... 0.17 nla nla 
Activities of daily living nla nla 0.063** 0 .. 024 
Physical performance score -1.42*** 0.09 -0.172*** 0.048 
Muscle strength (Newton-meters) -0.15*** 0.02 -0.020** 0.007 
J\1MSE score (cognitive function) -0.37"'" 0.15 -0.070 0.057 
NOTE: A positive coefficient indicates increased problems with performing activities of daily living .. * p < 0.05; 
** p < 0 .. 01; *** p < 0.001 
Physical performance 
Lastly. we analyzed the physical performance score as a dependent variable. The final 
model consisted of age (beta= -0.355. 95%CI: -0.480. -0.229: p=<.0001). IGF BP-3 
(beta=0.035. 95%CI: 0.012. 0.058: p=0.003). and total testosterone (beta=0.127: 95%CI: 
0.003. 0.251: p= 0.04). 
DISCUSSION 
The definition for successful aging is subjective. influenced by cultural and individual 
values. In our study we avoided the issue of defining successful aging by focusing on 
aspects which cannot be seen as arguable. All would agree that a better HRQOL. 
reduced loneliness. and reduced problems with performing ADLs is desirable. regardless 
of one's preferred definition of successful aging. We studied the factors associated with 
HRQOL and found that problems with ADLs and loneliness were associated with a lower 
HRQOL. 
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We found that most men in our study lived independently, with or without assistance 
(76%). Interestingly. the Longitudinal Aging Study Amsterdam (1998) involving older 
people living in the Netherlands reported that 93% of men aged 77-92 years lived 
independently. a frequency much higher than what we found. This study also reported 
that 28% of the men living independently received no domestic help and 87% received no 
assistance regarding self-care. in contrast to the 83% and 70% we found in our study 
(19). 
In this study. we found that 42% of the men were at least moderately lonely. in 
concordance with previous studies involving Dutch older people where frequencies 
ranging from 32% to 63% and 71% have been reported (20). 
HRQOL 
The positive association between problems with performing ADLs and lower HRQOL 
has been noted before (21). Regarding the positive association between loneliness and 
reduced HRQOL. Mullins et al. found that a poor self-reported health status was 
associated with greater level of loneliness (22). 
ADL 
Physical performance. muscle strength and living situation were associated with 
ADL. Guralnik et al found that persons with higher physical performance scores had 
fewer problems witb mobility and with ADLs (15). 
Loneliness 
We found that being a widower. increased problems performing ADLs, reduced 
physical performance, and reduced muscle strength were associated with increased 
loneliness. In a previous study. men without a partner showed increased levels of 
loneliness (20). The explanation given for this finding involved the quantity and quality 
of social relations. Older people without a partner do not only lack another person who 
can represent an important source of love and support, but they lead a more isolated life 
as a result. participate less often in social activities. feel left out more often and can rely 
on fewer people in times of need. 
The association between physical performance and loneliness has been noted before 
(20) where a negative association between functional status and loneliness was reported. 
One solely psychological explanation is that poor health leads to a general feeling of 
dissatisfaction which in turn manifests itself in loneliness. A different explanation is 
that the restrictions resulting from poorer physical performance mean that older people 
with functional problems are less able to improve and maintain their social network in 
order to meet their needs and desires. It has been suggested that the limited possibility 
to perform practical tasks independently and the desire not to ask others continually for 
help exacerbates the feelings of loneliness (20). It has been reported that persons with 
more social ties show fewer functional problems and this association appears stronger in 
men than in women (23). When men receive more emotional support. less loneliness is 
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experienced. more practical support is received. and a reduced risk of mortality 1s 
observed (24). 
Physical performance 
Impairments at an older age are not irreversible aspects of the aging and disease. and 
instead they can be reduced and maybe even prevented (25). Moreover amongst those 
seniors without handicaps. objective measures of 'physical performance' are very 
predictive of later handicaps. Various studies have shown that physical performance can 
be improved (15). Moderate levels of exercise such as walking at a normal pace appear to 
result in similar effects regarding physical performance to those seen following more 
energetic exercise forms such as walking fast (4). However. while reduction of 
impairment can be achieved by exercise. the activity of exercise is difficult to integrate 
into the lives of seniors and the dropout rate of exercise programs is very high (2.5). An 
alternative is the use of medicines to improve physical performance (25). We found that 
a number of different types of hormones were associated with physical performance. 
However. one might question the real significance of these associations. That is. does the 
presence of such associations indicate that hormone therapy would improve physical 
performance? Such an intervention needs to be evaluated using a randomized controlled 
study design. 
Improvements in physical performance can act to reduce problems with ADL as well 
as reduce loneliness. However. the association between physical performance and 
loneliness was relatively weak though statistically significant. meaning that loneliness 
can only somewhat be ameliorated by improving physical performance. Since this is the 
case, it is useful to consider other means of reducing loneliness. Linnemann & Leene 
have stated that seniors mainly seek support in their existing primary network when 
feelings of loneliness arise. Many people become confronted with a steadily shrinking 
network of contacts. Moreover. it is not possible to replace old contacts with new ones. 
An important task is to ensure that physical limitations do not present an obstacle 
against participation in an active social life since the removal of difficulties faced in 
taking part in social activities is an important success factor (26). How can this problem 
with loneliness be helped? One possibility would be to arrange for more home visits. for 
example by health care workers. in a sort of preventive care effort. Interest from a health 
care perspective would lie in the rationale that reduced loneliness will eventually lead to 
reduced need for health care. A longitudinal study is necessary to examine the 
effectiveness of such an intervention (26). Another possibility would be the creation of 
opportunities where seniors could meet other seniors. for example the organization of 
excursions such as sightseeing trips, sporting events. and theatre performances. One 
variant would be a sort of matchmaking initiative. where seniors flrst would be asked to 
identify their interests and then subsequently would be "matched" with other seniors 
reporting the same interests. A more medical approach would involve the use of 
medication for depression. which may lead to reduced loneliness (27). 
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Hormones 
It is well-known that growth hormone deficient as well as hypogonadal adults have an 
impaired quality of life compared to controls (28). In the elderly, the association between 
a decrease in serum hormone levels and quality of life is much less clear (29). Only few 
studies have investigated the effect of hormone replacement on quality of life in the 
elderly (30). In this study serum IGFBP-3 levels. which are a representative of 24-hour 
growth hormone secretion. as well as IGF-I were strongly positively related with health-
related quality of life. How will growth hormone exert its potential effect on quality of 
life? Although IGFBP-3 levels were also positively related to physical performance, the 
relation between IGFBP-3 and HRQOL seemed not to be determined by physical 
performance. The significant relations between IGFBP-3 and the dimensions of the EQ-
5D utility may give some other indications. In addition. a strong positive association was 
found between serum testosterone levels and the EuroQol visual analogue scale, which is 
a measurement of a more subjective and personal quality of life experience. It could be 
hypothesized that higher testosterone levels are related to a better functional ability. 
and therefore are related to a better health-related quality of life. However. the relation 
between testosterone and HRQOL was independent of physical performance and muscle 
strength. The presence of disease itself may also be associated with decreased 
testosterone levels. 
Study limitations 
As noted earlier, all men included in this study originally had to fulfill a number of 
criteria to be included in this study, such as living independently in the community and 
the absence of dementia. As a result, some of our findings are not generalisable to all 
type of older people (e.g., average physical performance). Nevertheless, some results are 
still relevant. The associations we found between ADL, loneliness and HRQOL 
corresponded with what one could have expected beforehand. Had a random sample been 
examined, it is quite likely that these associations would have been even stronger 
(10.22). 
Some of the men invited to participate in the study were not able to participate. for 
example because they were too sick. Undoubtedly the ADL scores and HRQOL scores 
would have been poorer had these men participated in the study. However. their 
presence in the study would likely have made the associations we found even stronger. 
Given the cross-sectional nature of this study. any conclusions regarding causal 
relationships therefore depend on plausibility and assumptions. 
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ABSTRACT 
Background We investigated the relative importance of several physicaL endocrine 
and inflammatory parameters as potential predictors of mortality in a group of 403 
relatively active. non-disabled independently living elderly men of around SO years of 
age. 
Methods The physical characteristics measured included a measure of physical 
performance. muscle strength. bone mineral density of total body and proximal femur 
and body composition. Endocrine parameters included serum insulin-like growth factor 
(IGF)-I and its binding proteins (IGFBP) -L -2 and -3 concentrations. testosterone. 
cortisoL DHEA(S). free T4. (reverse) T3 and albumin concentrations. Inflammatory 
parameters C-Reactive Protein (via a high-sensitive assay) and serum interleukin-6 were 
measured. Intima-media thickness (Th1T) of the carotid artery was also measured. 
Mortality was registered in the subsequent four years. 
Results Four years after the initial investigation, 75 subjects had died (19%). Age. 
smoking, co-morbidity and IMT of the carotid artery were powerful predictors of death. 
However. in addition and independent of them a number of other factors and parameters 
emerged to be of importance in the prediction of death. High physical performance. 
muscle strength and bone mineral density were associated with a lower risk of mortality 
(RR=O. 71 (0.57- 0.89). RR=O. 70 (0.55 - 0.90) and RR=0.7 4 (0.57- 0.95) respectively). Of 
the hormones. high serum IGFBP-1. free T4 and T3 concentrations all predicted 
mortality (RR=l.29 (1.06 - 1.58). RR=l.27 (1.01 - 1.60) and RR=l.30 (1.02 - 1.60) 
respectively). Finally. low serum albumin and high C-reactive protein and interleukin-6 
levels were associated with a higher mortality rate (RR=0.68 (0 .. 53- 0.86). RR=l.33 (1.07 
- 1.67) and RR=l.74 (1.35 - 2.24) respectively). With the seven most significant 
parameters 78% of subjects could be correctly identified with respect to alive or death 
after four years (area under the ROC curve of 0. 78). 
Conclusions To the best of our knowledge. this is the first study in which apart from 
the well-known conditions like smoking. co-morbidity and atherosclerosis. the relative 
importance of a range of potential physicaL endocrine and inflammatory predictors of 
mortality were addressed in one single study. It appeared that several endocrine and 
inflammatory factors are equally important as indicators of physical functional ability. 
like bone mineral density and muscle strength. in predicting four year mortality in the 
elderly. independent of co-morbidity. Importantly. the concentrations of these factors 
were within the normal range. 
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INTRODUCTION 
There is considerable variation in biologic aging in healthy individuals. with some 
persons exhibiting extensive decline in physiological functions with age and others little 
or none. This suggests that there are more and less "'successful" patterns of aging (1). 
Genetic factors, lifestyle. and societal investments in a safe and healthy environment are 
important determinants of successful aging (1). Traditionally. aging has been considered 
physiological and unavoidable. In recent years it has become evident that it may not be 
necessary to accept the grim stereotype of aging as an inevitable process of decline and 
loss (2.3). Prevention of loss of physical functions can be achieved by exercise (3). while 
hormone replacement with growth hormone (4-6) and testosterone (7) have been 
demonstrated to increase muscle mass. and in some instances increase muscle strength 
in elderly individuals. To be informed about one's individual condition and to select those 
who may benefit from intervention. the use and knowledge of modifiable parameters 
that predict survival or mortality may be usefuL It is well-known that co-morbidity and 
advanced atherosclerosis are indicators of mortality (8). Although several studies 
indicate the predictive value for mortality of e.g. physical and inflammatory parameters. 
to date no study has been performed in which a broad spectrum of potential parameters 
was studied in a single elderly population. 
In the present study we investigated the relative importance of a range of possible 
predictors of mortality in a group of 403 non-disabled independently living elderly men. 
Functional ability. hormone concentrations of the gonadal. adrenaL somatotropic and 
thyroidal a.-xis as well as inflammatory parameters were studied and related to mortality 
in the subsequent four years. 
METHODS 
Subjects 
A single-center cohort study was conducted in 403 independently living men. aged 70 
years and higher. At baseline. 1567 men 70 years and older were invited of which the 
addresses were drawn from the municipal register of a medium sized town in the 
Netherlands. A total of 886 men did not respond to the mailed invitation in which it was 
mentioned that only subjects who lived independently and had no severe mobility 
problems could participate. Eventually 403 men participated (25.7%). The main reason 
not to participate among the respondents was because they were currently under the 
care of a medical specialist or general practitioner (28%). while 16% was excluded on the 
basis of physical (10%) or cognitive (6%) problems. Participants signed an informed con-
sent. The study was approved by the Medical Ethics Committee of the Erasmus 
University Hospital Rotterdam. 
At baseline a 21 item medical history was obtained by a structured questionnaire, 
according to the following groups: musculoskeletal impairments (including arthrosis and 
fractures); cardiovascular impairments (including symptoms or treatment of angina 
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pectoris. congestive heart failure. hypertension. arythmias. myocardial infarction. 
cerebrovascular accidents and shortness of breath); prostate problems (hyperplasia and 
cancer); other malignancies: endocrine disorders (diabetes mellitus and thyroid disease): 
and other conditions (dizziness and disturbed vision which impairs mobility). We divided 
the cohort in five groups according to the number of complaints or diseases present as 
indicated by the 21 item medical history (from 0 till :2: 5). None of the subjects was 
treated for systemic infectious. inflammatory or malignant disorders at the time of the 
investigation. 
A number of participants were taking medications for hypertension (n=96). angina 
pectoris or a myocardial infarction more than si.;;: months ago (n=S5). mild congestive 
heart failure (n=2S). chronic obstructive pulmonary disease (n=40). diabetes (n=28), and 
h;rpercholesterolemia (n=7). 
A complete physical examination was performed. 
Four years after the initial investigation 75 men (19%) had died (8 in the first year, 16 
in the second year. 21 in the third year and 30 men in the fourth year). 
Physical characteristics 
Physical Performance 
Lower extremity function. or physical performance. was assessed as described by 
Guralnik et al.(9). including measurements of standing balance. walking speed and 
ability to rise from a chair. A summary performance scale was created by summing the 
category scores for the walking, chair stand. and balance test. which ranged from 0 
(worst performance) to 12 (best performance). Mean scores of the three tests as well as of 
the summary performance scale measured in this study were similar to those reported in 
subjects of the same age group investigated by Guralnik (9). 
Activities of daily living 
Self-reported disability or satisfaction in performing activities of daily living was 
assessed by a self-administered questionnaire modified from the Stanford Health 
Assessment Questionnaire as described by Pincus et al (10). A score of 8 points was 
obtained if the participants reported no problems in activities of daily living. needed no 
help and when there was no difference compared with the situation 6 months ago. A 
minimum score of 0 was given if participants improved compared to 6 months 
previously. while a maximum score of 36 points was assigned to participants who 
reported severe problems in activities of daily living, needed help and had more 
problems in activities of daily living compared to 6 months ago. The lower the points 
measured in this ADL score. the lower the degree of disability. The Mini-Mental State 
Examination was used to obtain and estimate cognitive function (11). 
Muscle Strength 
Isometric leg extensor strength was measured as described by Hsieh and Philips 
using the Hoggan MicroFET hand held dynamometer (12.13). The measurement 
requires that the participant, in a seated position. pushes with maximal strength to the 
dynamometer. which is held at the tibia. The investigator holds the dynamometer in the 
hand with an extended arm and pushes back until the breaking point is reached. To 
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obtain one measure of leg muscle strength. "ma.'Ximum leg extensor strength'' was 
defined as the maximum strength for the right or left leg in a position of 1200. 
Statistical analyses were based on the physical unit measurement. moments (N*m), 
obtained by multiplying the maximum strength (in Newton) and the distance of the 
dynamometer to the knee joint (in meters). 
Isometric grip strength (IGS) was tested using an adjustable hand-held dynamometer 
(J.AJVIAR dynamometer) in the non-dominant hand (14). Each test was repeated three 
times and the average, eA"Pressed in kilo ponds (kp), was used in the analysis. 
Bone mineral density and Body Composition 
Total body bone mineral density was measured using dual energy x-ray 
absorptiometry (DXA Lunar. Madison, WI). as were hip bone mineral densities at the 
femoral neck. trochanter and Ward's triangle. In addition total lean body mass and fat 
mass were measured (15.16). Quality control including calibration was performed 
routinely every morning for DXA. using the standard provided by the manufacturer. 
Measures of carotid atherosclerosis 
To determine carotid artery intima-media thickness as a quantitative measure of 
generalized atherosclerosis (17). ultrasonography of the left and right common carotid 
artery and the bifurcation was performed with a 7.5-MHz linear array transducer (ATL 
Ultramark N. Advanced Technology Laboratories). A careful search was performed for 
all interfaces of the near and far wall of the distal common carotid artery and the far 
wall of the carotid bifurcation (18). The actual measurements of the intima-media 
thickness were performed off line as described previously (19). 
The common carotid artery. carotid bifurcation and internal carotid artery were also 
evaluated for the presence (yes I no) of atherosclerotic lesions on both the near and far 
wall of the carotid arteries. Plaques were defined as a focal widening relative to adjacent 
segments. with protrusions into the lumen composed of only calcified deposits or a 
combination of calcification and non-calcified material (20). Also the total number of 
plaques was calculated. 
Horm.one measurements 
Blood samples were collected in the morning after an overnight fast. Serum was 
separated by centrifugation and stored at -40°C. The period of storage at -400C varied 
from 0 till 5 months. Total Insulin-like Growth Factor (IGF) -I was determined by a IGF-
Bind.ing Protein-blocked RIA in the presence of large excess of IGF-II as described. (21) 
Intra- and interassay CVs were 1.6% and 6.4% respectively. IGFBP-1. IGFBP-2. and 
IGFBP-3 were all measured with in-house radioimmunoassays (RIA) as described 
previously with intra-assay coefficients of variation (CV) of 3.4%. 2.9% and 1.9% and 
inter-assay CV of 8.1 %. 10.3% and 9.2%. respectively (21). Insulin was measured by a 
commercially available RIA (Nfedgenix Diagnostics. intra-assay and inter-assay CV: 
8.0% and 13.7%). 
Albumin (gil) was measured by photometry using a commercial kit (1\LB. Boehringer. 
Mannheim. Germany). Serum concentrations of total testosterone (TT. nmol!l). and sex 
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hormone binding globulin (SHBG, nmol/l) were measured by RIA using commercial kits 
(Diagnostic System Laboratories, Sinsheim, Germany). The intra~assay CV were 8.1% 
and 3.0% respectively. The inter~assay CV were respectively 10.5% and 4.4%. In 
addition. serum concentrations of estrone (E1, nmolll), estradiol (E2, nmolll), DHEA 
(nmoVl), and DHEAS (~moVl) were also measured by RV\. using commercial h.-its 
(Diagnostic System Laboratories). The intra~assay CV were 5.6%, 5.3%, 3.8%. and 2.1% 
respectively. The inter~assay CV were 10.2%. 8.1%. 8.6%. and 5.1% respectively. Non 
SHBG bound testosterone (nmolfl) was calculated according to a method described by 
Sodergiird et al.(22). Cortisol (nmolll) and insulin (miU/1) were measured by RIA 
(Diagnostic System Laboratories). 
Thyroid~stimulating hormone (TSH) was measured using an iinmunometric technique 
(Amerlite TSH-30. Ortho-Clinical Diagnostics. Amersham. UK). Free thyroxine (FT4). 
thyroxine (T4). triiodothyronine (T3). and reverse T3 were all measured by RIA 
(Amerlite MAB FT4 assay. Ortho-Clinical Diagnostics. Amersham. UK: (23)). Thyroid 
binding globulin was measured by a chemoluminiscence method. Intra~ and 
intervariability coefficients of all the assays were below 11%. 
C~Reactive Protein (CRP) concentrations were determined by a high sensitive method 
using a latex~enhanced immunoephelometric assay on a BN II analyser (Dade Behring. 
Liederbach. Germany). Interleukin-6 was measured using a commercially available 
immulite assay (Diagnostic Products Corporation). 
Data analyses 
Results are expressed. unless otherwise indicated. as mean and standard deviation 
with the interquartile (IQ) range. Variables which were not normally distributed were 
logarithmically transformed. Cox regression was used to analyse the associations under 
study with mortality as outcome. The relative risks and its 95% Confidence Interval (CI) 
are based on the hazard ratios per standard deviation increase using a Cox proportional 
hazards model. Multivariate analysis was used to adjust for age. as well as to assess the 
contribution of different independent variables to the dependent variable. Analyses were 
performed using Stata statistical package (StataCorp. 1997. Stata Statistical Software: 
Release 5.0). 
RESULTS 
Mean age of the study population was 77.8 yr (Standard Deviation 3.6). Baseline 
study characteristics are given in Table 1. 70 Subjects were current smokers. while 281 
subjects were former smokers. 51 Subjects had never smoked. 
General predictors of mortality 
Higher age was associated with an increased risk of mortality. Subjects who had 
never smoked had a significantly lower risk of mortality compared to subjects who ever 
smoked or smoked at the moment (Table 2). A higher number of complaints or diseases 
was significantly related to a higher risk of mortality (Table 2). In addition. indicators of 
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(sub)clinical atherosclerosis such as a thicker intima~media of the carotid bifurcation as 
well as a higher number of plaques in the carotid artery were associated with a higher 
relative risk of mortality (Table 2). 
Predictors of mortality; physical characteristics 
Independent of age. the risk of death decreased significantly with increasing scores on 
the physical performance test (Table 2). More problems in activities of daily living were 
related to a higher risk of mortality of borderline significance (Table 2). Increasing 
muscle strength and bone mineral density values of the total body and the femur were, 
independent of age, significantly related to a lower risk of mortality (Table 2). After 
adjustment for age. subjects with physical performance scores (A) in the lowest quartile. 
as well as subjects with the lowest muscle strength (B) and the lowest bone mineral 
density (C). and subjects with the highest number of problems in activities of daily living 
died significantly earlier after the investigation compared to subjects in the highest 
quartiles (Figure 1 A-C). 
Predictors of mortality; somatotropic honnones 
High IGFBP~l and IGFBP~2 concentrations. independent of age and insulin 
concentrations. predicted mortality (Table 2). After adjustment for the presence of 
plaques and the distensibility of the carotid artery, IGFBP~l remained significantly 
related to mortality. However, after adjustment for intima-media thickness of the carotid 
bifurcation. IGFBP-1 no longer predicted mortality (RR=l.29 (0.94 -1.78). Serum IGF-I. 
IGFBP-3. insulin and glucose concentrations did not predict mortality. after adjustment 
for age. 
Predictors of mortality; gonadal and adrenal honnones 
Serum luteinizing hormone. total and bioavailable testosterone. estradioL estrone, 
DHEA. DHEAS and cortisol concentrations were not related to 4-year mortality after 
adjustment for age (Table 2). However. after adjustment for serum cortisol. subjects with 
DHEAS concentrations in the lowest quartile had a significant higher relative risk of 
mortality compared to subjects with DHEAS concentrations in the highest quartile (RR 
= 2.14 (1.04- 4.41) for the 1" quartile versus RR = 1 for the 4" quartile. P=0.04). After 
adjustment for intima-media thickness of the bifurcation of the carotid artery. this 
relation was no longer significant (RR = 1.56 (0. 75 - 3.25) for the 1 ~t quartile versus RR = 
1 for the 4" quartile. P=0.24). 
Predictors of mortality; thyroidal honnones 
A.fter adjustment for age. high serum free thyroxine (T4) concentrations were 
significantly associated with an increased risk of 4~year mortality (Table 2). Serum 
triiodothyronine (T3) were not related to mortality. T3 was strongly related to albumin 
levels. However. after adjustment for albumin. high serum T3 levels were predictive of 
mortality (Table 2). Serum TSH. total T4. and reverse T3 were not related to 4-year 
mortality. 
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Table L Baseline characteristics of the studv-population of 403 elderly men 
General characteristics 
Age (yr) 
Number of diseases (0 - :'2::5) 
Smoking (number) 
Body Mass Index (kg/m2) 
Intima-Media Thickness of carotid bifurcation (j.tm) 
Number of plaques in carotid artery (n) 
Physical characteristics 
Physical Performance (points) 
Activities of daily living (points) 
Maximum Leg Extensor Strength (Nm) 
Isometric Grip Strength (kp) 
Total Body Bone Mineral Density (g/cm:2) 
Femoral Ward Bone 1:1ineral Density (g/cm:2) 
Somatotropic hormones 
Insulin-like Growth Factor-! (ng!l) 
IGF- Binding Protein -1 (ngll) 
IGF- Binding Protein -2 (!-lgll) 
IGF- Binding Protein -3 (!J.g!l) 
Insulin (mUll) 
Gonadal hormones 
Luteinizing hormone (Ufl) 
Total Testosterone (nmolll) 
Estradiol (nmolll) 
Estrone (nmolll) 
Adrenal hormones 
Dehyd.roepiand.rostenedione (nmolll) 
Dehyd.roepiand.rostenedione Sulfate (J.lmolll) 
Cortisol (nmol/1) 
Thyroidal hormones 
Thyroid Stimulating Hormone (U!l) 
Thyroxine (nmol!l) 
Free Thyroxine (pmol/l) 
Total Triiodothyronine (nmol!l) 
Reverse Triiodothyronine (nmol!l) 
Parameters of Inflammation 
Albumin (gil) 
C-Reactive Protein (mg!l) 
Interleukin-6 (pg/ml) 
Mean (S.D.) 
77.8 (3.6) 
2. 73 (1.72) 
Ever: 351 Never; 51 
25.4 (3.04) 
1.33 (0.56) 
3.35 (2.64) 
8.5 (2.4) 
10.7 (4.3) 
103.2 (20.9) 
34.3 (6.92) 
1.17 (0.10) 
0.72 (0.16) 
100.9 (29.2) 
31.7 (15.5) 
0.62 (0.32) 
2.59 (0.70) 
8.91 (4.25) 
9.38 (8.41) 
8.83 (2.98) 
0.10 (0.06) 
0.10 (0.04) 
7.34 (3.78) 
1.96 (1.38) 
481.4 (183.9) 
1.15 (0.93) 
80.4 (15.9) 
16.6 (3.07) 
1.43 (0.23) 
0.33 (0.09) 
45.6 (2.76) 
3.87 (8.83) 
191.7 (111.4) 
157 
Chapter9 
Predictors of mortality; parameters of inflammation and nutrition 
Low serum albumin concentrations were associated with a higher 4~year mortality 
rate (Table 2). Independent of age. baseline CRP levels predicted 4-year mortality (Table 
2. Figure 2A). High serum interleukin-6 (IL-6) levels very strongly predicted 4-year 
mortality (Table 2). It appeared that only 1 subject had died amongst subjects with IL-6 
concentrations in the lowest quartile (Figure 2B). Both CRP and IL~6 levels remained 
predictive of mortality after adjustment of parameters of subclinical atherosclerosis. 
Relations between the predictors of mortality 
To determine the relative importance of these predictors. we performed a multivariate 
analysis. including all parameters which were significantly related to 4-year mortality. 
The result of this analysis is shown in Table 3. In this multivariate analysis, the intima-
media thickness of the carotid bifurcation was not included. because due to logistic 
reasons the measurement was not performed with 107 subjects. However, if the intima-
media thickness was included. the results were comparable to the results described in 
Table3. The significant parameters of the model described in Table 3 results in an area 
under the Receiver Operating Curve characteristic of 0. 78. indicating that with these 
parameters the prediction was correct in 78% of the subjects whether or not they would 
die within 4 years (Table 4). 
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Table 2. Predictors of 4-vear mortalitv. 
General characteristics 
Age (yr) 
Number of diseases (0 - ~5) 
Smoking (current+ ever vs never) 
Body Mass Index (kg/m2) 
Intima-Media Thickness of carotid bifurcation (J.tm) 
Number of plaques in carotid artery (n) 
Physical characteristics 
Physical Performance (points) 
Activities of daily living (points) 
Maximum Leg E:-..-tensor Strength (Nm) 
Isometric Grip Strength (kp) 
Total Body Bone Mineral Density (g/cm2) 
Femoral Ward Bone Mineral Density (g/cm2) 
Somatotropic hormones 
Insulin-like Growth Factor-! (ng/1) 
IGF- Binding Protein -1 (ng!l) 
IGF- Binding Protein -2 (J.lg/1) 
IGF- Binding Protein -3 (J.tgll) 
Insulin (mUll) 
Gonadal hormones 
Luteinizing hormone (U!l) 
Total Testosterone (nmolfl) 
Estradiol (nmol!l) 
Estrone (nmolfl) 
Adrenal hormones 
DHE.<\. (nmolJI) 
DHE.<\.S ("molJI) 
Cortisol (nmol!l) 
Thyroidal hormones 
Thyroid Stimulating Hormone (U/1) 
Thyroxine (nmolfl) 
Free Thyroxine (pmol!l) 
Total Triiodothyronine (nmol!l) 
Total Triiodothyronine adjusted for albumin 
Reverse Triiodothyronine (nmol!l) 
Parameters of Inflammation 
Albumin (gil) 
C-Reactive Protein (mg/1) 
Interleukin-6 (pg/ml) 
Relative Risk (95% CI) 
L39 (1.14- 1.70) 
1.50 (L03- 2.17) 
2.61 (L0-1- 6.56) 
0.91 (0.71-1.15) 
L35 (L06- 1.72) 
1.27 (1.02 ~ 1.57) 
0.71 (0.57- 0.89) 
1.19 (LOO- L43) 
0.75 (0.60- 0.95) 
0.70 (0.55- 0.90) 
0.81 (0.64- L01) 
0.74 (0.57- 0.95) 
0.95 (0.75- L21) 
1.29 (L06- L58) 
L22 (L01- 1.48) 
0.90 (0.69- 1.17) 
L09 (0.89- L35) 
0.94 (0.75 -1.18) 
0.92 (0.74- 1.14) 
0.87 (0.66- 1.14) 
L01 (0. 78- L31) 
1.07 (0.87- L31) 
0.84 (0.64- 1.10) 
1.19 (0.95- 1.48) 
L05 (0.85 -L30) 
L22 (0.96- L55) 
L27 (L01- 1.60) 
L34 (0.89- 1.44) 
L30 (L02- L66) 
1.14 (0.91- L43) 
0.68 (0.53- 0.86) 
L33 (L07- L67) 
1.74 (1.35- 2.24) 
P-value 
0.001 
0.04 
0.04 
0.45 
0.01 
0.03 
0.004 
0.06 
0.02 
0.005 
0.07 
0.02 
0.68 
O.Gl 
0.04 
0.44 
0.40 
0.60 
0.45 
0.32 
0.92 
0.51 
0.20 
0.12 
0.62 
0.11 
0.04 
0.30 
0.03 
0.25 
0.002 
0.01* 
<0.001* 
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The Relative Risk and it 95% CI was based on the hazard ratio per standard deviation increase. 
"!,· C-reactive Protein and Interleukin-6levels were logarithmically transformed 
Table 3. Relative Risk of 4-year mortality after performing a multivariate analysis including the 
significant (P<0.05) predictors of mortality of Table 2. 
Mortality 
Age (year) 
Number of diseases 
Smoking (current +ever vs never) 
Number of plaques (n) 
Physical Performance (points) 
Ma.-..cimum Leg Extensor Strength (Nm) 
Isometric Grip Strength (kp) 
Femoral Ward Bone l\1ineral Density (g/cm2) 
Insulin-like Growth Factor Binding Protein-1 (ngll) 
Insulin-like Growth Factor Binding Protein-2 (J.Lg/l) 
Free T4 (pmoV!) 
T3 (nmol!l) 
Albumin (gil) 
C-Reactive Protein (mgll) 
!nterleukin -6 (pg/ml) 
Relative Risk (95% CI) 
1.4 7 (1.09- 1.98) 
1.31 (0.78- 2.20) 
2.83 (0.88- 9.10) 
1.19 (0.89- 1.58) 
0.90 (0.64- 1.26) 
0.95 (0.65- 1.39) 
0.83 (0.58- 1.18) 
0.70 (0.53- 0.94) 
0.75 (0.52- 1.09) 
0.87 (0.58- 1.28) 
1.38 (1.03- 1.85) 
1.70 (1.18- 2.45) 
0.54 (0.38- 0.77) 
1.51 (1.14- 2.01) 
1.86 (1.30- 2.68) 
P-value 
0.01 
0.31 
0.08 
0.23 
0.53 
0.80 
0.30 
0.02 
0.13 
0.47 
0.03 
0.004 
0.001 
0.004* 
0.001 * 
The Relative Risk and its 95% CI was based on the hazard ratio per standard deviation increase. 
* C-reactive Protein and Interleukin-6levels were logarithmically transformed 
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Figure 2. Kaplan-Meier survival curves showing the relation between one minus overall survival 
and C-Reactive Protein (A) and interleukin-6 concentrations (B). P-value denotes the significancy 
between the flrst and the fourth quartile. 
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Table 4. Additional values of the strongest predictors of 4-year mortality in a ROC analysis 
model. 
Mortality ROC % 
Age (,vear) 
Femoral Ward Bone Mineral Density (g/cm2) 
lubumin (gn) 
Free T4 (pmolll) 
T3 (runolll) 
C-Reactive Protein (mg/1) 
lnterleukin -6 (pg/ml) 
61 
68 (+7) 
70 (+2) 
71 (+1) 
71 (+0) 
73 (+2) 
78 (+5) 
The area under the Receiver Operating Curve (ROC) characteristic of 0.50 is the starting point. 
indicating that without being informed of any parameter. the prediction will be correct in 50% of 
the subjects whether or not they will die within 4 years. With age alone the prediction was correct 
in 61%. With age plus bone mineral density the prediction was correct in 68%. With all the 
parameters in this table the prediction was correct in 78% of the subjects whether or not they 
would die v.rithin 4 years. 
DISCUSSION 
To the best of our knowledge. this is the first study in which apart from the well-
known conditions like smoking. co-morbidity and intima-media thickness of the carotid 
artery. the relative importance of a range of possible physical, hormonal and 
inflammatory predictors of mortality was investigated in a single group of 403 non-
disabled. independently living elderly men. With regard to physical functional ability. 
low physical performance. muscle strength and bone mineral density all predicted 4-year 
mortality. Of the endocrine system. high IGFBP-1. IGFBP-2. T3 and free T4 
concentrations were all predictive of a higher mortality risk. Finally. low serum albumin 
and high C-reactive protein and interleukin-6 levels were associated with a higher 
incidence of 4-year mortality. while never having smoked predicted survival. With the 
seven most significant parameters 78% of subjects could be correctly identified with 
respect to alive or death after four years (area under the ROC curve of 0. 78). 
To appreciate the :findings of this study. some of its characteristics should be 
addressed. Only independently living men who were able to visit the study center by 
themselves were included. Also cognitive function of these individuals was largely intact. 
Only 30 individuals scored below 24 points in the mini-mental state examination, 
indicating mild cognitive impairment. The findings therefore pertain to relatively 
healthy. active old men. and may not necessarily apply to the whole population of elderly 
men. many of which live in dependent. supervised living conditions or in nursing homes. 
However. in elderly men with a broader range of functional ability. associations might 
well have been stronger. 
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Results from recent studies suggest that physical performance in older adults 
inversely predicts mortality independent of disease (24·26). This is confirmed in our 
population of elderly men. In addition. both lower muscle strength. mainly isometric grip 
strength. as well as lower bone mineral density were significantly associated with 
mortality independent of disease. Rantanen et al. recently described in a much younger 
population that hand grip strength is a long·term predictor of mortality in initially 
healthy men (27). Johansson et al. as well as Trivedi and Khaw recently described that 
low bone mineral density. apart from disease. is also a predictor of mortality in the 
elderly (28.29). Muscle strength and bone mineral density may be markers for general 
health or lead to imbalance and an increase in fractures. Both notions are associated 
with an increased mortality. 
Part of the age· related physiological changes might be influenced by the activity of the 
endocrine system (30.31). Therefore one could hypothesize that serum hormone 
concentrations not only relate to measures of functional ability. but also predict 
mortality. High IGFBP·l and IGFBP·2 concentrations were both associated with an 
increased risk of death. We previously described that high IGFBP-llevels are associated 
with measures of atherosclerosis (32). After adjustment for the presence of 
cardiovascular disease in particular, mean intima·media thickness of the carotid 
bifurcation. IGFBP·l no longer predicted mortality. suggesting that increasing IGFBP-1 
levels reflect the presence of (sub)clinical atherosclerosis. Further, since serum IGFBP·l 
levels seem to mirror insulin secretion (33). they may sel\l"e as an indicator of insulin 
resistance. 
In this population serum IGFBP·2 levels were strongly related to all measures of 
functional ability (data not shown). as well as mortality. In the multivariate analysis 
IGFBP·2 lost its significant association with mortality. suggesting that this relation may 
largely act through functional ability. 
Although testosterone was strongly related to bone mineral density and muscle 
strength in this study (13). testosterone was not independently related to mortality. 
Most studies describe that testosterone substitution in elderly men cause an increase in 
lean body mass. muscle strength and bone density (7). Testosterone might therefore 
influence mortality indirectly by improving functional ability via muscle strength and 
bone density. 
Subjects with the lowest DHEAS levels had a significantly higher risk of mortality 
compared to subjects with DHEAS levels in the highest quartile. These findings are in 
agreement with previous studies (29,34), in which it was also found that in men with 
DHEAS levels in the lowest quartiles. mortality rates are the highest compared to 
subjects with higher DHEAS levels. In our study. this difference was no longer 
significant after adjustment for subclinical atherosclerosis. It has been hypothesized that 
DHEAS levels might be protective for cardiovascular disease. However. the clinical 
significance of DHEA in cardiovascular disease remains uncertain (35). Low DHEAS 
levels. on the other hand. might also be an epiphenomenon related to the presence of 
disease (36). 
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Recently, it has been described that in a population-based study. subclinical 
hyperthyroidism predicts mortality (37). We could not confirm these results. Only a few 
subjects satisfied the criteria for subclinical hyperthyroidism (low TSH and normal free 
T4). However. we found that subjects with T3 levels in the lowest quartile. which were 
beneath the normal values for healthy adults (<1.42 mmol!l). had a significantly better 
4-year survival compared the other subjects. These subjects had normal reverse T3 and 
TSH levels. It can be hypothesized that the age-related decline in T3 levels might serve 
as an adaptive mechanism, analogous to the euthyroid sick syndrome during illness. to 
prevent excessive catabolism and consequently may influence mortality. 
In addition. higher free T4 levels, within the normal range. were associated with a 
higher risk of mortality. This relation appeared to be very strong and independent of e.g. 
disease. bone density and specific medication known to influence thyroid function. 
Although no definitive conclusions can be made. it should be mentioned that we were not 
informed about the possible subsequent development of overt hyperthyroidism in the 
population studied. Also. no information about autoimmune antibodies was available. 
Although serum reverse T3 concentrations were strongly inversely related to parameters 
of physical ability (data not shown), they did not predict mortality. This might indicate 
that increased reverse T3 concentrations are a sign of an adaptive mechanism to prevent 
excessive catabolism and therefore are not related to mortality. 
It has been established previously that low albumin levels are an independent 
predictor of mortality in different populations (reviewed by Goldwasser et al. (38)). In the 
multivariate analysis. the albumin concentration was one of the strongest predictors of 
mortality, indicating a very strong representation of an individuals' condition. Low 
albumin levels may reflect an impaired nutritional status and/or the presence of an 
acute phase reaction. as albumin is a negative acute phase protein. 
It has been demonstrated before that C-reactive protein (CRP) and interleukin (IL)-6 
concentrations reflect inflammation and predict cardiovascular disease. disability as well 
as mortality in a healthy. non-disabled population with or without cardiovascular 
disease (39.40). In this population CRP and IL-6 levels. within the normal range, both 
strongly predicted mortality. Remarkably. these associations were independent of co-
morbidity. subclinical cardiovascular disease. cardiovascular risk factors, the use of non-
steroidal anti-inflammatory drugs and physical ability. IL-6 is a cytokine involved in the 
regulation of the acute phase response and bone metabolism. IL-6 decreases the 
production of albumin by the liver and is known to influence multiple endocrine a"X:es 
{41.42). According to Figure 2. it is perhaps more appropriate to conclude. that low levels 
of IL-6 predict survival. This is in contrast to a study by Harris et al. (39), reporting that 
subjects with IL-6 levels in the highest quartile have a higher risk of mortality compared 
to those with lower IL-6 levels. Low IL-6 and CRP levels in the normal range may 
therefore be indicators for the absence of (subclinical) disease in general in the very old. 
Physical functional ability. hormonal and inflammatory parameters appear to be well 
informative to establish the mortality risk. It is remarkable that in this relatively 
healthy population, several physicaL hormonal and inflammatory parameters are 
strongly related to mortality, independent of co-morbidity and atherosclerosis. It should 
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be noted that most concentrations are within the normal range. In this study we focused 
on the relative importance of these predictors in order to establish prognosis. The 
independent value of the individual predictors of mortality. needs to be further 
examined. This may have important implications for future intervention strategies. 
notably exercise programs. hormonal or anti~ inflammatory treatment. 
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1. AIM OF THE THESIS 
The aim of this thesis was to obtain more insight in the relations between the 
endocrine system and the physical and psychological aging process in elderly men. A 
number of questions were addressed. 
1) Since it is difficult to define those subjects that age successfully with respect to 
physical function. we set out to determine which are the main physiological 
determinants of functional ability in the elderly. We also investigated which of the 
physical parameters predicted mortality. To emphasize the importance of the 
parameters of physical function. we assessed their relationship with quality of life. 
2) As the age-related decline in serum hormone levels occurs in parallel with the 
loss of physical function, bone mass. muscle mass and muscle strength. we investigated 
whether serum hormone levels of all endocrine a.xes involved were related to the physical 
functions measured. including bone mineral density and body composition. In addition. 
we defined whether these hormone concentrations could be used as an indicator of a good 
physical functional ability as well as survival or mortality. Furthermore. we established 
whether serum hormone concentrations were related to quality of life. 
3) Because serum sex hormones are mainly bound to their hormone binding 
globulins and albumin. it remained to be established whether the bioavailable hormone 
fraction is the best representation of the bioactive hormone concentration. Therefore. 
various measures were compared of bioactive androgens and estrogens to which tissues 
are exposed in their relationship with muscle strength. bone density and body 
composition. 
4) Because a common variant form of luteinizing hormone (LH) was detected in 
apparently healthy individuals. caused by point mutation-based substitutions of two 
amino acids (TrpSArg and Ilel5Thr) in the LHI3 subunit (1-3) and since it was suggested 
that the in vivo bioactivity of the LH variant is lower than that of the wild-type hormone 
(4.5). we determined whether differences in bioactivity of the variant LH were related to 
characteristics of physical functional ability. In addition the presence and concentration 
of this genetic LH variant in elderly men was determined . .AJ.so. its potential value as an 
"integrated' marker of both androgen and estrogen bio-activity was considered. 
5) Since atherosclerosis is an important cause of cardiovascular morbidity and 
mortality during aging, we assessed the presence of atherosclerosis by measurement of 
the carotid artery intima-media thickness and the number of plaques. In addition. as 
changes in endocrine systems may influence the atherosclerotic process. e.g. a decreased 
activity of the GH - IGF-1 axis. the relationships between plasma hormone 
concentrations and parameters of atherosclerosis were determined. 
6) It has been demonstrated before that C-reactive protein (CRP) and interleukin-6 
(IL-6) concentrations reflect inflammation and predict cardiovascular disease as well as 
mortality in a healthy. non-disabled population with or without cardiovascular disease 
(6. 7) . .AJ.so in our population it was investigated whether CRP and IL-6 were related to 
mortality. 
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.7) Finally, an attempt will be made to integrate the results of this thesis in relation 
to the concept of successful aging. The definition of successful aging as proposed by Rowe 
was taken as a starting point. 
2. STUDY POPULATION 
Names and addresses of all male inhabitants 70 years and older were drawn from the 
municipal register of Zoetermeer. The study was intended to include 400 subjects. 
Finally, 1567 men were invited. A total of 886 men did not respond to the mailed 
invitation in which it was mentioned that only subjects who lived independently and had 
no severe mobility problems could participate. A third requirement was that the 
participants did not have signs of dementia. Response rate of subjects invited aged = 80 
yr was 18.3% compared to 32.7% of subjects aged< 80 yr. After exclusion of subjects who 
did not live independently and of subjects with signs of dementia (measured by the mini-
mental state examination), 403 men participated (25.7%). 
After taking a medical history and performing a complete physical investigation 5 
groups of co-morbidity were established as described in chapter 9 (those with none. one. 
two, three. four or five or more diseases or complaints). In addition. two groups were 
formed using medication or none at all. None of the subjects were treated for systemic 
infections or malignancies at the time of inclusion in the study. 
Several aspects need to be discussed with regard to the study population and the way 
of inclusion. 
Aging can be approached in two different ways: one can direct one's attention to the 
ensuing deficits. or to the factors which play a protective role to the decline in function. 
These different approaches which are reflected in the concepts ·frailty' and ·successful 
aging' need to be explained. Frailty is defined as a syndrome of multi-system reduction 
in physiological capacity as a result of which an older person's function may be severely 
compromised by minor environmental challenges. giving rise to the condition ·unstable 
disability' (8). The variable presence of co-morbidity makes research findings more 
difficult to generalize. Therefore the alternative to focus research on the least frail and 
'non-diseased'. which implies the successfully aged. might be easier. Older persons with 
minimal physiologic loss. or none at all. when compared to the average of their younger 
counterparts. can be regarded as having aged more broadly successful in physiologic 
terms (9). The concept frailty focuses mainly on the physical aspects of aging. while the 
concept of successful aging includes a broader range of aspects such as physical, 
psychological and social aspects. Both concepts are not easy to define in a single 
measure. nor are there generally accepted criteria to categorize a certain individual. 
Although definitions of successful aging in gerontology are numerous, there is still no 
consensus on the definition of successful aging. Rowe et al defined it as including three 
main components: low probability of disease and disease-related disability. high 
cognitive and physical functional capacity. and active engagement with life (Figure 1) 
(10). Fries et al. defined successful aging as optimizing life expectancy. while simultane-
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ously minimizing physicaL psychological and social morbidity (11). Vaillant argued that 
in addition to physical health, there are three further dimensions, or outcomes. of 
successful aging: mental health. psychosocial efficiency and life satisfaction (12). 
ENGAGEMENT 
WITH LIFE 
AVOiDING 
DISEASE AND 
DJSABIUTY 
SUCCESSFUL 
AGING 
HIGH COGNITIVE 
AND PHYSICAL 
FUNCTION 
Figure!. The concept of 'Successful Aging' as illustrated by the model by Rowe with 'maintaining 
high cognitive and physical functional capacity'. 'avoiding disease and disability'. and 
'maintaining active engagement with life' as main determinants. 
In our study we could have approached aging by investigating frailty. which is defined 
as ·a state of reduced physiological reserves associated with an increased susceptibility to 
disability' (13). 
In our study population we focused on the least frail. which implies the successfully 
aged. To decrease the number of subjects with severe diseases to a minimum, we invited 
subjects who lived independently. had no severe mobility problems and did not have 
signs or symptoms of dementia. We acknowledge that we were not able to determine all 
aspects which compromise or influence successful aging as described by Rowe and 
illustrated in Figure 1. We did not investigate a random selection of the SO year old male 
in The Netherlands. and therefore we cannot generalize the prevalence of co~ morbidity 
and mean level of physical functioning to the general population. This was not a 
disadvantage in our study, since the aim was not to measure frequency. but to assess 
associations. In fact. in less selected populations with a broader range of functional 
ability, the associations found between parameters of the endocrine system and physical 
and psychological well~ being are likely to be stronger. 
As mentioned above. it was not possible to completely describe or defme successful 
aging. As will be explained in the following section. we used several questionnaires 
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representing aspects of quality of life as endpoints. Since also these quality of life 
questionnaires do not fully describe successful aging. we used mortality data as a 
derivative as well. Four years after the initial investigation 75 of the initial403 men had 
died. This number was obtained from the municipal register of Zoetermeer. Since 
information concerning the cause of death could not be provided. the general 
practitioners were notified. The general practitioners returned the forms of 56 subjects. 
A cause of death was given of 49 of these men, while of 7 men the cause was unknown. 
The main reason not to fill in the mortality form of the other 19 subjects. was a lack of 
cooperation or a loss of follow·up of the participants. The causes of death were in almost 
all cases defined by the attending general practitioners. as the great majority of these 
men had died at home. Although most individuals were given a diagnosis at death 
(mostly ischemic heart disease. pneumonia. consequences of a fall, or cancer). one cannot 
rely very much on these diagnoses. presented on the death certificates. Most very old 
individuals die with a variety of diagnoses, and the real cause of death remains 
uncertain. A review of autopsy findings in 200 persons older than 85 years identified no 
acceptable cause of death in at least 30% of the cases (14). 
3. STUDY METHODS 
A. Physical functional ability 
1. Subjective functional ability was assessed using the Modified Health Assessment 
Questionnaire (15). Several instruments for the functional assessment of older subjects 
have been developed. Self-administered or interviewer-administered instruments 
subjectively judge a persons' ability . .Although the ability to perform activities of daily 
living (ADL) has at times been synonym for physical function. ADL scales actually 
assess the basic capacity of persons to care for themselves and hence represent a narrow 
range of performance (16,17). Our population is probably a relatively strong and healthy 
sample from the general population. In addition. one of the inclusion criteria stated that 
subjects needed to be living independently. Variability of the scores of the modified 
health assessment questionnaire in our population was skewed. with a relatively large 
percentage of subjects scoring in the lower range of this questionnaire (having few 
problems in ADL). These factors suggest that it might have been more useful to utilize 
an i\DL scale to assess somewhat higher levels of performance. like instrumental ADL 
scales (18). Scales that assess a wider range of performance can more accurately classify 
the level and range of disability in any group of patients and are more likely to detect 
clinically important changes. Despite the small variability in ADL in our study group. we 
found several strong relations between different parameters of physical activity and 
ADL. suggesting that a greater variability when using a questionnaire with a wider 
range of performance would have resulted in even stronger associations. 
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2. Objective functional ability 
We were initially concerned that self~reported function would provide insufficient 
discriminatory power to describe the variation in impairments. Therefore. also a physical 
functional performance test was used (19). Relative to questionnaires, performance 
measures were not found to be more acceptable to respondents. easier to administer, or 
easier to interpret by several authors (20). Self-report and objective performance 
measures complement one another, and add both to the understanding of older person's 
functional status (21.22). The physical perfonnance test developed by Guralnik et 
al. used in this study has proven to be valid and easy to administer (21). This test does 
not require special equipment and can be performed in a few minutes. The combinations 
of the three parts of the test seem to give a good representation of physical function. It 
has been demonstrated previously several times that this performance test predicts the 
onset of disability in those initially reporting no disability in activities of daily living 
(23). 
Physical performance tests are better than self-reported disability in measuring 
changes during treatment I intervention, because small changes are easy to detect. ADL 
is an end-point for the weakest. and minor decreases in physical performance do not 
have to result in difficulties in ADL. Scores of ADL and the physical performance test 
(PPS) in our population were strongly related. Most of the associations between hormone 
measurements or physical characteristics and ADL were also present with PPS. 
However, some hormones were only related to ADL and other hormones were only 
related to PPS (next chapter). It therefore remains unanswered what the additional 
clinical or research benefits are of combining scores produced by different methods or 
items from different instruments in order to obtain the most accurate assessment of 
physical function. 
Muscle strength is also a measure of physical functional ability. It is well-
documented that the reductions in strength that occur with advancing age have negative 
consequences on gait and other aspects of physical performance capacity. particularly if 
the age-related decline in strength is exaggerated by inactivity or debilitating disease 
(13.24,25). From a physiologic and kinesiologic point of view. the measurement of 
strength is very complex. The force produced by a muscle group is influenced by the 
speed of limb movement and the mode of muscle contraction - isometric (static), 
eccentric (lengthening) and concentric (shortening). The muscle groups chosen to 
represent strength should be based on the relevance to the task of interest (26). Two 
types of strength measurements were performed in this study. 
Isometric grip strength in kilo pounds (IGS) was tested using an adjustable hand 
held dynamometer (J.A1VI.A.R dynamometer) in the non-dominant hand (27). Each test 
was repeated three times and the average was used in the analysis. 
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Isometric leg extensor strength was measured as described by Hsieh and Philips 
using the Hoggan MicroFET hand held dynamometer (28). The measurements were done 
as described in chapter 3. Few studies so far have described leg e::-..-tensor strength (LES) 
measured with the Hoggan microFET dynamometer (29). Kwoh et al. studied the 
reliability of the MicroFET in subjects after elective hip and knee athroplasty (30). He 
concluded that inter- and intra-assay variability came up to meet the requirements. 
According to Hsieh et al. manual dynamometry is an acceptable method when the 
.. break" test is used (28). Judgment of the strength using this method is dependent on 
the interpretation of the investigator. Since in the cross-sectional part of this study. two 
investigators measured LES, it was checked regularly during the course of the 
investigation whether the two investigators performed the strength measurements in a 
similar way. with the same results. A reliability investigation recommended that 
measurements of leg extensor strength with the microFET should be performed by a 
maximum of two persons to meet up the requirements of the inter-observer variability 
(31). In our study. a few subjects (n=12) with isometric grip strength between 30 and 50 
kg reached the maximum achievable value of the microFET. as shown in Figure 2. 
Because of the small number this had no implications for our analyses. However. this 
technique may not be suitable for younger and more powerful subjects. Bohannon et al. 
indeed reported that weaker subjects gave higher reliability of muscle strength 
measurements than stronger subjects (32,33). When the leg was held at 120°. LES was 
significantly higher compared to the extended position. This is to be e::-..--pected. as the 
biomechanical circumstances for the quadriceps are more favourable at 120°. In addition. 
the insertion distance to the turning point is larger at 120° than at 180°. Moreover. when 
the quadriceps is more extended at 120°. force per moment increases. Although the non-
dominant leg is in general slightly weaker. there was almost no difference in the relation 
between strength of the dominant and the non-dominant leg and other variables. 
The marked associations between the measurements in different positions. and 
between isometric grip strength (IGS) and all the measurements of LES (Figure 2). 
indicate that measuring knee extensor strength at 120° with the Hoggan microFET 
dynamometer provides an easy method to measure strength in elderly men. especially in 
a home-based setting. This is also illustrated by the normal distribution in our 
population (Figure 3). 
B. Body Composition 
Bone mineral density was measured using dual energy X-ray absorptiometry. This 
is a standardized method to measure bone density and equilibration was performed 
routinely every morning. We measured bone mineral density of total body and femur 
(neck. ward and trochanter). We did not measure bone mineral density of the lumbar 
spine. since in this older population the results of such a measurement will be disturbed 
by the presence of arthrosis. 
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Fat mass and lean body mass were also measured using dual energy X-ray 
absorptiometry. It is not possible to differentiate between subcutaneous and visceral fat 
mass with this technique. Because it is mainly the visceral fat we are interested in. some 
relations may not precisely describe the exact associations. This has to be taken into 
account when interpreting the results. 
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Neither is it possible to differentiate between skeletal muscle mass and smooth 
muscle mass. However. most of the differences in muscle mass between the participants 
will be in skeletal muscle. and therefore it can be used to describe its relations with for 
example hormone levels. The strong positive relation between leg extensor strength and 
lean body mass. suggests that it is indeed a good method in measuring lean body mass. 
C. Quality of life, loneliness and cognitive function 
Successful aging compromises terms like psychological well being. quality of life 
(QoL) and life satisfaction. which are all used interchangeable . .Although there are no 
generally accepted definitions and approaches for assessment. there is broad agreement 
that in measuring health-related quality of life we should assess a number of crucial 
areas including physical function. psychological state. somatic symptoms. social function 
including relationships. sexual function and occupational function and possibly financial 
state (34). With reference to this agreement, the terms successful aging and QoL can also 
be used interchangeably. However, QoL is measured by subjective indicators only. while 
successful aging can be measured by both objective and subjective indicators. There are 
numerous general and ill-specific quality of life (QoL) questionnaires. which are critically 
reviewed by Gill and Feinstein (35). Of main importance is that there are marked inter-
and intra-individual differences in the perception and evaluation of objective aspects of 
life or disease. For example. the "illness paradox" describes the discrepancy between 
"objectively" poor health (as assessed by an outside observer) and a positive self-
assessment. In this study we used a QoL questionnaire (QLS). described in chapter 7. 
which has been recently developed by Henrich and Herschbach (36). This is a 
questionnaire. in which in its development the attempt was made to deal adequately 
with the problem of the relative importance of individual aspects of quality of life. Recent 
studies with QLS have shown that weighing of the individual items for their importance 
to the respondent is an effective way to incorporate the concept of subjectivity of quality 
oflife in the quality oflife instrument (36). This questionnaire has been validated for the 
Dutch population (36). In our population the questionnaire was relatively easy to 
administer after a good explanation. It took less than 30 minutes to fill in the three 
modules of the questionnaire, which is important against the potentially decreasing 
attention span of the oldest old. 
During the follow-up study. 4 years after the initial investigation. health-related 
quality of life was also measured using the EuroQol EQ-5D instrument. a widely used 
and validated generic quality of life instrument with 5 dimensions: mobility, self-care. 
usual activities. pain/discomfort and aiLxiety/depression. Each dimension has three 
levels: no limitations. some limitations and severe limitations. In addition. the 
participants were asked to describe their overall actual health state using the EuroQol 
visual analogue scale (VAS). where 0 represents the worst imaginable health state and 1 
indicates perfect health. 
Loneliness was measured using the Loneliness Questionnaire where possible scores 
range from 0 (not lonely) to 11 (e:x.-tremely lonely) (37). This questionnaire has previously 
been shown to be reliable and valid (37.38). 
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The Mini~Mental State Examination was used to assess cognitive function. Only 30 
subjects had a score between 18 and 24 points, which indicates mild cognitive 
impairment. The other subjects scored above 24 points. Most of the subjects scored only 2 
questions wrong. and therefore this test was not suitable to differentiate between subtle 
cognitive distinctions (39). 
D. Ultrasound of the carotid artery 
As a measure of generalized atherosclerosis ultrasound of the internal carotid artery 
was performed. The intima~media thickness of the common carotid artery and the 
bifurcation was measured as well as the number of plaques (described in chapter 6). 
Thickening of the intima-media of the carotid artery is generally considered to be a 
sensitive early marker of generalized atherosclerosis since such thickening has been 
associated with an unfavorable cardiovascular risk profile (40-42). other localizations of 
atherosclerosis (43.44) and an increased risk of myocardial infarction (45.46). 
E. Serum hormone concentrations and parameters of inflammation 
In this study serum concentrations of hormones and hormone binding proteins of the 
growth hormone. gonadaL adrenal and thyroid a..xes were measured as described in the 
previous chapters. To minimize the diurnal as well as the seasonal variation all blood 
samples were obtained in the summer (l\!Iay until beginning of September) in a fasting 
condition (between 8.00 and 10.00 hr a.m.) and stored at -40°C. The storage time varied 
from 1 to -5 months. 
Serum IGF-1 and IGFBP-3 levels show little circadian fluctuations (47). Serum 
IGFBP-2 levels slightly increase in the evening {48). The main regulator of serum 
IGFBP-1 levels is insulin. which negatively influences IGFBP-1. To obtain 
standardized measurements of glucose. insulin, IGFBP-1 and BP-2 concentrations all 
blood samples were taken in a fasting condition. 
Testosterone concentrations in men have a slight diurnal rhythm. which decreases 
during aging. being the lowest in the morning (49). Serum testosterone concentrations in 
our population were relatively low compared to studies. which have been described 
previously in somewhat younger populations (-50). First of all there are no reference 
values for testosterone concentrations in older men. Mean serum testosterone 
concentrations have never been described in a relatively large population of this age 
group. The relatively low testosterone concentrations might also be due to different 
methods used to measure testosterone concentrations. Results in different tests are 
especially variable at low concentrations (51). Before trying to compare testosterone 
concentrations among older populations. reference standards are needed. And even then 
it is difficult to compare cohorts. since testosterone concentrations are probably also 
related to the presence of co-morbidity. 
With regard to estradiol and estrone concentrations in elderly men. little is known. 
No reference values are available for these measurements either. Estradiol and estrone 
seem to be relatively stable during the day (49). To minimize the variation all samples 
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were measured in one single assay. Serum estradiol concentrations were normally 
distributed in our population. 
Plasma DHEAS levels reflect synthesis by the adrenal cortex, because the adrenal is 
normally the predominant source of DHEAS. Unconjugated DHEA is present in much 
lower circulating levels. Unconjugated DHEA and cortisol share a common circadian 
rhythm (52). A low metabolic clearance rate for DHEAS results in uniformly high 
plasma and therefore stable DHEAS levels. 
In contrast to serum T3, T4 and reverse T3. serum TSH shows a circadian rhythm. 
with a nocturnal surge. 
It was not possible to measure the T4 sulfate (T4S) concentrations of all samples in 
a single assay. Intra~ and inter~variability coefficients of the T4S assay were 17% and 
19%. respectively, in the low concentration range measured in these elderly men . 
.Although T4S concentrations were normally distributed in our population. the results 
presented in chapter 5 should be interpreted with caution. because the T4S 
concentrations were rather low in this population and as a consequence the assay quality 
is also low. 
C-Reactive Protein (CRP) concentrations were determined by a high sensitive 
method using a latex-enhanced immunoephelometric assay on a BN II analyser. 
Interleuhin-6 was measured using the commercially available Immulite assay. It is 
unclear whether interleukin-6 has a circadian pattern in the circulation (53,54). 
However, in one study, the intraclass correlation coefficient was 0.87 for plasma 
interleukin-6 levels that were measured eight times during 36 days. suggesting stability 
for at least one month (55). 
4.RESULTS 
Before we discuss the results of this thesis. some aspects of cross-sectional studies 
need to be addressed. A particular difficulty of cross-sectional studies looking at 
associations concerns the cause and consequence of the measurement of interest and the 
possible risk factor. For e~ample. in the study of the relations with quality of life. we 
found that subjects with the lowest quality of life have the lowest muscle strength. We 
might conclude from this that low muscle strength leads to a lower quality of life, but an 
equally valid possibility is that low quality of life leads to reduced muscle strength. 
Because we have collected both sets of information at the same time we cannot draw a 
clear inference of causality. 
It has to be mentioned that if two laboratory values are both related to the dependent 
variable. adjusting for one another to figure out which is the more potent indicator is 
difficult, because the direction of cause and consequence are unknown. In addition, when 
two parameters are strongly related it might be possible that both parameters loose their 
significance with the dependent variable when adjusted for one another. For example. as 
described in chapter 6. serum testosterone and estrone concentrations were both related 
to intima-media thickness. It may be that only one of these hormones is related to 
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intima·media thickness and that the other one is just a confounder, since testosterone 
and estrone by themselves are strongly interrelated. By performing this adjustment we 
were not able to determine which of these hormones was most powerfully related to 
intima·media thickness. In contrast. when mutually adjusted both hormones lost the 
significance of their relationship with intima·med.ia thickness. However. one cannot 
conclude that the relations between testosterone and estrone with intima·media 
thickness have no significance. 
It is important not only to know whether a relation is statistically significant, but it is 
also important to be informed about the strength of the significant relations. The linear 
regression coefficient. which is the slope of the equation. describes the degree of change 
which is necessary to in· or decrease the dependent value with one unit. So, to determine 
whether a relation is biologically andlor clinically significant. one should examine the 
regression coefficient. Another statistic by which we can be informed about the strength 
of the association. although somewhat less intelligible. is the R·squared value {R2) which 
represents the proportion of the total variation explained by the model. For example, the 
significant association between quality of life (of the health part) and leg extensor 
strength has a P-value of <0.001 and a R2 of 0.11. which implies that 11% of the 
variation in quality of life is explained by muscle strength. while 89% is explained by 
other factors. Since in this study we were only able to investigate a number of 
parameters it can occur that a significant association can have a P-value of <0.001, while 
the R·squared value remains low. i\lso. apart from the relevance of the association. R-
squared is also determined by variability in the measurement. It depends on the 
character of the dependent variable whether such a significant association has biological 
andior clinical implications. VVhen associations are described with dependent variables 
which are mainly determined by genetic factors, which cannot be modified. such a 
relation may certainly have biological implications. In addition. when only small changes 
of the dependent variable are necessary to establish clinical changes. such an association 
will also be of importance. 
A. Physical functional ability and Quality of Life 
a) Determinants of functional ability 
Many of the predictors of physical functional status appear to be potentially 
modifiable. and research must be done to refine diagnostic criteria and develop practical 
methods of measurement of key physiological capacities. This in order to identify proper 
targets for interventions with disabled elderly or of preventive interventions in 'normal' 
elderly individuals. with the ultimate goal to enhance the proportion of the older 
population that ages successfully. 
Among the physical characteristics measured in this study several relationships were 
observed as illustrated in Figure 4A. Since it is a cross-sectional study. the arrows in this 
scheme are theoretical. but were assumed to reflect the most likely direction of cause 
and effect. For example. it is hypothesized that good muscle strength is necessary to 
maintain a high physical performance. A person needs a certain amount of leg extensor 
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strength to be able to rise from a chair. In our study. muscle strength was strongly 
related to all parts of the physical performance test, but most strongly to the chair stand 
part. Although the opposite direction is also possible: a good physical performance might 
lead to a high activity level, which in turn might improve muscle strength. Thus, 
regarding the results of this study it is hypothesized that muscle strength is a positive 
determinant of functional ability (measured subjectively by the number of problems in 
activities of daily living and objectively by physical performance). while fat mass is a 
negative determinant. 
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Figure 4A. Correlation between the physical characteristics. r denotes correlation coefficient. 
b) How to define chronological and successful aging? 
1. Chronological aging 
As mentioned earlier. in order to define proper targets for intervention and to 
establish a prognosis. it is necessary to define what is the physical capacity of an 
individual in relation to his or her chronological age. So far this is not known. As there 
are probably large inter-individual differences, while these capacities are probably 
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dependent on multiple individual and environmental conditions. it is hypothesized that 
this capacity at least should be that of an older individual free of disease. This capacity 
then. can serve as a reference for subjects with disease. Since we investigated a 
relatively healthy population of elderly men. we suggest that we can indeed address the 
following question in our population. What should we measure to be informed about the 
"chronological" physical capacity of an older subject? In other words, what is or are the 
key physical characteristics of aging? 
One could measure physical performance according to Guralnik et al. which is an 
objective measure of functional ability (21). This test was in our population related to 
nearly all other physical parameters of aging and is probably influenced by them. One 
could also measure leg extensor strength. It is a parameter, which seems to influence 
functional ability. but is not a measure of functional ability itself. 
The most attractive way. however, to define which is the key physical characteristic of 
aging in this study seems its the predictive value of death. Impaired activities of daily 
living (ADL), a low physical performance, muscle strength and bone mineral density 
were all associated with an increased risk of mortality. The fact that muscle strength 
and the number of problems in activities of daily living were no longer significantly 
associated with death after adjustment for physical performance might imply that they 
were a confounder. On the other hand it might also imply that muscle strength increases 
physical performance. which is associated with survival, thereby representing only a 
mechanical pathway. We therefore conclude that muscle strength and functional ability 
(objectively measured with the physical performance test) are considered the key 
characteristics of the physical functional status of independently living elderly men. The 
studies described in this thesis show that measuring muscle strength and physical 
performance only is probably sufficient in e:x:pressing the functional ability in elderly 
men. Whether this is really sufficient should be verified in longitudinal and intervention 
studies. 
Also. bone mineral density was a very strong predictor of mortality. It is remarkable 
that even in men who are relatively healthy. this is such a strong predictor. Although we 
do not have information about the cause of death. this finding might have important 
consequences for intervention programs. Improving bone mineral density by hormone 
substitution or strength-enhancing programs. might lead to a decrease in fractures and 
as a consequence a longer time of independent living until death. Indeed muscle strength 
and bone mineral density are parameters which might be influenced by intervention 
therapy directly, like hormonal replacement. while activities in daily living and physical 
performance can be influenced indirectly by improvement of for example muscle 
strength. balance and co-morbidity. It still needs to be elucidated whether bone density 
gives information additive to that of the physical capacity expressed against 
chronological age. 
2. Successful aging 
We mentioned earlier in this chapter that we can not fully defme and assess 
successful aging. and it is certainly not possible to assess it in one single measurement. 
Quality of life (QoL). however. is often used in the context of terms like successful aging 
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and it might be used as a relatively good indicator. We therefore decided to use it as an 
end-point in this study. The questionnaire of Henrich and Herschbach (QLS) that we 
used, includes a large number of aspects (dimensions) of quality of life. 
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Figure 4B. Correlation between parameters of physical functional ability and quality of life 
satisfaction. r denotes correlation coefficient. 
As expected. physical functional ability was strongly related with QLS (Figure 4B). A 
large number of problems in activities of daily living as assessed by the Modified Health 
Assessment Questionnaire was strongly associated with low values of all three parts of 
QLS. This was not very surprising. Neither very surprisingly was the positive relation 
between muscle strength and all aspects of the QLS. However. although expected, this 
has never been demonstrated so clearly before and it emphasizes the importance of 
maintaining muscle strength in old age. \iVhether a good quality of life is a consequence 
of an overall good physical functional status or whether a good quality of life leads to a 
good physical functional status. cannot be established from the results of this study. 
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Therefore. an intervention study with for example a training program and with quality 
of life as outcome measure could be performed. The hypothesis that muscle strength 
improves quality of life has important implications for intervention strategies. like 
training programs or hormonal intervention intended to increase muscle strength. 
The physical performance score (PPS) was only related to QLS-Health. This suggests 
that QLS-Health is a parameter which assesses the satisfaction of physical function in a 
proper manner. The QLS-Health indeed includes questions referring to mobility. 
However. it remains unclear why PPS is only related to QLS-Health. while muscle 
strength is strongly related to all three parts. It might be due to the fact that PPS had a 
skewed distribution and therefore mainly identified individuals with a lower PPS. while 
muscle strength was normally distributed and therefore was describing subjects in the 
complete range of physical functional ability. This complete range might be necessary to 
show the relationship with QoL. 
The predictive data on mortality as described above also give additive information on 
successful aging. In conclusion. the measurement of a combination of both physical 
performance and muscle strength in older men seems to give the most optimal 
information about ones' chronological age and his life satisfaction as welL To emphasize 
the importance of the relationships between the physical characteristics and quality of 
life. it was demonstrated that subjects with the lowest quality of life had a higher risk of 
mortality compared to subjects with higher quality of life (Chapter 7). It is important to 
know, however. whether these relationships might at least in part be explained by lower 
hormone concentrations as well. Mter adjustment for both physical functional status and 
hormone levels. quality of life remained independently related to mortality. however. 
B. Endocrine aspects of aging 
We demonstrated in this thesis that several significant relationships exist between 
serum hormone concentrations of the different axes and physiological determinants of 
functional capacity. such as physical performance. muscle strength. body composition, as 
well as quality of life. In addition. some endocrine parameters may be used as indicators 
of physical functional status. as well as predictors of mortality. 
a) Somatotropic axis 
1. Relation with physical capacity 
Remarkably. but in agreement with other studies. serum IGF-I (total nor the free 
fraction) was not related to measures of physical functional status (56-61). IGF-I might 
not be a good marker of the activity of the somatotropic axis during aging. In agreement 
with this. normal serum IGF-I levels are frequently found in elderly individuals with 
growth hormone (GH)-deficiency (62). It is known that GH itself exerts anabolic effects 
(63). In addition. serum IGF-I concentrations might not reflect the bio-activity of IGF-I 
in the different target organs or tissues in a proper manner. Serum IGFBP-2 levels 
might better represent the integrative effect of growth hormone and IGF-I. 
In chapter 2. we described that low serum IGFBP-2 concentrations are highly 
significantly associated with a better overall physical functional status (Figure 4C). This 
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observation is new and raises many questions. Longitudinal studies should reveal 
whether a decrease in functional ability is accompanied by an increase in IGFBP-2 
concentrations. How this inverse relation might be explainable and how IGFBP-2 
concentrations are regulated has been addressed in chapter 2. In short. IGFBP-2 
concentrations are probably determined by the integrated effects of GH secretion, IGF-I 
and -II levels. insulin secretion, as well as the nutritional state. It is currently unknown 
whether the presence of (specific) disease(s) influences IGFBP-2 levels. IGFBP-2 
concentrations might also be related to the immune system, although they were not 
associated to the acute phase proteins IL-6 and CRP. The relationship between IGFBP-2 
levels and the nutritional state should also be investigated in more detail. These 
questions can be investigated by assessing the relationship between IGFBP-2 and the 
nutritional intake. Such a relationship has already been demonstrated in anorexia 
nervosa patients (64). 
Intervention studies with growth hormone might give answers to a number of 
questions raised by our study. However, we already know from the relatively few double-
blind placebo-controlled studies which have been performed previously. that the effect of 
growth hormone replacement therapy on muscle strength and/or physical performance is 
minimal in the elderly and that the side-effects are major (65-68). 
2.Relation with quality of life 
In chapter 7, it was demonstrated that serum IGF-I levels were related to the 
hormone-related module of the QLS . .Also, IGFBP-3 concentrations were positively 
related to QoL (Figure 4C). After adjustment for one another, both lost their significance 
v.rith QLS, suggesting that there is an interrelationship between IGF-I. IGFBP-3 and 
QLS. We did not measure growth hormone secretion in this study. GH is secreted in a 
pulsatile manner, with maximum secretion during sleep. Therefore one measurement at 
one time-point is insufficient to be informed about the mean or peak growth hormone 
concentrations. Instead. we measured serum IGFBP-3 concentrations, which are 
supposed to be a marker of the mean 24 hour growth hormone secretion. From the fact 
that both IGF-I and IGFBP-3 loose their significance when adjusted for one another. it 
can be hypothesized that growth hormone has a beneficial effect on QoL via its 
activating effect on the secretion of IGF-I. On the other hand. also growth hormone or 
even IGFBP-3 itself. as well as IGF-I may have independent effects on QoL. 
It is known that in growth hormone deficient adults QoL is decreased compared to 
controls (69). However. it has only once been described previously that serum IGFBP-1 
concentrations are inversely related to QoL (70). In our population the inverse 
relationship between serum IGFBP-1 and QoL. was independent ofiGF-I and IGFBP-3. 
indicating that it was not a confounder. Probably IGFBP-1 levels are an inverse marker 
of insulin secretion. Higher IGFBP-1 concentrations may also have an unfavorable effect 
on the development and progression of atherosclerosis (71). The presence of 
atherosclerosis and cardiovascular disease in turn might be associated with a low quality 
of life. In this study we adjusted the relationship between quality oflife and IGFBP-1 for 
symptoms of angina pectoris, a previous myocardial infarction and congestive heart 
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failure. The relation remained significant. Finally, it may also be that IGFBP-1 itself has 
an inhibitory effect in the brain. opposing the effect of growth hormone and/or IGF-I. 
Also IGFBP-2 levels were related to QLS. It seemed. however, that IGFBP-2 is an 
intermediate or confounder in this association, since after adjustment for parameters of 
physical ability. it remained no longer significantly related to QLS. Again it cannot be 
excluded that a more complex relation exists between QoL. the somatotropic a.'\.is and 
physical functional ability. 
The effect of growth hormone on QoL has hardly been examined in the elderly 
population. Therefore intervention programs with growth hormone to increase QoL 
might be an option to investigate the effect of growth hormone on QoL. However, again it 
has to be taken into account that it is likely to induce many side-effects as well. 
3. Relation with mortality 
In chapter 9 it was hypothesized that the predictive value of IGFBP-1 on mortality 
might be due to the presence of atherosclerosis or insulin resistance. This hypothesis 
could only be partially examined in this study. Therefore further research is necessary to 
investigate the role of the somatotropic a.Us. and specifically IGFBP-1. on mortality. 
b) Pituitary-Gonadal axis 
1. Relation with physical capacity 
With regard to the pituitary-gonadal a..Us, we demonstrated in chapter 4. that 
luteinizing hormone (LH). independent of testosterone reflects serum androgen activity 
in a different way than testosterone. possibly reflecting more closely the combined 
feedback effect of estrogen and androgen. Testosterone was positively related to muscle 
strength and bone mineral density and inversely to fat mass. Remarkably no significant 
association was present with physical performance measured objectively nor with lean 
body mass. An inverse relation between testosterone and the number of problems in 
activities of daily living (ADL) became non-significant after adjustment for muscle 
strength, suggesting that ADL was a confounder or that testosterone is an important 
determinant of functional ability. 
It might therefore be that the measurement of both testosterone and LH will define 
elderly men who might benefit from testosterone replacement therapy better. It remains 
to be established whether LH, perhaps in combination with testosterone. might serve as 
a parameter of the optimal dose and the effect of androgen replacement therapy. 
In chapter 3. we demonstrated that non-SHBG-bound testosterone was more strongly 
associated with muscle strength and bone mineral density than total testosterone. To 
define whether subjects are hypogonadal it might therefore be better to measure non-
SHBG-bound testosterone than total testosterone. This especially applies to elderly men. 
since serum SHBG concentrations increase during aging. Also very important was our 
observation that the testosterone I SHBG ratio does not seem to be a good measure in 
representing the non-SHBG-bound fraction, especially not in a cross-sectional study. 
since part of the associations found are explained by the inverse association of SHBG. 
Serum non-SHBG-bound or bioavailable testosterone concentrations were calculated 
according to the method described by S6dergiird et al.. which is explained in chapter 3 
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(72). In a computer program this calculation is easy to perform. However. in clinical 
practice it is suggested that this calculation should be performed in elderly men with 
clinical symptoms of testosterone deficiency in whom serum total testosterone 
concentrations do not help defining testosterone deficiency. 
After calculating the SHBG-bound, the albumin-bound and the free fraction of 
testosterone using the "S6derg3.rd'' method, it appeared that only 35% of the total 
testosterone was bound to SHBG. while >60% was bound to albumin. According to 
endocrine te).."t books and recent papers by Vermeulen et al. (50), the percentage 
testosterone bound to SHBG should be much higher, while the albumin fraction should 
be much lower. Most of the studies which have investigated the percentages of these 
fractions have been done in smaller and much younger populations. Still. it is a 
considerable difference compared to other studies. which we cannot fully explaill. The 
assumption that the calculation is indeed performed in the right way and actually gives 
the correct percentages is demonstrated by the fact that the SHBG-bound fraction of 
testosterone was not related to for example muscle strength. However. the only way to 
be certain that these percentages are correct is to measure bioavailable testosterone in 
-vitro. 
It seems that also the non-SHBG-bound fraction of estradiol is superior to total 
estradiol in describing the relations between estradiol bio-acti-vity and it target organs. 
These differences between the non-SHBG-bound fraction and total estradiol are. 
however. less pronounced compared to testosterone. Therefore in future research it 
should be determined whether it is indeed preferable to measure non-SHBG-bound 
estradiol. 
2. Relation with quality of life 
Although it has been demonstrated that in elderly men bioavailable testosterone 
levels are lower in men with defined depression compared to other men (73). the benefits 
of testosterone replacement therapy on mood and quality of life have not been well 
investigated. In our cross-sectional study we demonstrated a positive relationship 
between bioavailable testosterone and QLS-Health. In addition. we found significant 
relationships between serum testosterone concentrations and specific questions of the 
QLS questionnaire. in particular the questions concerning physical condition. mobility. 
and "independence from help'' of the Health-module. This suggests that a potential 
beneficial effect of testosterone on QoL is mediated -via a better physical functional 
ability. Indeed. the relation between QLS-Health and bioavailable testosterone became 
non-significant after adjustment for leg extensor strength. However. as mentioned 
pre-viously. the beneficial effect of testosterone replacement on quality of life should be 
further investigated in intervention studies. 
A remarkable association was found in this study between serum estradiol and QoL. 
It was thought so far that a potential improvement in well being in women or men was 
due to their own specific sex steroid. In post-menopausal women, estrogen replacement 
therapy is known to improve subjective well being (7 4). and testosterone replacement in 
hypogonadal men has been reported to improve well being (75). However. in -view of the 
association found in this study. this hypothesis might have to be changed. Although this 
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association between serum estradiol and QoL in elderly men was found in a cross-
sectional study, it might be hypothesized that it is estradiol itself. which exerts the 
beneficial effect on well-being, directly in the brain or indirectly by improving certain 
physical characteristics. Future research should focus on the conversion of testosterone 
to estradiol. and its serum concentrations. during testosterone replacement studies with 
QoL as outcome measure. In addition. the precise role of estradiol in elderly men must 
be elucidated in future research: it has to be investigated whether estradiol exerts 
beneficial effects on other physical characteristics of aging apart from bone mineral 
density: and whether a potential effect on QoL is a direct effect in the brain . 
.'3. Relation with mortality 
Although serum LH. testosterone. and estradiol levels were not directly associated 
with an increased or decreased risk of mortality four years after the initial investigation. 
taking the results of the literature as well as the results of this study into account it 
seems beneficial to replace testosterone in some elderly men. In most studies done so far 
on testosterone replacement therapy. the beneficial effects seem to be greater than the 
potential risks. However. only a few studies have investigated properly the effects of 
testosterone replacement therapy on quality of life and the mechanism of such a 
potential effect. In addition. it is still unclear which elderly men should be treated with 
testosterone therapy. Are these men defined by lowered serum testosterone levels or 
subjects with clinical symptoms of androgen deficiency? How to interpret serum levels 
and symptoms in the presence of other diseases? Androgen deficiency is very difficult to 
define. since many symptoms overlap with those of disease and of aging. In conclusion 
testosterone replacement should be administered only to very well defined groups of 
otherwise 'healthy' elderly men with clear clinical symptoms of androgen deficiency. in 
the presence of lowered serum testosterone and/or high LH levels. Also the use of 
androgen and estrogen receptor modulators might be used to further elucidate the role of 
estrogens in men. 
c) Pituitary-Adrenal axis 
1. Relation with physical capacity 
In agreement with previous findings. serum dehydroepiandrosterone (DHEA) an its 
sulfate (DHEAS) both decreased with age in our population. DHEA is sold in the United 
States in high amounts and has been called the "fountain of youth''. Most knowledge 
concerning the potential function of DHEA. however. was derived from animal studies. 
mainly from rodents. which do not produce DHEA themselves. Looking at the results of 
these studies. DHEA (S) is supposed to have a variety of functions. like preventing 
obesity. cancer. and cardiovascular disease and it might improve physical as well as 
psychological well being. However. several studies on DHEA replacement in humans 
J-ielded inconsistent and controversial results (76-81). 
In our population. we have found two significant correlations between DHEAS and 
the physical characteristics of aging: e.g .. a positive relation between DHEAS and 
physical performance and one with total body bone mineral density (not femoral neck 
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bone mineral density). Since these relations lost their significance after adjustment for 
testosterone or estradioL it is suggested that DHEAS exerts its potential effect through 
conversion into testosterone and estradiol. 
2. Relation with quality of life 
Serum DHEAS was positively related to the Health-module of the QLS questionnaire. 
However. as for the relationship with bone density. this relationship became non-
significant after adjustment for estradiol. \Vhether. DHEA(S) still might have an effect 
on QoL. through conversion into estradioL cannot be established from this study. 
Serum cortisol concentrations were inversely related to the general module and the 
hormonal module of QLS. The negative influence of cortisol on the QoL might represent 
a cumulative deleterious effect of longterm exposure of the human body to relatively 
high cortisol concentrations, as suggested by McEwen et al. (82). It has be taken into 
account that only one single measurement of cortisol was done in this study. however . 
.J. Relation with mortality 
Serum DHEAS levels were not linearly related to mortality. However. subjects with 
DHEAS concentrations in the lowest quartile had a significant higher age-adjusted risk 
of mortality compared to subjects with the highest DHEAS levels. This might imply that 
a threshold exists; only very low DHEAS seem to be disadvantageous. This has for 
example been demonstrated by the fact that women with adrenal insufficiency. and 
therefore very low DHE..t,(S) levels. benefit from DHEA therapy (78). 
In conclusion. our results combined with data recently published on the potential 
beneficial effects of DHEA administration in men. which induced a slight improvement 
on mood scores (79). suggest that this steroid itself only plays a minor role in the aging 
process. It remains. however. intriguing that DHEAS circulates in the human serum in 
such high concentrations. probably being a reservoir which is at the tissue level 
transformed to biologically active sex steroids. The role of DHEA as ··fountain of youth .. 
remains far away. however. 
d) Pituitary-Thyroidal axis 
l.Relation with physical capacity 
In chapter 5. we demonstrated that in a subgroup of elderly men low serum reverse 
triiodothyronine (rT3) and free thyroxine (free T4) concentrations were associated with 
an overall better physical functional status (Figure 4C). Of course it is known that rT3 
levels tend to be elevated in subjects with certain diseases. summarized as ·non-thyroidal 
illness'. Therefore one may ask whether in our population we are also only describing 
·non-th:srroidal illness·. However. only 45 subjects met the biochemical criteria for ·non-
thyroidal illness'. Remarkably. rT3 levels remained associated with several parameters 
of physical function in the absence of systemic disease and the low T3 syndrome. Serum 
rT3 levels may therefore be a marker of physical function in the elderly. whether or not 
determined by disease or a poor nutritional status. 
In the elderly population no studies have been carried out so far on thyroxine sulfate 
(T4S). Although we demonstrated strong associations of T4S with physical functional 
characteristics, it is necessary to clarify the importance of T4S measurements both in 
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older and younger populations. Our study indicates. however. that T4S indeed appears 
to be an important determinant of the activity of the thyroidal a.'-.is. The actual 
measurement of T4S should be refined. since inter- and intra-assay variability of the 
assay are considerable. 
2.Relation with quality of life 
Of the thyroidal a.-...is, serum free T4 and reverse T3 levels were inversely associated 
with the health section of QLS. The negative relation between serum TSH 
concentrations and QLS-Health showed a trend towards significance. After adjustment 
for free T4 or reverse T3, the inverse relation between TSH and QLS-Health became 
strongly significant. The relationships described between serum rT3. free T4 and TSH 
and health-related QoL were all independent of the presence of diseases. the use of 
medications and the physical characteristics of aging. So it appears that a lower activity 
of the thyroidal a.'-is is associated with a lower health related quality of life. From this 
cross-sectional study, no conclusions can be drawn with regard to the mechanisms 
behind these relationships. However. it cannot be excluded that mild thyroid dysfunction 
has direct negative effects on mood and behaviour, since the previous relationships were 
all independent. This hypothesis is strengthened by the fact that hypothyroidism is often 
associated with depression and that subclinical hypothyroidism may be associated with 
mood disturbances (83). It has to be mentioned. however, that in our population no overt 
hypothyroidism was present and only 6 subjects had subclinical hypothyroidism (TSH 
between 4 and 10 IU/1. with normal free F4levels). 
B.Relation with mortality 
After adjustment for serum albumin levels. subjects with T3 levels in the lowest 
quartile of this population had a significantly lower risk of 4-year mortality compared to 
subjects in the other quartiles. Low free T4 concentrations were also associated with a 
lower risk of mortality. These remarkable findings are not completely understood at 
present. 
Further, it was eA-pected that reverse T3 would be associated with mortality. since 
high reverse T3 seemed to be an indicator of disease and a poor physical functional 
status. 
Since these results have not been reported before. they should by confirmed in other 
studies. In addition. we should focus on the mechanism of the predictive value of serum 
T3 and free T4 concentrations. 
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Figure 4C. Associations between hormones and binding proteins of the somatotropic axis. 
gonadal a.'Xis. adrenal a.'\."i.s and thyroidal a.xis and parameters of physical functional ability and 
quality of life satisfaction. BP-1 (IGFBP-1). BP-2 (IGFBP-2). BP-3 (IGFBP-3). Bio-T (bioavailable 
testosterone). E2 (estradiol). T3. (triiodothyronine). FT4 (Free Thyroxine). rT3 (reverse 
triiodothyronine). 
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C. Co-morbidity and atherosclerosis 
1. Co-morbidity 
As already pointed out in the methods section of this chapter, several subjects used 
medications for certain diseases. The majority was treated with one or more drugs 
(n::;;237). It might be hypothesized that all the previously described relations are 
(partially) dependent on the presence of co-morbidity. Or stated otherwise. high serum 
IGFBP-2. LH. and reverse T3levels. and low IGF-L IGFBP-3. testosterone. estradiol and 
DHEAS levels would just represent a state of disease. And this state of disease might be 
associated with a lowered physical functional status. To figure out whether the 
. previously described relationships were independent of co-morbidity. all the relations 
were adjusted for the parameters of these conditions. 
First of all, subjects with for example signs or symptoms of angina pectoris. 
congestive heart failure. previous myocardial infarction or a cerebrovascular accident, or 
knee pain indeed had slightly lower muscle strength. lower physical performance. as well 
as a larger number of problems in activities of daily living. This did not influence the 
relations between the physical characteristics as illustrated in Figure 4A. however. 
Subjects with the above mentioned diseases did not have different serum hormone 
concentrations of the somatotropic. gonadal and adrenal a. xis. The relationship between 
the hormones of the thyroidal a.'..is and co-morbidity was discussed in the previous 
paragraph. 
Co-morbidity was also associated with a decreased quality of life as illustrated in 
chapter 7. Again this association did not influence the relationship between quality of 
life and physical functional ability or serum hormone levels. 
In conclusion. the presence of co-morbidity was associated with a lower physical 
functional status and a decreased satisfaction of quality of life. However. co-morbidity 
did not appear to be a confounder in the associations between physical functional status 
or quality of life and serum hormone levels of the somatotropic, gonadal or adrenal a.-xis. 
2. Atherosclerosis 
In the context of this thesis we determined the relationship between serum hormone 
levels and parameters of atherosclerosis. In chapter 6 we describe that serum free IGF-I 
concentrations as well as testosterone and estrone concentrations are inversely related 
to the intima-media thickness of the carotid artery. In chapter 6 we also mentioned that 
in a previous study high fasting serum free IGF-I levels have been associated with a 
reduced number of atherosclerotic plaques. symptomatic cardiovascular disease and 
lower serum triglycerides levels (71). In the present study. free IGF-I. rather than total 
IGF-I. was independently related to the mean intima-media thickness of the carotid 
bifurcation, suggesting that it is the easily dissociable IGF-I fraction which may be able 
to act directly on the vascular wall. On the other hand. a potential effect of free IGF-I on 
the vascular wall may also be indirect via changes in cholesterol levels or insulin 
sensitivity. However. in this cross-sectional study the relation between free IGF-I and 
intima-media thickness was not dependent on cholesterol. glucose or insulin levels. 
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It has never been described previously that testosterone concentrations are related to 
the intima-media thickness of the carotid artery. First of all, the question is whether 
testosterone directly influences the vascular wall or indirect via for example changes in 
the lipid profile or the physical functional ability. The relation between testosterone and 
intima-media thickness was independent of serum cholesterol concentrations. However. 
a definitive answer to this question may only be given by performing a placebo-controlled 
trial with testosterone administration. and monitoring the effect on intima-media 
thickness. Secondly. it can be asked whether, as with IGF-I. serum free or non-SHBG-
bound testosterone levels are more strongly related to the intima-media thickness. This 
was not the case in our study (data not shown). 
3. Parameters of inflammation 
It has been demonstrated before that C-reactive protein and interleukin-6 (IL-6) 
concentrations reflect inflammation and predict cardiovascular disease as well as 
mortality in a healthy. non-disabled populations with or without previous cardiovascular 
disease (6,7). In our population serum CRP levels only predicted mortality in subjects 
with prevalent cardiovascular disease. IL-6 levels, on the other hand. predicted mortality 
in those with and without cardiovascular disease. IL-6 levels, within the normal range, 
were the strongest biochemical predictor of mortality in our population of independently 
living older men, independent of disease. bone density and disability. cortisoL insulin. 
CRP and albumin levels and smoking. It cannot be established from the results of this 
study. whether low IL-6 serves merely as an indicator of subjects with a lower risk of 
mortality or whether it plays a role in a physiological pathway. 
It has also been described that the combination of low IGF-I and high IL-6 levels 
predicted disability and death in a population of older women (84) and that high IL-6 
levels predict a greater cognitive decline in elderly men and women (85). Therefore it 
should be investigated whether IL-6 not only predicts mortality but also a lower physical 
functional capacity and cognition. In addition, it could be investigated whether other 
biomarkers act synergistically with IL-6 to predict mortality. 
5. CONCLUSIONS 
In an attempt to gain a greater understanding of the process of aging and its 
determinants, the concepts '·frailty'' and "successful aging'' have become popular. Frailty 
focuses mainly on the physical aspects of aging. while the concept of successful aging 
includes a much broader range of aspects of life, such as physicaL psychological and 
social aspects. In this thesis the definition of successful aging as illustrated in the model 
by Rowe (Figure 1) was taken as a starting point in order to gain insight in the role and 
the interactions of the different physical and endocrine factors which are assumed to be 
important to age successfully. Rowe developed a definition of successful aging with 
·maintaining high cognitive and physical functional capacity', 'avoiding disease and 
disability', and 'maintaining active engagement with life· as main determinants. 
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However. for an individual assessment of successful aging adequate, reproducible, and if 
possible predictive measures are needed. Consequently one of the aims of our study was 
to fmd parameters which reliably reflect the three different parts of the model. To 
measure overall successful aging we used two parameters~ quality of life and survival. 
Maintaining an optimal cognitive and physical functional capacity is one of the three 
main parts of the model. In our population cognition was relatively good. since most of 
the men had a high score on the "Mini~Mental State Examination'. With regard to 
physical functional capacity it is suggested that measuring physical performance 
according to the method described by Guralnik et al. and muscle strength might be 
sufficient to be informed about this aspect. However. physical performance may not be 
modified directly by interventions. but is more likely modified by changes in muscle 
strength. balance. bone mineral density and perhaps body composition. In order to select 
those who might benefit from intervention therapy and to monitor therapy, it may be 
useful to measure muscle strength and bone mineral density rather than, or in 
combination with physical performance. 
Avoiding disease and disability is the second component of the model by Rowe. In this 
population. men with certain diseases had a lower functional ability. measured 
subjectively as well as objectively. This indicates the correctness of the model. It is 
suggested that (subclinical) atherosclerosis is also an aspect of this part of the model. 
Reducing the atherosclerotic process might lead to a decrease in cerebro- and 
cardiovascular events. which in turn helps to age successfully. 
Finally. maintaining active engagement with lUe is the third part of the model by 
Rowe. It was tried to cover this part at least in part by measuring loneliness. Physical 
performance and loneliness were inversely related indicating the overlap between the 
active engagement in lUe part and the physical functional capacity part. In addition. 
subjects that were lonely were significantly less satisfied with life. 
Most aspects measured in the different parts were related to quality of lUe and 
survivaL indicating the combined area of successful aging (Figure 6). 
An important aim of this study was to investigate the role of the endocrine system 
and parameters of inflammation on the different parts of successful aging. Low serum 
IGFBP-2. luteinizing hormone and reverse T3 and high serum testosterone and estradiol 
concentrations were related to several aspects of a better physical functional capacity. 
High testosterone. estrone and free IGF~I levels were related to a lower degree of 
atherosclerosis. Further. high serum IGFBP-3 and estradiol levels and low IGFBP-1. 
cortisol and reverse T3 levels were associated with a better life satisfaction. Finally. low 
IGFBP~l. cortisoL T3 and free T4 concentrations were associated with a lower risk of 
mortality. This indicates that each endocrine axis has one or more parameters which are 
related to successful aging (Figure 7). However. whether these parameters directly 
influence the aging process or whether these are markers of a decreased activity of the 
a.xis and in turn potentially influence the aging process can not be fully established form 
the results of this study. Follow-up and intervention research is necessary to address 
these questions. 
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Figure 5. Parameters measured in our study of 403 elderly men implemented in the model of 
·successful Aging' by Rowe. 
High serum C-Reactive Protein strongly predicted 4-year mortality. while low 
interleukin-6 levels predicted 4-year survival. So far we have not investigated potential 
relations with the different parts of the model of successful aging. Although the 
predictive value of CRP and IL-6 on mortality was independent of subclinical 
atherosclerosis and physical capacity. the physiological pathway towards the predictive 
value on mortality should be further elucidated. 
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A number of other questions remain to be addressed. Does the decrease in activity of 
these endocrine a."\:es have one major set point? In other words, does a central pacemaker 
of endocrine aging exist? And secondly, do the hormones of the different axes influence 
one another? The results of our study suggest that all these previously described 
parameters of the different axes are independent of one another in their relationship to 
physical function, co-morbidity (and atherosclerosis), quality of life and survival and 
thus successful aging. These are important observations, since this implies that subjects. 
who might benefit from hormonal intervention therapy. can be selected according to the 
axis which is 'insufficient' during aging. In addition, combination therapies of two 
different hormones. might be an option. In a longitudinal study the strength of the 
decline or increase of hormonal parameters of the different a."<es studied should be 
compared to observe whether the decrease of the activity of the different axes occur in 
parallel. 
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SUMMARY 
Overall, the aim of this thesis was to obtain more insight in the relations between the 
endocrine system and the physical and psychological aging process in elderly men. In 
chapter 1 an overview is given about the current knowledge on the endocrine system 
and the aging process. The selection of the participants to this study included those that 
lived independently. maintaining a reasonable degree of physical capacity and a 
relatively good cognition. This allowed us to approach the concept of'successful aging'. In 
order to do so, a number of questions were addressed in a population of 403 men aged 
between 73 and 94 years: 
1) Since it is difficult to define those subjects that age successfully with respect to 
physical function. in chapter 2 we tried to determine which are the main physiological 
determinants of functional ability in the elderly. Muscle strength and functional ability 
(measured subjectively as the number of problems in activities of daily living and 
objectively as physical performance) are likely to be the key characteristics of physical 
functional status in independently living elderly men. since they were so strongly related 
to the other physical characteristics measured in this study. In addition. in chapter 9 it 
is demonstrated that functional ability. muscle strength and bone mineral density were 
strongly related to 4~year mortality. Muscle strength and bone mineral density may be 
markers for general health or a low muscle strength and bone density may lead to 
imbalance and an increase in fractures and as a consequence mortality. Further. in 
chapter 7 the importance of muscle strength and functional ability is emphasized by the 
fact that they were strongly positively related to quality of life, which was measured 
using a validated questionnaire consisting of three modules of S questions each. directed 
at general factors (QLS-General). health factors (QLS-Health). and factors related to 
hormone deficiency (QLS·Hormone). 
2) Secondly. since the age~related decline in serum hormone levels occurs in 
parallel with the loss of physical function, bone mass. muscle mass and muscle strength. 
it was investigated whether serum hormone levels of four endocrine a.xes were related to 
the physical functions measured. including bone mineral density and body composition. 
In chapter 2 it was investigated whether components of the somatotropic system 
contribute to the maintenance of functional ability. Low serum IGFBP~2 concentrations 
seem to be a powerful indicator for an overall good physical functional status, since 
IGFBP~2 concentrations were negatively related to activities in daily living. physical 
performance. muscle strength. bone mineral density of proximal femur. lean mass and 
fat mass. IGFBP-2 probably inversely reflects the integrated sum of nutritional status as 
well as of the biological effects of growth hormone. IGF-I. and insulin. Serum insulin 
concentrations were positively and IGFBP~l concentrations negatively related to lean 
mass and fat mass. 
In chapter 3 we tested the hypothesis that the changes in bone mass. body 
composition and muscle strength with age are related to the fall in circulating 
endogenous testosterone and estrogen concentrations. Serum testosterone was positively 
related with muscle strength and bone mineral density. An inverse association existed 
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between testosterone and fat mass. Independent of testosterone, estrone and estradiol 
were both positively associated with bone mineral density. 
Thyroid hormones regulate the metabolic thermostat by stimulation of the basal 
metabolic rate. Therefore physiological changes in thyroid hormone concentrations with 
aging might influence the overall physical functional status. In chapter 5 we 
investigated to what extent thyroid hormone concentrations are related to physical 
functional status. Serum reverse T3 appeared to be positively related to the number of 
problems in activities of daily living and inversely to physical performance, muscle 
strength. and bone mineral density. Also. serum free T4 levels were inversely related to 
physical performance. and grip strength and positively to the number of problems in 
activities of daily living. Serum T3 and T4 concentrations were not significantly related 
to physical functional status. T3 was inversely related to lean mass. Higher serum rT3 
concentrations result from a decreased peripheral metabolism of thyroid hormone and 
have been demonstrated to reflect a catabolic state. The relation between rT3 and 
physical functional status may reflect the presence of disease or a poor nutritional state. 
Since part of the age-related physiological changes seem to be influenced by the 
activity of the endocrine system, one could hypothesize that serum hormone 
concentrations not only relate to measures of functional ability. but also predict 
mortality. In chapter 9, it was defined which parameter of each axis was predictive of 
survival or mortality. Of the gonadaL adrenaL somatotropic and thyroidal hormones. 
high serum IGFBP-1. free T4 and T3 concentrations all predicted 4-year mortality. 
These hormonal parameters appear to be well informative to establish the mortality 
risk. independent of co-morbidity and atherosclerosis. Interestingly. most concentrations 
were within the normal range. 
In chapter 7. it was established whether serum hormone concentrations of the 
endocrine axes were related to quality of life. Serum bioavailable testosterone weakly 
correlated to QLS-Health. while DHEA(S) did not. Serum estradiol and IGFBP-3 
concentrations were strongly positively associated to all QLS modules. while cortisol and 
!GFBP-1 were inversely related with QLS-General and QLS-Hormone. In addition. 
IGFBP-1 was also inversely related to QLS-Health. Serum IGF-I concentrations were 
weakly positively associated with QLS-Hormone only. These data. although collected in 
a cross-sectional study indicate that hormonal intervention. which aims at increasing 
estradiol hie-availability and/or growth hormone levels might further improve quality of 
life in elderly independently living men. The importance of defining determinants of 
quality of life is shown by the fact that quality of life itself is an important predictor of 
mortality. 
In Chapter 8 the main study objective was to examine factors associated with 
successful aging amongst older men. By means of different instruments and 
questionnaires. we operationalised selected aspects of Rowe and Kahn's model of 
successful aging. Despite various associations on bivariate analysis. health-related 
quality of life measured by the EuroQol EQ-5D instrument (with .5 dimensions: mobility. 
self care. usual activities. pain/discomfort and an..\..iety/depression) was associated with 
only activities of daily living (A.DL) and loneliness on multiple regression . .A.DL and 
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loneliness in turn were both associated with physical performance level. Serum IGFBP-
3. which reflects growth hormone bioactivity, as well as testosterone concentrations were 
both strongly related to a better quality of life measured by the EuroQol. 
3) Because. serum hormones are mainly bound to their hormone binding globulins 
and albumin. it remained to be established whether the bioavailable hormone fraction is 
the best representation of the bioactive hormone concentration. Bioavailable or non-
SHBG-bound and free testosterone and estradiol were calculated according to a measure 
described by Sodergiird. In chapter 3 it is demonstrated that non-SHBG-bound and free 
testosterone were more strongly related to muscle strength. bone mineral density and fat 
mass than total testosterone and were also significantly related to hip bone mineral 
density. while total testosterone was not. Non-SHBG-bound testosterone seems to be the 
best parameter for serum levels of bioactive testosterone. which appears to play a direct 
role in the various physiological changes which occur during aging. Non-SHBG-bound 
estradiol was slightly stronger related to bone mineral density than total estradiol. 
Therefore. non-SHBG-bound estradiol seems to be the best parameter of serum bioactive 
estradiol in describing its positive relation with bone mineral density. 
4) Since recently a common variant form of luteinizing hormone (LH) was detected 
in apparently healthy individuals. caused by point mutation-based substitutions of two 
amino acids (TrpSArg and Ilel5Thr) in the LH~ subunit and since it was suggested that 
the in vivo bioactivity of the LH variant is lower than that of the wild-type hormone. it 
was determined in chapter 4 whether differences in bioactivity of variant LH were 
related to characteristics of physical functional ability. 12.5% of the study population 
was heterozygous for the LH variant allele. LH concentrations were inversely related to 
muscle strength and lean mass and both relations were independent of testosterone. LH 
was positively related to self-reported disability. LH seems to reflect serum androgen 
activity in a different way than testosterone, possibly reflecting more closely the 
combined feedback effect of estrogen and androgen. Testosterone levels and the degree of 
frailty were not different in the wild-type LH group compared with the heterozygote LH 
variant group. However. as a relatively higher proportion of subjects heterozygous for 
the LH variant allele had high LH and low T levels. the two LH forms may differ in 
biological response, in favor of wild-type LH. 
5) Since atherosclerosis is an important cause of cardiovascular morbidity and 
mortality during aging, and as changes in endocrine systems may influence the 
atherosclerotic process, the relationships between plasma hormone concentrations and 
parameters of atherosclerosis were determined in chapter 6. Serum testosterone, 
estrone and free IGF-1 were inversely related to intima-media thickness of the carotid 
artery. also after adjustment for age and body mass index. Free IGF-L rather than total 
IGF-I. was independently related to the mean intima-media thickness of the carotid 
bifurcation. suggesting that it is the easily dissociable IGF-I fraction which may be able 
to act on the vascular wall. Serum estradiol. DHEA(S). IGFBP-1. -2. -3 and leptin 
showed no association with parameters of atherosclerosis. 
6) It has been demonstrated before that C-reactive protein (CRP) and interleukin-6 
(IL-6) concentrations reflect inflammation and predict cardiovascular disease as well as 
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mortality in a healthy. non-disabled population with or without cardiovascular disease. 
Also in our population high CRP and IL-6 were strongly related to mortality as decribed 
in chapter 9. Low IL-6 and CRP levels in the normal range may therefore be indicators 
for the absence of (subclinical) disease in general in the very old. 
To be informed about one's individual condition and to select those who may benefit 
from intervention. the use and knowledge of modifiable parameters that predict survival 
or mortality may be useful. In chapter 9. apart from the well-known conditions like 
smoking. co-morbidity and intima-media thickness of the carotid artery. the relative 
importance of a range of potential physical. endocrine and inflammatory predictors of 
mortality were addressed. Low physical performance. muscle strength and bone mineral 
density. high serum IGFBP-L free T4 and T3 concentrations all predicted mortality. 
Finally. low serum albumin and high C-reactive protein and interleukin-6 levels were 
associated with a higher mortality rate. With the seven most significant parameters 78% 
of subjects could be correctly identified with respect to alive or death after four years . 
7) Finally. in the discussion described in chapter 10 an attempt was made to 
integrate the results of this thesis into the concept of successful aging. The definition of 
successful aging as defined by Rowe was taken as a starting point in order to obtain 
more insight in the value and the interactions of the different aspects which are 
important to age successfully. Rowe developed a concept of successful aging with 
'maintaining high cognitive and physical functional capacity'. ·avoiding disease and 
disability'. and ·maintaining active engagement with life' as main determinants. 
However. for an individual assessment of successful aging adequate. reproducible. and if 
possible predictive measures are needed. Therefore one of the aims of our study was to 
find parameters which reliably reflect the three different parts of the model. To measure 
overall successful aging we used two parameters: quality of life and survival. 
Maintaining a high cognitive and physical functional capacity is one of the three main 
parts of the model. In this population cognition was relatively good. since most of the 
men had a high score on the 'Mini-Mental State Examination'. With regard to physical 
functional capacity it is suggested that measuring physical performance according to the 
method described by Guralnik. and muscle strength might be sufficient to be iniormed 
about this aspect. 
Avoiding disease and disability is the second part of the model by Rowe. In this 
population. men with certain diseases had a lower functional ability. measured 
subjectively as well as objectively. This indicates the correctness of the model. It is 
suggested that (subclinical) atherosclerosis is also an aspect of this part of the model: 
Finally. maintaining active engagement with life is the third part of the model by 
Rowe. Physical performance and loneliness were inversely related indicating the overlap 
between the active engagement in life part and the physical functional capacity part. In 
addition. subjects who were lonely were significantly less satisfied with life. 
Most aspects measured of the different parts were related to quality of life and 
survival, indicating the combined area of successful aging. 
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SAMENVATTING 
Het algemene doel van dit proefscbrift was het verkrijgen van meer inzicht in de 
relaties tussen het endocriene systeem en het fysieke en psychologische 
verouderingsproces bij mannen. In hoofdstuk 1 wordt een overzicht gegeven van de 
huidige kennis van het endocriene systeem tijdens veroudering. Criteria voor de selectie 
van proefpersonen voor deze studie waren zelfstandig wonen en bet hebben van een 
redelijk goede fysieke en cognitieve capaciteit. Dit maakte bet bij benadering mogelijk 
het concept ·succesvol ouder worden· te onderzoeken. Hiervoor werden een aantal 
vraagstellingen geformuleerd en onderzocbt in een populatie van 403 mannen met een 
leeftijd tussen de 73 en 94 jaar: 
1) Aangezien bet moeilijk is die mannen te selecteren die succesvol ouder worden 
met betrekking tot hun fysieke functie. hebben we in hoofdstuk 2 getracht aan te tonen 
wat de belangrijkste determinanten zijn van de fysieke functionele status bij ouderen. 
Spierkracht en functioneel vermogen (welke subjectief werd gemeten als het aantal 
problemen in activiteiten in dagelijks leven en objectief als fysieke prestatie) zijn 
waarschijnlijk de belangrijkste kenmerken van de fysieke functionele status bij 
zelfstandig wonende oudere mannen. Bovendien wordt in hoofdstuk 9 aangetoond dat 
functioneel vermogen. spierkracht en botdichtheid sterk gerelateerd zijn aan de 4·jaars 
overleving. Spierkracht en botdichtheid zouden markers kunnen zijn voor de algemene 
conditie. Een lage spierkracht en botdichtheid zouden ook kunnen leiden tot een 
verhoogde kans op vallen en dientengevolge een verhoogd risico op fracturen en 
overlijden. Verder wordt in hoofdstuk 7 het belang van spierkracht en het functioneel 
vermogen benadrukt aangezien bleek dat beide sterk aan kwaliteit van leven zijn 
gerelateerd. Kwaliteit van leven werd gemeten middels een gevalideerde vragenlijst 
bestaande uit drie modules van elk 8 vragen, die gericht zijn op algemene factoren (QLS-
General), gezondheidsfactoren (QLS-Health) en factoren die gerelateerd zijn aan 
hormoon deficienties (QLS-Hormone). 
2) Omdat de leeftijdsgerelateerde daling van serum hormoon concentraties parallel 
verloopt met het verlies van functioneel vermogen, botdichtheid en spierkracht. werd 
onderzocht of hormoon concentraties van de verschillende endocriene assen gerelateerd 
waren aan de gemeten fysieke functies alsmede aan botdichtheid en 
lichaamssamenstelling. In hoofdstuk 2 hebben we onderzocht of componenten van het 
somatotrope systeem bijdragen aan bet behoud van bet functionele vermogen. Een lage 
serum IGFBP-2 concentratie lijkt een sterke indicator te zijn voor een algehele goede 
fysieke functionele status. omdat deze negatief gerelateerd was aan de activiteiten in bet 
dagelijks leven. de fysieke prestatie. spierkracht. botdichtheid van het prm..imale femur. 
spiermassa en vetmassa. IGFBP-2 reflecteert waarschijnlijk invers de gelntegreerde som 
van de voedingsstatus en de biologische effecten van groeihormoon. IGF-I en insuline. 
Serum insuline concentraties waren positief en IGFBP-1 concentraties negatief 
gerelateerd aan spiermassa en vetmassa. 
In hoofdstuk 3 werd de hypothese getest dat veranderingen in botmassa. 
lichaamssamenstelling en spierkracbt die optreden tijdens veroudering. gerelateerd zijn 
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aan de daling in circulerende testosteron en oestrogeen concentraties. Serum testosteron 
was positief gerelateerd aan spierkracht en botdichtheid. Een inverse associatie was 
aanwezig tussen testosteron en vetmassa. Onafhankelijk van testosteron. waren 
oestradiol en oestron beide positief geassocieerd met botdichtheid. 
Schildklierhormonen reguleren de metabole thermostaat door stimulatie van het 
basaal metabolisme. Derhalve zouden fysiologische veranderingen in schildklierhormoon 
concentraties tijdens veroudering wellicht de fysieke functionele status kunnen 
beinvloeden hetgeen werd onderzocht in hoofdstuk 5. Serum reverse T3 bleek positief 
gerelateerd te zijn aan het aantal problemen in activiteiten van het dagelijks leven en 
invers aan de fysieke prestatie. spierkracht en botdichtheid. Hogere serum reverse T3 
concentraties zijn het gevolg van een verminderd perifeer ·metabolisme van 
schildklierhormoon en het is aangetoond dat dit zou kunnen wijzen op een verhoogd 
katabolisme. De relatie tussen reverse T3 en de fysieke functionele status zou deels de 
aanwezigheid van ziekte of een slechte voedingsstatus kunnen representeren. Oak 
serum vrij T4 was invers gerelateerd aan de fysieke prestatie en knijpkracht en positief 
aan het aantal problemen in activiteiten van het dagelijks leven. De totale T3 en T4 
concentraties waren niet significant gerelateerd aan de fysieke functionele status. T3 
was alleen invers gerelateerd aan spiermassa. 
Aangezien de leeftijdsgerelateerde fysiologische veranderingen deels belnvloed lijken 
te worden door de activiteit van het endocriene systeem. zou men kunnen 
veronderstellen dat serum hormoon concentraties niet alleen gerelateerd zijn aan 
functioneel vermogen, maar dat zij oak mortaliteit voorspellen. In hoofdstuk 9 werd 
onderzocht of parameters van de gonaden-, bijnier-, somatotrope- en schildklier-as 
voorspellend waren voor overleving of overlijden. Hogere serum IGFBP-1. vrij T4 en 
totaal T3 concentraties voorspelden allen de 4-jaars mortaliteit. Deze hormonale 
parameters lijken zeer informatief voor het vaststellen van het overlijdensrisico, 
onafhankelijk van co-morbiditeit en atherosclerose. Opmerkelijk was dat de meeste 
concentraties binnen de normaal waarden voor gezonde volwassen lagen. 
In hoofdstuk 7 werd onderzocht of serum hormoon concentraties gerelateerd waren 
aan kwaliteit van leven. De bioactieve testosteron fractie was zwak gecorreleerd met het 
QLS-Health. terwijl DHEA(S) niet gerelateerd was aan kwaliteit van leven. Serum 
oestradiol en IGFBP-3 concentraties waren sterk positief gerelateerd aan alle modulen 
van de kwaliteit van leven vragenlijst. terwijl cortisol en IGFBP-1 invers gerelateerd 
waren aan QLS-General en QLS-Hormone. Bovendien was IGFBP-1 oak invers 
gerelateerd aan QLS-Health. Serum IGF-I concentraties waren zwak positief 
geassocieerd met alleen QLS-Hormone. Deze gegevens. ofschoon verzameld in een cross-
sectionele studie. suggereren dat hormonale interventie. gericht op het verhogen van 
oestradiol beschikbaarheid en! of groeihormoon concentraties. de kwaliteit van leven van 
zelfstandig wonende oudere mannen zou kunnen verbeteren. Het belang van het 
aantonen van determinanten van kwaliteit van leven blijkt uit het feit dat kwaliteit van 
leven zelf een belangrijke voorspeller van mortaliteit is. 
Het belangrijkste doel in hoofdstuk 8 was het onderzoeken van factoren die 
geassocieerd zijn met succesvol ouder worden bij oudere mannen. Geselecteerde aspecten 
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van het 'succesvol ouder worden" model van Rowe en Kahn werden onderzocht. Ondanks 
. verschillende associaties bij bivariate analyse. was bij multivariate analyse de 
gezondheidsgerelateerde kwaliteit van leven (welke gemeten werd middels de EuroQol 
EQ-5D vragenlijst bestaande uit 5 dimensies: mobiliteit, zelfverzorging, dagelijkse 
activiteiten, pijnlongemak en angstJdepressie) aileen geassocieerd met het aantal 
problemen in activiteiten van het dagelijks leven (ADL) en eenzaamheid. Problemen in 
ADL en eenzaamheid waren beide invers geassocieerd met fysieke prestatie. Oak serum 
IGFBP-3 concentraties, welke de groeihormoon bioactiviteit reflecteren. en testosteron 
concentraties waren beide sterk gerelateerd aan een betere kwaliteit van leven gemeten 
met de EuroQol. 
3) Omdat serum hormoon concentraties met name gebonden zijn aan hun specifieke 
transport eiwitten en albumine, moest nag worden vastgesteld of de vrije hormoon 
fractie de beste weerspiegeling is van de bioactieve hormoon concentraties. Niet-SHBG-
gebonden en vrij testosteron en oestradiol werden berekend volgens een methode welke 
is beschreven door SOderg&rd. In hoofdstuk 3 wordt aangetoond dat niet-SHBG-
gebonden en vrij testosteron sterker gerelateerd waren aan spierkracht, botdichtheid en 
vetmassa dan totaal testosteron en dat zij oak gerelateerd waren aan heup botdichtheid. 
terwijl totaal testosteron dat niet was. Niet-SHBG-gebonden testosteron lijkt de beste 
parameter voor de bioactieve testosteron concentratie, en lijkt een directe rol te spelen 
bij verschillende fysiologische veranderingen tijdens veroudering. Niet-SHBG-gebonden 
oestradiol was iets sterker gerelateerd aan botdichtheid dan totaal oestradiol. Daarom 
lijkt niet-SHBG-gebonden oestradiol de beste parameter voor de bioactieve oestradiol 
concentratie in het beschrijven van de relatie met botdichtheid. 
4) Recent is een variant van het lutelniserend hormoon (LH) gevonden in 
ogenschijnlijk gezonde individuen. veroorzaakt door substitutie van twee aminozuren 
(TrpSArg and Ilel5Thr) ten gevolge van puntmutaties in de LH~ subunit. Aangezien de 
in vivo bioactiviteit van deze LH variant mogelijk lager is dan die van het wild-type, 
hebben we in hoofdstuk 4 bepaald of de verschillende LH varianten gerelateerd waren 
aan de kenmerken van het fysieke functionele vermogen. 12.5% van de studie populatie 
was heterozygoot voor het LH variant allel. LH concentraties in de hele populatie waren 
invers gerelateerd aan spierkracht en spiermassa en beide relaties waren onafhankelijk 
van testosteron. LH was positief gerelateerd aan het aantal problemen in activiteiten 
van het dagelijks leven. LH weerspiegelt mogelijk de serum androgeen activiteit op een 
andere wijze dan testosteron. waarbij de LH concentratie wellicht het gezamenlijke 
terugkoppelingseffect van androgenen en oestrogenen reflecteert. Testosteron 
concentraties en de mate van frag:iliteit waren niet verschillend tussen de wild-type 
groep en de heterozygote LH variant groep. Echter, omdat een relatief hoog aantal van 
de mannen die heterozygoot waren voor het LH variant allel. hoge LH en lage 
testosteron concentraties hadden. zouden de twee vormen van LH kunnen verschillen in 
hun biologische respons. in het voordeel van het wild-type LH. 
5) Omdat atherosclerose tijdens veroudering een belangrijke oorzaak is van 
cardiovasculaire morbiditeit en mortaliteit. en omdat veranderingen in endocriene 
systemen het atherosclerotische proces zouden kunnen bei:nvloeden. werden in 
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hoofdstuk 6 de relaties tussen hormoon concentraties en maten van atherosclerose 
bepaald. Serum testosteron. oestron. en vrij IGF-I waren invers gerelateerd aan de 
intima-media dikte van de arteria carotis. ook na correctie voor leeftijd en B:Nil. Met 
name het vrije IGF-I i.p.v. het gebonden IGF-I. was onafhankelijk gerelateerd aan de 
intima-media dikte van de carotis bifurcatie. wat suggereert dat de vTije IGF-I fractie 
mogelijk anti-atherogene effecten heeft op de bloedvatwand. Serum oestradioL DHEA(S). 
IGFBP-1. -2 en -3 en leptine waren niet geassocieerd met parameters van atherosclerose. 
6) Het is reeds aangetoond dat C-reactive protein (CRP) and interleukine-6 (IL-6) 
concentraties een ontstekingsreactie weerspiegelen en dat zij beide voorspellend zijn 
voor mortaliteit in een gezonde. niet gelnvalideerde populatie met en zonder 
cardiovasculaire ziekte. Zoals beschreven in hoofdstuk 9. waren ook in onze populatie 
hoge CRP en IL-6 concentraties gerelateerd aan mortaliteit. Lage IL-6 en CRP 
concentraties binnen de normaal waarden zouden daarom bij ouderen kunnen wijzen op 
de afwezigheid van (subklinische) ziekte. 
Om iemands individuele conditie te beoordelen en om diegenen te selecteren die 
mogelijk baat kunnen hebben bij interventie therapie. is het wenselijk over parameters 
te beschikken die mortaliteit of overleving voorspellen. In hoofdstuk 9 wordt. 
behoudens de bekende condities zoals roken. ziekte en atherosclerose. het relatieve 
belang van een scala aan potentii:He fysieke. endocriene en inflammatoire voorspellers 
van mortaliteit besproken. Een lage fysieke prestatie. spierkracht en botdichtheid. hoge 
serum IGFBP-1. vrij T4 en totaal T3 concentraties waren allen voorspellend voor een 
verhoogd risico op overlijden. Ook lage albumine en hoge CRP en IL-6 concentraties 
waren geassocieerd met een verhoogde mortaliteit. Met de zeven meest significante 
voorspellers kon van 78% van de mannen de mortaliteit na vier jaar correct voorspeld 
worden. 
7) Ten slotte. in de discussie zoals beschreven in hoofdstuk 10. werd getracht om 
aile resultaten van dit proefschrift te integreren in het concept van succesvol ouder 
worden. De definitie van succesvol ouder worden zoals beschreven door Rowe werd als 
uitgangspunt genomen om meer inzicht te verkrijgen in de verschillende aspecten die 
belangrijk zijn voor het succesvol ouder worden. Rowe ontwikkelde een concept van 
succesvol ouder worden met 'het behoud van een goed cognitief en fysiek functioneel 
vermogen'. 'het vermijden van ziekte en handicap', en 'het behoud van een actieve 
betrokkenheid met het leven' als belangrijkste determinanten. Echter voor een 
individuele beoordeling van succesvol ouder worden zijn adequate. reproduceerbare en 
indien mogelijk voorspellende maten nodig. Daarom was een van de doelen van onze 
studie om parameters te vinden die betrouwbaar de drie verschillende onderdelen van 
het model van Rowe reflecteren. Om succesvol ouder worden in zijn algemeenheid te 
me ten hebben we twee parameters genomen: kwaliteit van leven en overleving. 
Het behouden van een goede cognitieve en fysieke functie is een van de clrie 
onderdelen van het model. In deze populatie was de cognitie relatief goed omdat de 
meeste mannen een hoge score behaalden bij de 'Mini-Mental State Examination'. Met 
betrekking tot de beoordeling van het fysieke functionele vermogen suggereren we dat 
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het voldoende zou kunnen zijn om de fysieke prestatie middels de methode van Guralnik 
en de spierkracht te meten. 
Het vermijden van ziekte en handicap is het tweede deel van het model van Rowe. In 
deze populatie hadden mannen met bepaalde ziekten een lager fysiek vermogen, zowel 
subjectief als objectief gemeten. Dit toont deels de correctheid van het model aan. Tevens 
suggereren we dat (subklinische) atherosclerose ook een aspect van d.it deel van het 
model is. 
Ten slotte. het behoud van een actieve betrokkenheid bij het leven is het derde deel 
van het model van Rowe. Fysieke prestatie en eenzaamheid waren negatief aan elkaar 
gerelateerd. wat de overlap tussen ·fysiek functioneel vermogen· en het 'betrokkenheid 
met het leven' deels aantoont. Bovend.ien hadden mannen die eenzaam waren een 
mindere kwaliteit van leven. 
De meeste aspecten van de verschillende onderdelen van het model waren gerelateerd 
met kwaliteit van leven en overleving of mortaliteit. Dit toont het gecombineerde deel 
van de drie onderdelen van het model aan. 
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